<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>1600</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="1600"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=1600&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=1500&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=1700&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927944422"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927944422?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927944422&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927944422&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0005272815000602"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927944422</prism:url><dc:identifier>SCOPUS_ID:84927944422</dc:identifier><eid>2-s2.0-84927944422</eid><dc:title>Respective effects of oxygen and energy substrate deprivation on beta cell viability</dc:title><dc:creator>Lablanche S.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Bioenergetics</prism:publicationName><prism:issn>00052728</prism:issn><prism:eIssn>18792650</prism:eIssn><prism:volume>1847</prism:volume><prism:issueIdentifier>6-7</prism:issueIdentifier><prism:pageRange>629-639</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbabio.2015.04.002</prism:doi><pii>S0005272815000602</pii><dc:description>© 2015 Elsevier B.V. Deficit in oxygen and energetic substrates delivery is a key factor in islet loss during islet transplantation. Permeability transition pore (PTP) is a mitochondrial channel involved in cell death. We have studied the respective effects of oxygen and energy substrate deprivation on beta cell viability as well as the involvement of oxidative stress and PTP opening. Energy substrate deprivation for 1 h followed by incubation in normal conditions led to a cyclosporin A (CsA)-sensitive-PTP-opening in INS-1 cells and human islets. Such a procedure dramatically decreased INS-1 cells viability except when transient removal of energy substrates was performed in anoxia, in the presence of antioxidant N-acetylcysteine (NAC) or when CsA or metformin inhibited PTP opening. Superoxide production increased during removal of energy substrates and increased again when normal energy substrates were restored. NAC, anoxia or metformin prevented the two phases of oxidative stress while CsA prevented the second one only. Hypoxia or anoxia alone did not induce oxidative stress, PTP opening or cell death. In conclusion, energy substrate deprivation leads to an oxidative stress followed by PTP opening, triggering beta cell death. Pharmacological prevention of PTP opening during islet transplantation may be a suitable option to improve islet survival and graft success.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104653</affiliation-url><afid>60104653</afid><affilname>Universite Grenoble Alpes</affilname><name-variant>Univ. Grenoble Alpes</name-variant><affiliation-city>Grenoble</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005851</affiliation-url><afid>60005851</afid><affilname>Centre Hospitalier Universitaire de Grenoble</affilname><name-variant>CHU</name-variant><affiliation-city>Grenoble</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005851</affiliation-url><afid>60005851</afid><affilname>Centre Hospitalier Universitaire de Grenoble</affilname><name-variant>CHU</name-variant><affiliation-city>Grenoble</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004718</affiliation-url><afid>60004718</afid><affilname>Universite de Geneve</affilname><name-variant>Université de Genève</name-variant><affiliation-city>Geneve</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35740749800</author-url><authid>35740749800</authid><authname>Lablanche S.</authname><surname>Lablanche</surname><given-name>Sandrine</given-name><initials>S.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35740749800</author-url><authid>35740749800</authid><authname>Lablanche S.</authname><surname>Lablanche</surname><given-name>Sandrine</given-name><initials>S.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35740749800</author-url><authid>35740749800</authid><authname>Lablanche S.</authname><surname>Lablanche</surname><given-name>Sandrine</given-name><initials>S.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505467444</author-url><authid>6505467444</authid><authname>Cottet-Rousselle C.</authname><surname>Cottet-Rousselle</surname><given-name>Cécile</given-name><initials>C.</initials><afid>60104653</afid><afid>60000905</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505467444</author-url><authid>6505467444</authid><authname>Cottet-Rousselle C.</authname><surname>Cottet-Rousselle</surname><given-name>Cécile</given-name><initials>C.</initials><afid>60104653</afid><afid>60000905</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603381362</author-url><authid>6603381362</authid><authname>Argaud L.</authname><surname>Argaud</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60000905</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56596390000</author-url><authid>56596390000</authid><authname>Laporte C.</authname><surname>Laporte</surname><given-name>Camille</given-name><initials>C.</initials><afid>60104653</afid><afid>60000905</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56596390000</author-url><authid>56596390000</authid><authname>Laporte C.</authname><surname>Laporte</surname><given-name>Camille</given-name><initials>C.</initials><afid>60104653</afid><afid>60000905</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007056092</author-url><authid>7007056092</authid><authname>Lamarche F.</authname><surname>Lamarche</surname><given-name>Frédéric</given-name><initials>F.</initials><afid>60104653</afid><afid>60000905</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007056092</author-url><authid>7007056092</authid><authname>Lamarche F.</authname><surname>Lamarche</surname><given-name>Frédéric</given-name><initials>F.</initials><afid>60104653</afid><afid>60000905</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56596168100</author-url><authid>56596168100</authid><authname>Richard M.</authname><surname>Richard</surname><given-name>Marie Jeanne</given-name><initials>M.J.</initials><afid>60005851</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006117804</author-url><authid>7006117804</authid><authname>Berney T.</authname><surname>Berney</surname><given-name>Thierry</given-name><initials>T.</initials><afid>60004718</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006618685</author-url><authid>7006618685</authid><authname>Benhamou P.</authname><surname>Benhamou</surname><given-name>Pierre Yves</given-name><initials>P.Y.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006618685</author-url><authid>7006618685</authid><authname>Benhamou P.</authname><surname>Benhamou</surname><given-name>Pierre Yves</given-name><initials>P.Y.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006618685</author-url><authid>7006618685</authid><authname>Benhamou P.</authname><surname>Benhamou</surname><given-name>Pierre Yves</given-name><initials>P.Y.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7007029277</author-url><authid>7007029277</authid><authname>Fontaine E.</authname><surname>Fontaine</surname><given-name>Eric</given-name><initials>E.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7007029277</author-url><authid>7007029277</authid><authname>Fontaine E.</authname><surname>Fontaine</surname><given-name>Eric</given-name><initials>E.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7007029277</author-url><authid>7007029277</authid><authname>Fontaine E.</authname><surname>Fontaine</surname><given-name>Eric</given-name><initials>E.</initials><afid>60104653</afid><afid>60000905</afid><afid>60005851</afid></author><authkeywords>Apoptosis | Beta cell | Ischemia-reperfusion injury | Permeability transition</authkeywords><intid>1535701226</intid><source-id>16791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923343417"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923343417?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923343417&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923343417&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1567539414001303"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923343417</prism:url><dc:identifier>SCOPUS_ID:84923343417</dc:identifier><eid>2-s2.0-84923343417</eid><dc:title>Considering effects of nanosecond pulsed electric fields on proteins</dc:title><dc:creator>Beebe S.</dc:creator><prism:publicationName>Bioelectrochemistry</prism:publicationName><prism:issn>15675394</prism:issn><prism:eIssn>1878562X</prism:eIssn><prism:volume>103</prism:volume><prism:pageRange>52-59</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bioelechem.2014.08.014</prism:doi><pii>S1567539414001303</pii><dc:description>© 2014 Elsevier B.V. Most, if not all, effects of intense, pulsed electric fields are analyzed in terms of electrical charging of plasma membranes and/or subcellular membranes. However, not all cell responses from nanosecond pulsed electric fields (nsPEFs) are fully explained by poration of cell membranes. Observations that nsPEFs induce a Ca2-dependent dissipation of the mitochondria membrane potential (δΨm), which is enhanced when high frequency components are present in fast rise-fall waveforms, are not compatible with a poration event. Ca2+ is shown to have little or no effect on propidium iodide uptake as a measure of plasma membrane poration and consequently intracellular membranes. Since most if not all Ca2+-regulated events are mediated by proteins, actions of nsPEFs on a protein(s) that regulate and/or affect the mitochondria membrane potential are possible. To show that nsPEFs can directly affect proteins, nsPEFs non-thermally inactivated the catalytic (phosphotransferase) activity of the catalytic subunit of the cAMP-dependent protein kinase, which is the prototype of the protein kinase superfamily that share a common catalytic mechanism and whose functions are highly dependent on their structure. These studies present indirect and direct evidences that nsPEFs can affect proteins and their functions, at least in part, by affecting their structure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007652</affiliation-url><afid>60007652</afid><affilname>Old Dominion University</affilname><name-variant>Old Dominion University</name-variant><affiliation-city>Norfolk</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004549539</author-url><authid>7004549539</authid><authname>Beebe S.</authname><surname>Beebe</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>60007652</afid></author><authkeywords>Calcium | CAMP-dependent protein kinase | Electric fields | Mitochondria membrane potential | Molecular dynamics</authkeywords><intid>1534960232</intid><source-id>16890</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927130750"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927130750?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927130750&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927130750&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014016700"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927130750</prism:url><dc:identifier>SCOPUS_ID:84927130750</dc:identifier><eid>2-s2.0-84927130750</eid><dc:title>Histone deacetylases and atherosclerosis</dc:title><dc:creator>Zheng X.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>355-366</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.12.048</prism:doi><pii>S0021915014016700</pii><dc:description>© 2015. Atherosclerosis is the most common pathological process that leads to cardiovascular diseases, a disease of large- and medium-sized arteries that is characterized by a formation of atherosclerotic plaques consisting of necrotic cores, calcified regions, accumulated modified lipids, smooth muscle cells (SMCs), endothelial cells, leukocytes, and foam cells. Recently, the question about how to suppress the occurrence of atherosclerosis and alleviate the progress of cardiovascular disease becomes the hot topic. Accumulating evidence suggests that histone deacetylases(HDACs) play crucial roles in arteriosclerosis. This review summarizes the effect of HDACs and HDAC inhibitors(HDACi) on the progress of atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010580</affiliation-url><afid>60010580</afid><affilname>China Three Gorges University</affilname><name-variant>China Three Gorges University</name-variant><affiliation-city>Yichang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010580</affiliation-url><afid>60010580</afid><affilname>China Three Gorges University</affilname><name-variant>China Three Gorges University</name-variant><affiliation-city>Yichang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56587142400</author-url><authid>56587142400</authid><authname>Zheng X.</authname><surname>Zheng</surname><given-name>Xia xia</given-name><initials>X.x.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56587142400</author-url><authid>56587142400</authid><authname>Zheng X.</authname><surname>Zheng</surname><given-name>Xia xia</given-name><initials>X.x.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56587270500</author-url><authid>56587270500</authid><authname>Zhou T.</authname><surname>Zhou</surname><given-name>Tian</given-name><initials>T.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56587270500</author-url><authid>56587270500</authid><authname>Zhou T.</authname><surname>Zhou</surname><given-name>Tian</given-name><initials>T.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56588061200</author-url><authid>56588061200</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xin An</given-name><initials>X.A.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56588061200</author-url><authid>56588061200</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xin An</given-name><initials>X.A.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23471330700</author-url><authid>23471330700</authid><authname>Tong X.</authname><surname>Tong</surname><given-name>Xiao hong</given-name><initials>X.h.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23471330700</author-url><authid>23471330700</authid><authname>Tong X.</authname><surname>Tong</surname><given-name>Xiao hong</given-name><initials>X.h.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:15834068700</author-url><authid>15834068700</authid><authname>Ding J.</authname><surname>Ding</surname><given-name>Jia wang</given-name><initials>J.w.</initials><afid>60010580</afid><afid>60010580</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:15834068700</author-url><authid>15834068700</authid><authname>Ding J.</authname><surname>Ding</surname><given-name>Jia wang</given-name><initials>J.w.</initials><afid>60010580</afid><afid>60010580</afid></author><authkeywords>Endothelial cells | HDACs | Macrophage cells | Plaque | Thrombosis | Vascular smooth muscle cells</authkeywords><intid>35569992</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920173685"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920173685?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920173685&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920173685&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214647414000385"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920173685</prism:url><dc:identifier>SCOPUS_ID:84920173685</dc:identifier><eid>2-s2.0-84920173685</eid><dc:title>Impact of a novel homozygous mutation in nicotinamide nucleotide transhydrogenase on mitochondrial DNA integrity in a case of familial glucocorticoid deficiency</dc:title><dc:creator>Fujisawa Y.</dc:creator><prism:publicationName>BBA Clinical</prism:publicationName><prism:issn>22146474</prism:issn><prism:volume>3</prism:volume><prism:pageRange>70-78</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbacli.2014.12.003</prism:doi><pii>S2214647414000385</pii><dc:description>© 2014. Background: Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disorder that is characterized by isolated glucocorticoid deficiency. Recently, mutations in the gene encoding for the mitochondrial nicotinamide nucleotide transhydrogenase (NNT) have been identified as a causative gene for FGD; however, no NNT activities have been reported in FGD patients carrying NNT mutations. Methods: Clinical, biochemical and molecular analyses of lymphocytes from FDG homozygous and heterozygous carriers for the F215S NNT mutation were performed. Results: In this study, we described an FGD-affected Japanese patient carrying a novel NNT homozygous mutation (c.644T&gt;C; F215S) with a significant loss-of-function (NNT activity. =. 31% of healthy controls) in peripheral blood cells' mitochondria. The NNT activities of the parents, heterozygous for the mutation, were 61% of the controls. Conclusions: Our results indicated that (i) mitochondrial biogenesis (citrate synthase activity) and/or mtDNA replication (mtDNA copy number) were affected at ≤60% NNT activity because these parameters were affected in individuals carrying either one or both mutated alleles; and (ii) other outcomes (mtDNA deletions, protein tyrosine nitration, OXPHOS capacity) were affected at ≤30% NNT activity as also observed in murine cerebellar mitochondria from C57BL/6J (NNT-/-) vs. C57BL/6JN (NNT+/+) substrains. General significance: By studying a family affected with a novel point mutation in the NNT gene, a gene-dose response was found for various mitochondrial outcomes providing for novel insights into the role of NNT in the maintenance of mtDNA integrity beyond that described for preventing oxidative stress.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005684</affiliation-url><afid>60005684</afid><affilname>Hamamatsu University School of Medicine</affilname><name-variant>Hamamatsu University School of Medicine</name-variant><affiliation-city>Hamamatsu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014439</affiliation-url><afid>60014439</afid><affilname>UC Davis</affilname><name-variant>University of California</name-variant><affiliation-city>Davis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107072417</affiliation-url><afid>107072417</afid><affilname>Nagaoka Chuo General Hospital</affilname><name-variant>Nagaoka Chuo General Hospital</name-variant><affiliation-city>Matsumoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027970</affiliation-url><afid>60027970</afid><affilname>Niigata University School of Medicine</affilname><name-variant>Niigata University</name-variant><affiliation-city>Niigata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014439</affiliation-url><afid>60014439</afid><affilname>UC Davis</affilname><name-variant>University of California</name-variant><affiliation-city>Davis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7101833179</author-url><authid>7101833179</authid><authname>Fujisawa Y.</authname><surname>Fujisawa</surname><given-name>Yasuko</given-name><initials>Y.</initials><afid>60005684</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006765052</author-url><authid>7006765052</authid><authname>Napoli E.</authname><surname>Napoli</surname><given-name>Eleonora</given-name><initials>E.</initials><afid>60014439</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36342891000</author-url><authid>36342891000</authid><authname>Wong S.</authname><surname>Wong</surname><given-name>Sarah</given-name><initials>S.</initials><afid>60014439</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56465305600</author-url><authid>56465305600</authid><authname>Song G.</authname><surname>Song</surname><given-name>Gyu</given-name><initials>G.</initials><afid>60014439</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36538422800</author-url><authid>36538422800</authid><authname>Yamaguchi R.</authname><surname>Yamaguchi</surname><given-name>Rie</given-name><initials>R.</initials><afid>60005684</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55808284500</author-url><authid>55808284500</authid><authname>Matsui T.</authname><surname>Matsui</surname><given-name>Toshiharu</given-name><initials>T.</initials><afid>107072417</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55539617000</author-url><authid>55539617000</authid><authname>Nagasaki K.</authname><surname>Nagasaki</surname><given-name>Keisuke</given-name><initials>K.</initials><afid>60027970</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35390869500</author-url><authid>35390869500</authid><authname>Ogata T.</authname><surname>Ogata</surname><given-name>Tsutomu</given-name><initials>T.</initials><afid>60005684</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006419894</author-url><authid>7006419894</authid><authname>Giulivi C.</authname><surname>Giulivi</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60014439</afid><afid>60014439</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006419894</author-url><authid>7006419894</authid><authname>Giulivi C.</authname><surname>Giulivi</surname><given-name>Cecilia</given-name><initials>C.</initials><afid>60014439</afid><afid>60014439</afid></author><authkeywords>Familial glucocorticoid deficiency | Mitochondrial biogenesis | Mitochondrial replication | Nicotinamide nucleotide transhydrogenase | Oxidative phosphorylation | Oxidative stress</authkeywords><intid>1034434246</intid><source-id>21100317907</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923107299"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923107299?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923107299&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923107299&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000409"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923107299</prism:url><dc:identifier>SCOPUS_ID:84923107299</dc:identifier><eid>2-s2.0-84923107299</eid><dc:title>The impact of price reductions on individuals' choice of healthy meals away from home</dc:title><dc:creator>Nordström J.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>103-111</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.01.023</prism:doi><pii>S0195666315000409</pii><dc:description>© 2015 Elsevier Ltd. Food high in energy but low in nutritional value is an important contributor to several serious illnesses, and one type of food that is particularly high in energy but low in nutrition is food consumed away from home. In this paper, we examine the demand and willingness to pay for healthy, Keyhole-labelled meals. A Keyhole-labelled meal is particularly low in energy, fat, sugar and salt, but particularly high in fibre. The results suggest that to get the majority of individuals to choose the healthy option regularly it would be necessary to alter the relative price between healthy and less healthy meals. Generally groups of individuals with a poor nutritional intake require a larger compensation (subsidy) before they choose the healthy alternative. About one third of respondents would choose the healthy option regularly if the prices for a healthy and less healthy meal were the same. In particular groups of individuals who already have a relatively good nutritional intake would select the healthy option. Groups with a generally poor nutritional intake (men and individuals with lower education and lower income) would gain health benefits from a subsidy of Keyhole-labelled meals.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030840</affiliation-url><afid>60030840</afid><affilname>Kobenhavns Universitet</affilname><name-variant>University of Copenhagen</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008827</affiliation-url><afid>60008827</afid><affilname>University of Wyoming</affilname><name-variant>University of Wyoming</name-variant><affiliation-city>Laramie</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8532973700</author-url><authid>8532973700</authid><authname>Nordström J.</authname><surname>Nordström</surname><given-name>Jonas</given-name><initials>J.</initials><afid>60029170</afid><afid>60030840</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8532973700</author-url><authid>8532973700</authid><authname>Nordström J.</authname><surname>Nordström</surname><given-name>Jonas</given-name><initials>J.</initials><afid>60029170</afid><afid>60030840</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24831991400</author-url><authid>24831991400</authid><authname>Thunström L.</authname><surname>Thunström</surname><given-name>Linda</given-name><initials>L.</initials><afid>60008827</afid></author><authkeywords>Food away from home | Food demand | Healthy | Restaurant | Subsidy</authkeywords><intid>1784917321</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923231029"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923231029?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923231029&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923231029&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000537"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923231029</prism:url><dc:identifier>SCOPUS_ID:84923231029</dc:identifier><eid>2-s2.0-84923231029</eid><dc:title>Profiling healthy eaters. Determining factors that predict healthy eating practices among Dutch adults</dc:title><dc:creator>Swan E.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.02.006</prism:doi><pii>S0195666315000537</pii><dc:description>© 2015 Elsevier Ltd. Research has identified multiple factors that predict unhealthy eating practices. However what remains poorly understood are factors that promote healthy eating practices. This study aimed to determine a set of factors that represent a profile of healthy eaters. This research applied Antonovsky's salutogenic framework for health development to examine a set of factors that predict healthy eating in a cross-sectional study of Dutch adults. Data were analyzed from participants (n = 703) who completed the study's survey in January 2013. Logistic regression analysis was performed to test the association of survey factors on the outcome variable high dietary score. In the multivariate logistic regression model, five factors contributed significantly (p &lt; .05) to the predictive ability of the overall model: being female; living with a partner; a strong sense of coherence (construct from the salutogenic framework), flexible restraint of eating, and self-efficacy for healthy eating. Findings complement what is already known of the factors that relate to poor eating practices. This can provide nutrition promotion with a more comprehensive picture of the factors that both support and hinder healthy eating practices. Future research should explore these factors to better understand their origins and mechanisms in relation to healthy eating practices.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002483</affiliation-url><afid>60002483</afid><affilname>University of Amsterdam</affilname><name-variant>University of Amsterdam</name-variant><affiliation-city>Amsterdam</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55089140000</author-url><authid>55089140000</authid><authname>Swan E.</authname><surname>Swan</surname><given-name>Emily</given-name><initials>E.</initials><afid>60004156</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8545527700</author-url><authid>8545527700</authid><authname>Bouwman L.</authname><surname>Bouwman</surname><given-name>Laura</given-name><initials>L.</initials><afid>60004156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603938971</author-url><authid>6603938971</authid><authname>Hiddink G.</authname><surname>Hiddink</surname><given-name>Gerrit Jan</given-name><initials>G.J.</initials><afid>60004156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56524272600</author-url><authid>56524272600</authid><authname>Aarts N.</authname><surname>Aarts</surname><given-name>Noelle</given-name><initials>N.</initials><afid>60004156</afid><afid>60002483</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56524272600</author-url><authid>56524272600</authid><authname>Aarts N.</authname><surname>Aarts</surname><given-name>Noelle</given-name><initials>N.</initials><afid>60004156</afid><afid>60002483</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603482105</author-url><authid>6603482105</authid><authname>Koelen M.</authname><surname>Koelen</surname><given-name>Maria</given-name><initials>M.</initials><afid>60004156</afid></author><authkeywords>Diet | Health promotion | Healthy eating | Nutrition | Salutogenesis | Sense of coherence</authkeywords><intid>34939989</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925967823"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925967823?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925967823&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925967823&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167629615000326"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925967823</prism:url><dc:identifier>SCOPUS_ID:84925967823</dc:identifier><eid>2-s2.0-84925967823</eid><dc:title>Recessions, healthy no more?</dc:title><dc:creator>Ruhm C.</dc:creator><prism:publicationName>Journal of Health Economics</prism:publicationName><prism:issn>01676296</prism:issn><prism:eIssn>18791646</prism:eIssn><prism:volume>42</prism:volume><prism:pageRange>17-28</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jhealeco.2015.03.004</prism:doi><pii>S0167629615000326</pii><dc:description>© 2015 Elsevier B.V. Over the 1976-2010 period, total mortality shifted from strongly procyclical to being weakly or unrelated to macroeconomic conditions. The association is likely to be poorly measured when using short (less than 15 year) analysis periods. Deaths from cardiovascular disease and transport accidents continue to be procyclical; however, countercyclical patterns have emerged for fatalities from cancer mortality and external causes. Among the latter, non-transport accidents, particularly accidental poisonings, play an important role.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020337</affiliation-url><afid>60020337</afid><affilname>National Bureau of Economic Research</affilname><name-variant>NBER</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701734412</author-url><authid>6701734412</authid><authname>Ruhm C.</authname><surname>Ruhm</surname><given-name>Christopher J.</given-name><initials>C.J.</initials><afid>60020337</afid></author><authkeywords>Health | Macroeconomic conditions | Mortality | Recessions</authkeywords><intid>1035383001</intid><source-id>14166</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928658597"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928658597?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928658597&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928658597&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015002294"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928658597</prism:url><dc:identifier>SCOPUS_ID:84928658597</dc:identifier><eid>2-s2.0-84928658597</eid><dc:title>Accurate and reproducible reconstruction of coronary arteries and endothelial shear stress calculation using 3D OCT: Comparative study to 3D IVUS and 3D QCA</dc:title><dc:creator>Toutouzas K.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>510-519</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.011</prism:doi><pii>S0021915015002294</pii><dc:description>© 2015 Elsevier Ireland Ltd. Background: Geometrically-correct 3D OCT is a new imaging modality with the potential to investigate the association of local hemodynamic microenvironment with OCT-derived high-risk features. We aimed to describe the methodology of 3D OCT and investigate the accuracy, inter- and intra-observer agreement of 3D OCT in reconstructing coronary arteries and calculating ESS, using 3D IVUS and 3D QCA as references. Methods-Results: 35 coronary artery segments derived from 30 patients were reconstructed in 3D space using 3D OCT. 3D OCT was validated against 3D IVUS and 3D QCA. The agreement in artery reconstruction among 3D OCT, 3D IVUS and 3D QCA was assessed in 3-mm-long subsegments using lumen morphometry and ESS parameters. The inter- and intra-observer agreement of 3D OCT, 3D IVUS and 3D QCA were assessed in a representative sample of 61 subsegments (n=5 arteries). The data processing times for each reconstruction methodology were also calculated. There was a very high agreement between 3D OCT vs. 3D IVUS and 3D OCT vs. 3D QCA in terms of total reconstructed artery length and volume, as well as in terms of segmental morphometric and ESS metrics with mean differences close to zero and narrow limits of agreement (Bland-Altman analysis). 3D OCT exhibited excellent inter- and intra-observer agreement. The analysis time with 3D OCT was significantly lower compared to 3D IVUS. Conclusions: Geometrically-correct 3D OCT is a feasible, accurate and reproducible 3D reconstruction technique that can perform reliable ESS calculations in coronary arteries.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60067083</affiliation-url><afid>60067083</afid><affilname>University of Athens Medical School</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026834</affiliation-url><afid>60026834</afid><affilname>A.H.E.P.A. Hospital</affilname><name-variant>AHEPA Hospital</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025084</affiliation-url><afid>60025084</afid><affilname>Shanghai Jiaotong University</affilname><name-variant>Shanghai Jiaotong University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114673980</affiliation-url><afid>114673980</afid><affilname>New Tokyo Hospital</affilname><name-variant>New Tokyo Hospital</name-variant><affiliation-city>Chiba</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026208</affiliation-url><afid>60026208</afid><affilname>Center For Research And Technology - Hellas</affilname><name-variant>Centre for Research and Technology Hellas</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015066</affiliation-url><afid>60015066</afid><affilname>Aristotle University of Thessaloniki Medical School</affilname><name-variant>Aristotle University</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026208</affiliation-url><afid>60026208</afid><affilname>Center For Research And Technology - Hellas</affilname><name-variant>Centre for Research and Technology Hellas</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082439</affiliation-url><afid>60082439</afid><affilname>General Hospital of Nikaia Saint Panteleimon</affilname><name-variant>General Hospital of Nikea</name-variant><affiliation-city>Piraeus</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">31</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35408441000</author-url><authid>35408441000</authid><authname>Toutouzas K.</authname><surname>Toutouzas</surname><given-name>Konstantinos</given-name><initials>K.</initials><afid>60067083</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13907765800</author-url><authid>13907765800</authid><authname>Chatzizisis Y.</authname><surname>Chatzizisis</surname><given-name>Yiannis S.</given-name><initials>Y.S.</initials><afid>60016782</afid><afid>60026834</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13907765800</author-url><authid>13907765800</authid><authname>Chatzizisis Y.</authname><surname>Chatzizisis</surname><given-name>Yiannis S.</given-name><initials>Y.S.</initials><afid>60016782</afid><afid>60026834</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35280814100</author-url><authid>35280814100</authid><authname>Riga M.</authname><surname>Riga</surname><given-name>Maria</given-name><initials>M.</initials><afid>60067083</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35975982900</author-url><authid>35975982900</authid><authname>Giannopoulos A.</authname><surname>Giannopoulos</surname><given-name>Andreas</given-name><initials>A.</initials><afid>60026834</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:10641064200</author-url><authid>10641064200</authid><authname>Antoniadis A.</authname><surname>Antoniadis</surname><given-name>Antonios P.</given-name><initials>A.P.</initials><afid>60016782</afid><afid>60026834</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:10641064200</author-url><authid>10641064200</authid><authname>Antoniadis A.</authname><surname>Antoniadis</surname><given-name>Antonios P.</given-name><initials>A.P.</initials><afid>60016782</afid><afid>60026834</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24479856500</author-url><authid>24479856500</authid><authname>Tu S.</authname><surname>Tu</surname><given-name>Shengxian</given-name><initials>S.</initials><afid>60015618</afid><afid>60025084</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24479856500</author-url><authid>24479856500</authid><authname>Tu S.</authname><surname>Tu</surname><given-name>Shengxian</given-name><initials>S.</initials><afid>60015618</afid><afid>60025084</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56609777500</author-url><authid>56609777500</authid><authname>Fujino Y.</authname><surname>Fujino</surname><given-name>Yusuke</given-name><initials>Y.</initials><afid>114673980</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6505862904</author-url><authid>6505862904</authid><authname>Mitsouras D.</authname><surname>Mitsouras</surname><given-name>Dimitrios</given-name><initials>D.</initials><afid>60016782</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:16033143200</author-url><authid>16033143200</authid><authname>Doulaverakis C.</authname><surname>Doulaverakis</surname><given-name>Charalampos</given-name><initials>C.</initials><afid>60026208</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55926177100</author-url><authid>55926177100</authid><authname>Tsampoulatidis I.</authname><surname>Tsampoulatidis</surname><given-name>Ioannis</given-name><initials>I.</initials><afid>60026208</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8948544900</author-url><authid>8948544900</authid><authname>Koutkias V.</authname><surname>Koutkias</surname><given-name>Vassilis G.</given-name><initials>V.G.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8948544900</author-url><authid>8948544900</authid><authname>Koutkias V.</authname><surname>Koutkias</surname><given-name>Vassilis G.</given-name><initials>V.G.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:6602320652</author-url><authid>6602320652</authid><authname>Bouki K.</authname><surname>Bouki</surname><given-name>Konstantina</given-name><initials>K.</initials><afid>60082439</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55770974200</author-url><authid>55770974200</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yingguang</given-name><initials>Y.</initials><afid>60015618</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6603613668</author-url><authid>6603613668</authid><authname>Chouvarda I.</authname><surname>Chouvarda</surname><given-name>Ioanna</given-name><initials>I.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:6603613668</author-url><authid>6603613668</authid><authname>Chouvarda I.</authname><surname>Chouvarda</surname><given-name>Ioanna</given-name><initials>I.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:55978320200</author-url><authid>55978320200</authid><authname>Cheimariotis G.</authname><surname>Cheimariotis</surname><given-name>Grigorios</given-name><initials>G.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:55978320200</author-url><authid>55978320200</authid><authname>Cheimariotis G.</authname><surname>Cheimariotis</surname><given-name>Grigorios</given-name><initials>G.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7005468952</author-url><authid>7005468952</authid><authname>Maglaveras N.</authname><surname>Maglaveras</surname><given-name>Nicos</given-name><initials>N.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:7005468952</author-url><authid>7005468952</authid><authname>Maglaveras N.</authname><surname>Maglaveras</surname><given-name>Nicos</given-name><initials>N.</initials><afid>60015066</afid><afid>60026208</afid></author><author seq="17"><author-url>http://api.elsevier.com/content/author/author_id:7004756014</author-url><authid>7004756014</authid><authname>Kompatsiaris I.</authname><surname>Kompatsiaris</surname><given-name>Ioannis</given-name><initials>I.</initials><afid>60026208</afid></author><author seq="18"><author-url>http://api.elsevier.com/content/author/author_id:56609552100</author-url><authid>56609552100</authid><authname>Nakamura S.</authname><surname>Nakamura</surname><given-name>Sunao</given-name><initials>S.</initials><afid>114673980</afid></author><author seq="19"><author-url>http://api.elsevier.com/content/author/author_id:36044511200</author-url><authid>36044511200</authid><authname>Reiber J.</authname><surname>Reiber</surname><given-name>Johan H C</given-name><initials>J.H.C.</initials><afid>60015618</afid></author><author seq="20"><author-url>http://api.elsevier.com/content/author/author_id:56638728500</author-url><authid>56638728500</authid><authname>Rybicki F.</authname><surname>Rybicki</surname><given-name>Frank</given-name><initials>F.</initials><afid>60016782</afid></author><author seq="21"><author-url>http://api.elsevier.com/content/author/author_id:6701769279</author-url><authid>6701769279</authid><authname>Karvounis H.</authname><surname>Karvounis</surname><given-name>Haralambos</given-name><initials>H.</initials><afid>60026834</afid></author><author seq="22"><author-url>http://api.elsevier.com/content/author/author_id:36045489100</author-url><authid>36045489100</authid><authname>Stefanadis C.</authname><surname>Stefanadis</surname><given-name>Christodoulos</given-name><initials>C.</initials><afid>60067083</afid></author><author seq="23"><author-url>http://api.elsevier.com/content/author/author_id:55873309000</author-url><authid>55873309000</authid><authname>Tousoulis D.</authname><surname>Tousoulis</surname><given-name>Dimitris</given-name><initials>D.</initials><afid>60067083</afid></author><author seq="24"><author-url>http://api.elsevier.com/content/author/author_id:56254126200</author-url><authid>56254126200</authid><authname>Giannoglou G.</authname><surname>Giannoglou</surname><given-name>George D.</given-name><initials>G.D.</initials><afid>60026834</afid></author><authkeywords>Intravascular Ultrasound | Method comparison study | Optical Coherence Tomography | Quantitative Coronary Angiography | Shear Stress</authkeywords><intid>535824640</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929172152"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929172152?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929172152&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929172152&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929172152</prism:url><dc:identifier>SCOPUS_ID:84929172152</dc:identifier><eid>2-s2.0-84929172152</eid><dc:title>Asthma in the elderly</dc:title><dc:creator>Zein J.</dc:creator><prism:publicationName>Current Geriatrics Reports</prism:publicationName><prism:eIssn>21967865</prism:eIssn><prism:volume>4</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>174-182</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s13670-015-0124-y</prism:doi><dc:description>© 2015 Springer Science+Business Media New York. Asthma is more prevalent and more severe in older individuals. Here, we review the literature on asthma in the elderly, with special focus on the pathophysiologic and immunologic mechanisms, healthcare utilization, the role of menopause and obesity, and the impact of chronic asthma on biological aging. Aging of the lung is characterized by constant decline in lung function, which is accelerated by occupational or tobacco exposure and pollution that may contribute to new onset asthma or greater severity of asthma in the elderly. Gender and sex hormones are critical determinants of asthma severity, such that perimenopausal women have more severe asthma, but postmenopausal women are protected from asthma. Immunosenescence places older adults at risk for infections, which may lead to airway hyper-reactivity and asthma exacerbations. Furthermore, the chronic low-level inflammatory state of aging is associated with decreased function of regulatory T (Treg) cells, which are important to resolve inflammation. The rate of obesity increases with age, and obesity independently places individuals at higher risk for asthma. Recent provocative studies suggest that asthma is characterized by accelerated molecular aging as defined by shorter leukocyte telomere lengths. Overall, older asthmatics suffer from greater morbidity, mortality, and healthcare utilization. More studies of the older asthmatic are needed to understand mechanisms and identify times for intervention to improve asthma control and outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021160</affiliation-url><afid>60021160</afid><affilname>Cleveland Clinic Foundation</affilname><name-variant>Cleveland Clinic Foundation</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021160</affiliation-url><afid>60021160</afid><affilname>Cleveland Clinic Foundation</affilname><name-variant>Cleveland Clinic Foundation</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9734318000</author-url><authid>9734318000</authid><authname>Zein J.</authname><surname>Zein</surname><given-name>Joe G.</given-name><initials>J.G.</initials><afid>60021160</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005108319</author-url><authid>7005108319</authid><authname>Erzurum S.</authname><surname>Erzurum</surname><given-name>Serpil C.</given-name><initials>S.C.</initials><afid>60021160</afid><afid>60021160</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005108319</author-url><authid>7005108319</authid><authname>Erzurum S.</authname><surname>Erzurum</surname><given-name>Serpil C.</given-name><initials>S.C.</initials><afid>60021160</afid><afid>60021160</afid></author><authkeywords>Aging | Asthma | Cost | Elderly | Genetic | Healthcare | Immunosenescence | Menopause | Molecular | Obesity</authkeywords><intid>2035912294</intid><source-id>21100358312</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928019791"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928019791?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928019791&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928019791&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015002373"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928019791</prism:url><dc:identifier>SCOPUS_ID:84928019791</dc:identifier><eid>2-s2.0-84928019791</eid><dc:title>Genetic variants in LEKR1 and GALNT10 modulate sex-difference in carotid intima-media thickness: A genome-wide interaction study</dc:title><dc:creator>Dong C.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>462-467</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.019</prism:doi><pii>S0021915015002373</pii><dc:description>© 2015 Elsevier Ireland Ltd. Background: There is an established sex-difference in carotid artery intima-media thickness (cIMT), a recognized marker of subclinical atherosclerosis. However, the genetic underpinnings of sex-differences in gene-IMT associations are largely unknown. Methods: With a multistage design using 731,037 single nucleotide polymorphisms (SNP), a genome wide interaction study was performed in a discovery sample of 931 unrelated Hispanics, followed by replication in 153 non-Hispanic whites and 257 non-Hispanic blacks. Assuming an additive genetic model, we tested for sex-SNP interactions on cIMT using regression analysis. Results: We did not identify any genome-wide significant SNPs but identified 14 loci with suggestive significance. Specifically, SNP-by-sex interaction was found for rs7616559 within LEKR1 gene (P=3.5E-06 in Hispanic discovery sample, P=0.018 in White, and P=1.3E-06 in combined analysis) and for rs2081015 located within GALNT10 gene (P=4.5E-06 in Hispanic discovery sample, P=0.042 in Blacks, and P=5.3E-07 in combined analysis). For rs7616559 within LEKR1, men had greater cIMT than women in G allele carriers (beta±SE: 0.044±0.007, P=4.2E-09 in AG carriers; beta±SE: 0.064±0.007, P=6.2E-05 in GG carriers). For rs2081015 within GALNT10, men had greater cIMT than women in C allele carriers (beta±SE: 0.022±0.007, P=0.002 in CT carriers; beta±SE: 0.051±0.008, P=3.1E-10 in CC carriers). Conclusions: Our genome-wide interaction analysis reveals multiple loci that may modulate sex difference in cIMT. Of them, genetic variants on LEKR1 and GALNT10 genes have been associated with control of adiposity and weight. Given the consistent findings across different-ethnic groups, further studies are warranted to perform investigations of functional genetic variants in these regions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029251</affiliation-url><afid>60029251</afid><affilname>University of Miami</affilname><name-variant>University of Miami</name-variant><affiliation-city>Coral Gables</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027509</affiliation-url><afid>60027509</afid><affilname>Universita degli Studi di Roma Tor Vergata</affilname><name-variant>University of Rome Tor Vergata</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103767</affiliation-url><afid>60103767</afid><affilname>IRCCS San Raffaele Pisana</affilname><name-variant>IRCCS San Raffaele Pisana</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24470893200</author-url><authid>24470893200</authid><authname>Dong C.</authname><surname>Dong</surname><given-name>Chuanhui</given-name><initials>C.</initials><afid>60029251</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23008189700</author-url><authid>23008189700</authid><authname>Della-Morte D.</authname><surname>Della-Morte</surname><given-name>David</given-name><initials>D.</initials><afid>60029251</afid><afid>60027509</afid><afid>60103767</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23008189700</author-url><authid>23008189700</authid><authname>Della-Morte D.</authname><surname>Della-Morte</surname><given-name>David</given-name><initials>D.</initials><afid>60029251</afid><afid>60027509</afid><afid>60103767</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23008189700</author-url><authid>23008189700</authid><authname>Della-Morte D.</authname><surname>Della-Morte</surname><given-name>David</given-name><initials>D.</initials><afid>60029251</afid><afid>60027509</afid><afid>60103767</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:26867496800</author-url><authid>26867496800</authid><authname>Beecham A.</authname><surname>Beecham</surname><given-name>Ashley</given-name><initials>A.</initials><afid>60029251</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56469897600</author-url><authid>56469897600</authid><authname>Wang L.</authname><surname>Wang</surname><given-name>Liyong</given-name><initials>L.</initials><afid>60029251</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:23024259800</author-url><authid>23024259800</authid><authname>Cabral D.</authname><surname>Cabral</surname><given-name>Digna</given-name><initials>D.</initials><afid>60029251</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56584895600</author-url><authid>56584895600</authid><authname>Blanton S.</authname><surname>Blanton</surname><given-name>Susan H.</given-name><initials>S.H.</initials><afid>60029251</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101699499</author-url><authid>7101699499</authid><authname>Sacco R.</authname><surname>Sacco</surname><given-name>Ralph L.</given-name><initials>R.L.</initials><afid>60029251</afid><afid>60029251</afid><afid>60029251</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101699499</author-url><authid>7101699499</authid><authname>Sacco R.</authname><surname>Sacco</surname><given-name>Ralph L.</given-name><initials>R.L.</initials><afid>60029251</afid><afid>60029251</afid><afid>60029251</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7101699499</author-url><authid>7101699499</authid><authname>Sacco R.</authname><surname>Sacco</surname><given-name>Ralph L.</given-name><initials>R.L.</initials><afid>60029251</afid><afid>60029251</afid><afid>60029251</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004124868</author-url><authid>7004124868</authid><authname>Rundek T.</authname><surname>Rundek</surname><given-name>Tatjana</given-name><initials>T.</initials><afid>60029251</afid><afid>60029251</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004124868</author-url><authid>7004124868</authid><authname>Rundek T.</authname><surname>Rundek</surname><given-name>Tatjana</given-name><initials>T.</initials><afid>60029251</afid><afid>60029251</afid></author><authkeywords>Atherosclerosis | Carotid intima-media thickness | Carotid ultrasonography | Race-ethnicities | Sex-gene interaction</authkeywords><intid>2035710924</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924587806"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924587806?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924587806&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924587806&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115000569"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924587806</prism:url><dc:identifier>SCOPUS_ID:84924587806</dc:identifier><eid>2-s2.0-84924587806</eid><dc:title>Critical buckling pressure in mouse carotid arteries with altered elastic fibers</dc:title><dc:creator>Luetkemeyer C.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>46</prism:volume><prism:pageRange>69-82</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.02.013</prism:doi><pii>S1751616115000569</pii><dc:description>© 2015 Elsevier Ltd. Arteries can buckle axially under applied critical buckling pressure due to a mechanical instability. Buckling can cause arterial tortuosity leading to flow irregularities and stroke. Genetic mutations in elastic fiber proteins are associated with arterial tortuosity in humans and mice, and may be the result of alterations in critical buckling pressure. Hence, the objective of this study is to investigate how genetic defects in elastic fibers affect buckling pressure. We use mouse models of human disease with reduced amounts of elastin (. Eln+/-) and with defects in elastic fiber assembly due to the absence of fibulin-5 (. Fbln5-/-). We find that Eln+/- arteries have reduced buckling pressure compared to their wild-type controls. Fbln5-/- arteries have similar buckling pressure to wild-type at low axial stretch, but increased buckling pressure at high stretch. We fit material parameters to mechanical test data for Eln+/-, Fbln5-/- and wild-type arteries using Fung and four-fiber strain energy functions. Fitted parameters are used to predict theoretical buckling pressure based on equilibrium of an inflated, buckled, thick-walled cylinder. In general, the theoretical predictions underestimate the buckling pressure at low axial stretch and overestimate the buckling pressure at high stretch. The theoretical predictions with both models replicate the increased buckling pressure at high stretch for Fbln5-/- arteries, but the four-fiber model predictions best match the experimental trends in buckling pressure changes with axial stretch. This study provides experimental and theoretical methods for further investigating the influence of genetic mutations in elastic fibers on buckling behavior and the development of arterial tortuosity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028590</affiliation-url><afid>60028590</afid><affilname>St. Louis University</affilname><name-variant>St. Louis University</name-variant><affiliation-city>St Louis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003212</affiliation-url><afid>60003212</afid><affilname>University of Texas at San Antonio</affilname><name-variant>University of Texas at San Antonio</name-variant><affiliation-city>San Antonio</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010261</affiliation-url><afid>60010261</afid><affilname>Washington University in St. Louis</affilname><name-variant>Washington University in St. Louis</name-variant><affiliation-city>St Louis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56545655600</author-url><authid>56545655600</authid><authname>Luetkemeyer C.</authname><surname>Luetkemeyer</surname><given-name>Callan M.</given-name><initials>C.M.</initials><afid>60028590</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56545025100</author-url><authid>56545025100</authid><authname>James R.</authname><surname>James</surname><given-name>Rhys H.</given-name><initials>R.H.</initials><afid>60028590</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56545466500</author-url><authid>56545466500</authid><authname>Devarakonda S.</authname><surname>Devarakonda</surname><given-name>Siva Teja</given-name><initials>S.T.</initials><afid>60028590</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:42161752200</author-url><authid>42161752200</authid><authname>Le V.</authname><surname>Le</surname><given-name>Victoria P.</given-name><initials>V.P.</initials><afid>60028590</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56544796500</author-url><authid>56544796500</authid><authname>Liu Q.</authname><surname>Liu</surname><given-name>Qin</given-name><initials>Q.</initials><afid>60003212</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:22034218500</author-url><authid>22034218500</authid><authname>Han H.</authname><surname>Han</surname><given-name>Hai Chao</given-name><initials>H.C.</initials><afid>60003212</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6506993650</author-url><authid>6506993650</authid><authname>Wagenseil J.</authname><surname>Wagenseil</surname><given-name>Jessica E.</given-name><initials>J.E.</initials><afid>60010261</afid></author><authkeywords>Elastin | Fibulin-5 | Mechanics | Tortuosity</authkeywords><intid>1785170112</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927662649"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927662649?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927662649&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927662649&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0969996115000960"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927662649</prism:url><dc:identifier>SCOPUS_ID:84927662649</dc:identifier><eid>2-s2.0-84927662649</eid><dc:title>Targeting P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptor for the treatment of central post-stroke pain in a rodent model</dc:title><dc:creator>Kuan Y.</dc:creator><prism:publicationName>Neurobiology of Disease</prism:publicationName><prism:issn>09699961</prism:issn><prism:eIssn>1095953X</prism:eIssn><prism:volume>78</prism:volume><prism:pageRange>134-145</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.nbd.2015.02.028</prism:doi><pii>S0969996115000960</pii><dc:description>© 2015 Elsevier Inc. Stroke is a leading cause of death and disability in industrialized countries. Approximately 8-14% of stroke survivors suffer from central post-stroke pain (CPSP) when hemorrhagic stroke occurs in lateral thalamic regions, which severely affects their quality of life. Because the mechanisms of CPSP are not well understood, effective treatments have not been developed. In the present study, we tested the hypothesis that persistent CPSP is caused by P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptor activation after brain tissue damage and subsequent elevations in inflammatory cytokines. A thalamic hemorrhagic rat model was used, characterized by thermal and mechanical allodynia that develops in the subacute to chronic phases upon CPSP onset. We found a significant increase in P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; expression in reactive microglia/macrophages in thalamic peri-lesion tissues at 5weeks post-hemorrhage. Thalamic P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptors were directly involved in pain transmission and hypersensitivity. The systemic targeting of P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptors during the acute stage of hemorrhage rescued abnormal pain behaviors and neuronal activity in the thalamocingulate pathway by reducing reactive microglia/macrophage aggregation and associated inflammatory cytokines. After CPSP onset, the targeting of interleukin-1β reversed abnormal pain sensitivity. The aberrant spontaneous thalamocortical oscillations in rats with CPSP were modulated by blocking P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptors. Taken together, our results suggest that targeting P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; may be bi-effective in the treatment of CPSP, as both a pain blocker and immunosuppressant that inhibits inflammatory damage to brain tissue. P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptors may serve as a potential target to prevent the occurrence of CPSP and may be beneficial for the recovery of patients from stroke.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027614</affiliation-url><afid>60027614</afid><affilname>Institute of Biomedical Sciences Academia Sinica Taiwan</affilname><name-variant>Academia Sinica</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073385</affiliation-url><afid>60073385</afid><affilname>National Taiwan University Hospital</affilname><name-variant>National Taiwan University Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56592149900</author-url><authid>56592149900</authid><authname>Kuan Y.</authname><surname>Kuan</surname><given-name>Yung Hui</given-name><initials>Y.H.</initials><afid>60027614</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56591583200</author-url><authid>56591583200</authid><authname>Shih H.</authname><surname>Shih</surname><given-name>Hsi Chien</given-name><initials>H.C.</initials><afid>60027614</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591100800</author-url><authid>56591100800</authid><authname>Tang S.</authname><surname>Tang</surname><given-name>Sung Chun</given-name><initials>S.C.</initials><afid>60073385</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56591779700</author-url><authid>56591779700</authid><authname>Jeng J.</authname><surname>Jeng</surname><given-name>Jiann Shing</given-name><initials>J.S.</initials><afid>60073385</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004018133</author-url><authid>7004018133</authid><authname>Shyu B.</authname><surname>Shyu</surname><given-name>Bai Chuang</given-name><initials>B.C.</initials><afid>60027614</afid></author><authkeywords>Anterior cingulate cortex | Central pain | Medial thalamus | P&lt;inf&gt;2&lt;/inf&gt;X&lt;inf&gt;7&lt;/inf&gt; receptor | Stroke</authkeywords><intid>1535646009</intid><source-id>17466</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926470664"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926470664?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926470664&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926470664&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000362"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926470664</prism:url><dc:identifier>SCOPUS_ID:84926470664</dc:identifier><eid>2-s2.0-84926470664</eid><dc:title>Chemotherapeutic potential of diazeniumdiolate-based aspirin prodrugs in breast cancer</dc:title><dc:creator>Basudhar D.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>101-114</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.01.029</prism:doi><pii>S0891584915000362</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Diazeniumdiolate-based aspirin prodrugs have previously been shown to retain the anti-inflammatory properties of aspirin while protecting against the common side effect of stomach ulceration. Initial analysis of two new prodrugs of aspirin that also release either nitroxyl (HNO) or nitric oxide (NO) demonstrated increased cytotoxicity toward human lung carcinoma cells compared to either aspirin or the parent nitrogen oxide donor. In addition, cytotoxicity was significantly lower in endothelial cells, suggesting cancer-specific sensitivity. To assess the chemotherapeutic potential of these new prodrugs in treatment of breast cancer, we studied their effect both in cultured cells and in a nude mouse model. Both prodrugs reduced growth of breast adenocarcinoma cells more effectively than the parent compounds while not being appreciably cytotoxic in a related nontumorigenic cell line (MCF-10A). The HNO donor also was more cytotoxic than the related NO donor. The basis for the observed specificity was investigated in terms of impact on metabolism, DNA damage and repair, apoptosis, angiogenesis and metastasis. The results suggest a significant pharmacological potential for treatment of breast cancer.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010065</affiliation-url><afid>60010065</afid><affilname>University of Arizona</affilname><name-variant>University of Arizona</name-variant><affiliation-city>Tucson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006577</affiliation-url><afid>60006577</afid><affilname>National Institutes of Health, Bethesda</affilname><name-variant>National Institute of Health</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26656572800</author-url><authid>26656572800</authid><authname>Basudhar D.</authname><surname>Basudhar</surname><given-name>Debashree</given-name><initials>D.</initials><afid>60010065</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56583388400</author-url><authid>56583388400</authid><authname>Cheng R.</authname><surname>Cheng</surname><given-name>Robert C.</given-name><initials>R.C.</initials><afid>60006577</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55917390200</author-url><authid>55917390200</authid><authname>Bharadwaj G.</authname><surname>Bharadwaj</surname><given-name>Gaurav</given-name><initials>G.</initials><afid>60010065</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6601999320</author-url><authid>6601999320</authid><authname>Ridnour L.</authname><surname>Ridnour</surname><given-name>Lisa A.</given-name><initials>L.A.</initials><afid>60006577</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7007069640</author-url><authid>7007069640</authid><authname>Wink D.</authname><surname>Wink</surname><given-name>David A.</given-name><initials>D.A.</initials><afid>60006577</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56584867300</author-url><authid>56584867300</authid><authname>Miranda K.</authname><surname>Miranda</surname><given-name>Katrina M.</given-name><initials>K.M.</initials><afid>60010065</afid></author><authkeywords>Anti-inflammatory | Anticancer | Aspirin | DEA/NO | Diazeniumdiolate | IPA/NO | Nitroxyl Nitric oxide | NONOate | NSAID</authkeywords><intid>1035449344</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928890866"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928890866?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928890866&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928890866&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928890866</prism:url><dc:identifier>SCOPUS_ID:84928890866</dc:identifier><eid>2-s2.0-84928890866</eid><dc:title>Differential Response to Medical Therapy for Male Lower Urinary Tract Symptoms</dc:title><dc:creator>Bechis S.</dc:creator><prism:publicationName>Current Bladder Dysfunction Reports</prism:publicationName><prism:issn>19317212</prism:issn><prism:eIssn>19317220</prism:eIssn><prism:volume>10</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>177-185</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11884-015-0295-6</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Medical therapy has assumed a critical role in the treatment of male lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction. Targeting both bladder and prostate, these medications provide an effective means to manage LUTS for millions of men. However, significant proportion of men do not respond adequately to medical therapy and go on to surgical treatment of bladder outlet obstruction. In order to provide patients with appropriate therapy, prevent unnecessary exposure to drug side effects, and reduce medical costs, it is important to identify those men in whom medication will not be effective. In this review, we focus on the risk factors that predict failure of the common medical therapies for male LUTS. In addition, we describe recently discovered molecular targets that show promise for treatment of LUTS recalcitrant to conventional therapies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029929</affiliation-url><afid>60029929</afid><affilname>Massachusetts General Hospital</affilname><name-variant>Massachusetts General Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:9237551200</author-url><authid>9237551200</authid><authname>Bechis S.</authname><surname>Bechis</surname><given-name>Seth K.</given-name><initials>S.K.</initials><afid>60029929</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56621563600</author-url><authid>56621563600</authid><authname>Kim M.</authname><surname>Kim</surname><given-name>Michelle M.</given-name><initials>M.M.</initials><afid>60029929</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622692600</author-url><authid>56622692600</authid><authname>Wintner A.</authname><surname>Wintner</surname><given-name>Anton</given-name><initials>A.</initials><afid>60029929</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55363777900</author-url><authid>55363777900</authid><authname>Kreydin E.</authname><surname>Kreydin</surname><given-name>Evgeniy I.</given-name><initials>E.I.</initials><afid>60029929</afid></author><authkeywords>Benign prostatic hyperplasia | Lower urinary tract symptoms | Medical therapy | Personalized medicine | Risk stratification</authkeywords><intid>1785863137</intid><source-id>19600157013</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921966011"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921966011?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921966011&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921966011&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0950329315000105"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921966011</prism:url><dc:identifier>SCOPUS_ID:84921966011</dc:identifier><eid>2-s2.0-84921966011</eid><dc:title>Emotional responses towards food packaging: A joint application of self-report and physiological measures of emotion</dc:title><dc:creator>Liao L.</dc:creator><prism:publicationName>Food Quality and Preference</prism:publicationName><prism:issn>09503293</prism:issn><prism:volume>42</prism:volume><prism:pageRange>48-55</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodqual.2015.01.009</prism:doi><pii>S0950329315000105</pii><dc:description>© 2015 Elsevier Ltd. In this paper we investigate consumers' emotional responses to food packaging. More specifically, we use self-report and physiological measures to jointly assess emotional responses to three typical food packaging elements: colours (low-wavelength vs. high-wavelength), images (positive vs. negative) and typefaces (simple vs. ornate). A sample of 120 participants was exposed to mock package design concepts of chocolate blocks. The results suggest that images generate an emotional response that can be measured by both self-report and physiological measures, whereas colours and typefaces generate emotional response that can only be measured by self-report measures. We propose that a joint application of self-report and physiological measures can lead to richer information and wider interpretation of consumer emotional responses to food packaging elements than using either measure alone.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031846</affiliation-url><afid>60031846</afid><affilname>University of South Australia</affilname><name-variant>University of South Australia</name-variant><affiliation-city>Adelaide</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019578</affiliation-url><afid>60019578</afid><affilname>Monash University</affilname><name-variant>Monash University</name-variant><affiliation-city>Melbourne</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029616</affiliation-url><afid>60029616</afid><affilname>Aarhus Universitet</affilname><name-variant>University of Aarhus</name-variant><affiliation-city>Aarhus</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56498448200</author-url><authid>56498448200</authid><authname>Liao L.</authname><surname>Liao</surname><given-name>Lewis Xinwei</given-name><initials>L.X.</initials><afid>60031846</afid><afid>60019578</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56498448200</author-url><authid>56498448200</authid><authname>Liao L.</authname><surname>Liao</surname><given-name>Lewis Xinwei</given-name><initials>L.X.</initials><afid>60031846</afid><afid>60019578</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24447721400</author-url><authid>24447721400</authid><authname>Corsi A.</authname><surname>Corsi</surname><given-name>Armando Maria</given-name><initials>A.M.</initials><afid>60031846</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:22952682000</author-url><authid>22952682000</authid><authname>Chrysochou P.</authname><surname>Chrysochou</surname><given-name>Polymeros</given-name><initials>P.</initials><afid>60031846</afid><afid>60029616</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:22952682000</author-url><authid>22952682000</authid><authname>Chrysochou P.</authname><surname>Chrysochou</surname><given-name>Polymeros</given-name><initials>P.</initials><afid>60031846</afid><afid>60029616</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9738205600</author-url><authid>9738205600</authid><authname>Lockshin L.</authname><surname>Lockshin</surname><given-name>Larry</given-name><initials>L.</initials><afid>60031846</afid></author><authkeywords>Chocolate | Emotion | Facial electromyography | Food | Packaging | Physiological measures | Self-Assessment Manikin | Skin conductance</authkeywords><intid>2034728652</intid><source-id>23161</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930011520"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930011520?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930011520&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930011520&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214426915000099"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930011520</prism:url><dc:identifier>SCOPUS_ID:84930011520</dc:identifier><eid>2-s2.0-84930011520</eid><dc:title>Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis</dc:title><dc:creator>Beck M.</dc:creator><prism:publicationName>Molecular Genetics and Metabolism Reports</prism:publicationName><prism:eIssn>22144269</prism:eIssn><prism:volume>3</prism:volume><prism:pageRange>21-27</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ymgmr.2015.02.002</prism:doi><pii>S2214426915000099</pii><dc:description>© 2015 The Authors. Published by Elsevier Inc. Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. Data were extracted from FOS, a Shire-sponsored database, for comparison with data from three published studies. Outcomes evaluated were the annualized rate of change in estimated glomerular filtration rate (eGFR) and left ventricular mass indexed to height (LVMI) as well as time to and ages at a composite morbidity endpoint and at death. FOS data were extracted for 740 treated patients who were followed for a median of ∼ 5 years. Compared with no treatment, patients treated with agalsidase alfa demonstrated slower decline in renal function and slower progression of left ventricular hypertrophy. Treated male patients with baseline eGFR &lt; 60 mL/min/1.73 m&lt;sup&gt;2&lt;/sup&gt; had a mean (standard error of the mean [SEM]) annualized change in eGFR of - 2.86 (0.53) mL/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;/y compared with - 6.8 (1.5) in the published untreated cohort. The mean (SEM) rate of LVMI increase with treatment was 0.33 (0.10) g/m&lt;sup&gt;2.7&lt;/sup&gt;/y in males and 0.48 (0.09) in females, compared with 4.07 (1.03) in untreated males and 2.31 (0.81) in untreated females. Morbidity occurred later in treated patients, with ∼ 16% risk of a composite morbidity event (26% in males) after 24 months with ERT versus ∼ 45% without treatment, with first events and deaths also occurring at older ages in patients administered ERT (e.g., estimated median survival in treated males was 77.5 years versus 60 years in untreated males). Findings from these retrospective comparisons of observational data and published literature support the long-term benefits of ERT with agalsidase alfa for Fabry disease in slowing the progression of renal impairment and cardiomyopathy. Treatment also appeared to delay the onset of morbidity and mortality. Interpretation of these findings should take into account that they are based on retrospective comparisons with previously published data.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022135</affiliation-url><afid>60022135</afid><affilname>Klinikum der Johannes-Gutenberg-Universitat und Fachbereich Medizin</affilname><affiliation-city>Mainz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022148</affiliation-url><afid>60022148</afid><affilname>UCL</affilname><name-variant>University College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115063993</affiliation-url><afid>115063993</afid><affilname>Shire</affilname><name-variant>Shire</name-variant><affiliation-city>Zug</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028462</affiliation-url><afid>60028462</afid><affilname>Hospital Universitari Germans Trias i Pujol</affilname><name-variant>Hospital Germans Trias i Pujol</name-variant><affiliation-city>Badalona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015913</affiliation-url><afid>60015913</afid><affilname>Dalhousie University</affilname><name-variant>Dalhousie University</name-variant><affiliation-city>Halifax</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109179474</affiliation-url><afid>109179474</afid><affilname>Shire</affilname><name-variant>Shire</name-variant><affiliation-city>Lexington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014120</affiliation-url><afid>60014120</afid><affilname>Hospital de Clinicas de Porto Alegre</affilname><name-variant>Universidade Federal do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7402768953</author-url><authid>7402768953</authid><authname>Beck M.</authname><surname>Beck</surname><given-name>Michael</given-name><initials>M.</initials><afid>60022135</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403462852</author-url><authid>7403462852</authid><authname>Hughes D.</authname><surname>Hughes</surname><given-name>Derralynn</given-name><initials>D.</initials><afid>60022148</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003869133</author-url><authid>7003869133</authid><authname>Kampmann C.</authname><surname>Kampmann</surname><given-name>Christoph</given-name><initials>C.</initials><afid>60022135</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56556705700</author-url><authid>56556705700</authid><authname>Larroque S.</authname><surname>Larroque</surname><given-name>Sylvain</given-name><initials>S.</initials><afid>115063993</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7402756333</author-url><authid>7402756333</authid><authname>Mehta A.</authname><surname>Mehta</surname><given-name>Atul</given-name><initials>A.</initials><afid>60022148</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603601969</author-url><authid>6603601969</authid><authname>Pintos-Morell G.</authname><surname>Pintos-Morell</surname><given-name>Guillem</given-name><initials>G.</initials><afid>60028462</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6508207095</author-url><authid>6508207095</authid><authname>Ramaswami U.</authname><surname>Ramaswami</surname><given-name>Uma</given-name><initials>U.</initials><afid>60022148</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:55574202622</author-url><authid>55574202622</authid><authname>West M.</authname><surname>West</surname><given-name>Michael</given-name><initials>M.</initials><afid>60015913</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56658747300</author-url><authid>56658747300</authid><authname>Wijatyk A.</authname><surname>Wijatyk</surname><given-name>Anna</given-name><initials>A.</initials><afid>109179474</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005600401</author-url><authid>7005600401</authid><authname>Giugliani R.</authname><surname>Giugliani</surname><given-name>Roberto</given-name><initials>R.</initials><afid>60014120</afid></author><authkeywords>Agalsidase alfa | Enzyme replacement therapy | Fabry disease | Long-term effectiveness</authkeywords><intid>2036044984</intid><source-id>21100326555</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928614294"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928614294?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928614294&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928614294&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S001448351500130X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928614294</prism:url><dc:identifier>SCOPUS_ID:84928614294</dc:identifier><eid>2-s2.0-84928614294</eid><dc:title>Early adaptive response of the retina to a pro-diabetogenic diet: Impairment of cone response and gene expression changes in high-fructose fed rats</dc:title><dc:creator>Thierry M.</dc:creator><prism:publicationName>Experimental Eye Research</prism:publicationName><prism:issn>00144835</prism:issn><prism:eIssn>10960007</prism:eIssn><prism:volume>135</prism:volume><prism:pageRange>37-46</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exer.2015.04.012</prism:doi><pii>S001448351500130X</pii><dc:description>© 2015 Elsevier Ltd. The lack of plasticity of neurons to respond to dietary changes, such as high fat and high fructose diets, by modulating gene and protein expression has been associated with functional and behavioral impairments that can have detrimental consequences. The inhibition of high fat-induced rewiring of hypothalamic neurons induced obesity. Feeding rodents with high fructose is a recognized and widely used model to trigger obesity and metabolic syndrome. However the adaptive response of the retina to short term feeding with high fructose is poorly documented. We therefore aimed to characterize both the functional and gene expression changes in the neurosensory retina of Brown Norway rats fed during 3 and 8 days with a 60%-rich fructose diet (n=16 per diet and per time point). Glucose, insulin, leptin, triacylglycerols, total cholesterol, HDL-cholesterol, LDL-cholesterol and fructosamine were quantified in plasma (n=8 in each group). Functionality of the inner retina was studied using scotopic single flash electroretinography (n=8 in each group) and the individual response of rod and cone photoreceptors was determined using 8.02Hz Flicker electroretinography (n=8 in each group). Analysis of gene expression in the neurosensory retina was performed by Affymetrix genechips, and confirmed by RT-qPCR (n=6 in each group). Elevated glycemia (+13%), insulinemia (+83%), and leptinemia (+172%) was observed after 8 days of fructose feeding. The cone photoreceptor response was altered at day 8 in high fructose fed rats (δ=0.5 log unit of light stimulus intensity). Affymetrix analysis of gene expression highlighted significant modulation of the pathways of eIF2 signaling and endoplasmic reticulum stress, regulation of eIF4 and p70S6K signaling, as well as mTOR signaling and mitochondrial dysfunction. RT-qPCR analysis confirmed the down regulation of Crystallins, Npy, Nid1 and Optc genes after 3 days of fructose feeding, and up regulation of End2. Meanwhile, a trend towards an increased expression of αA- and αB-crystallin proteins was observed at day 8. Our results are consistent with early alterations of the functioning and gene expression in the retina in a pro diabetogenic environment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020315</affiliation-url><afid>60020315</afid><affilname>INRA Institut National de La Recherche Agronomique</affilname><name-variant>INRA Institut National de La Recherche Agronomique</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008134</affiliation-url><afid>60008134</afid><affilname>CNRS Centre National de la Recherche Scientifique</affilname><name-variant>CNRS</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031810</affiliation-url><afid>60031810</afid><affilname>Universite de Bourgogne</affilname><name-variant>Université de Bourgogne</name-variant><affiliation-city>Dijon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008134</affiliation-url><afid>60008134</afid><affilname>CNRS Centre National de la Recherche Scientifique</affilname><name-variant>CNRS</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103368</affiliation-url><afid>60103368</afid><affilname>Universite de Strasbourg</affilname><name-variant>Universit&amp;eacute; de Strasbourg</name-variant><affiliation-city>Strasbourg</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017969</affiliation-url><afid>60017969</afid><affilname>IGBMC Institut de Genetique et de Biologie Moleculaire et Cellulaire</affilname><name-variant>IGBMC</name-variant><affiliation-city>Illkirch-Graffenstaden</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112760311</affiliation-url><afid>112760311</afid><affilname>University Hospital</affilname><name-variant>University Hospital</name-variant><affiliation-city>Lyon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112760311</affiliation-url><afid>112760311</afid><affilname>University Hospital</affilname><name-variant>University Hospital</name-variant><affiliation-city>Lyon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">37</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56422035200</author-url><authid>56422035200</authid><authname>Thierry M.</authname><surname>Thierry</surname><given-name>Magalie</given-name><initials>M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56422035200</author-url><authid>56422035200</authid><authname>Thierry M.</authname><surname>Thierry</surname><given-name>Magalie</given-name><initials>M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56422035200</author-url><authid>56422035200</authid><authname>Thierry M.</authname><surname>Thierry</surname><given-name>Magalie</given-name><initials>M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506847570</author-url><authid>6506847570</authid><authname>Pasquis B.</authname><surname>Pasquis</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506847570</author-url><authid>6506847570</authid><authname>Pasquis B.</authname><surname>Pasquis</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506847570</author-url><authid>6506847570</authid><authname>Pasquis B.</authname><surname>Pasquis</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506085893</author-url><authid>6506085893</authid><authname>Buteau B.</authname><surname>Buteau</surname><given-name>Bénédicte</given-name><initials>B.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506085893</author-url><authid>6506085893</authid><authname>Buteau B.</authname><surname>Buteau</surname><given-name>Bénédicte</given-name><initials>B.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506085893</author-url><authid>6506085893</authid><authname>Buteau B.</authname><surname>Buteau</surname><given-name>Bénédicte</given-name><initials>B.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9633353700</author-url><authid>9633353700</authid><authname>Fourgeux C.</authname><surname>Fourgeux</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9633353700</author-url><authid>9633353700</authid><authname>Fourgeux C.</authname><surname>Fourgeux</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:9633353700</author-url><authid>9633353700</authid><authname>Fourgeux C.</authname><surname>Fourgeux</surname><given-name>Cynthia</given-name><initials>C.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35607400300</author-url><authid>35607400300</authid><authname>Dembele D.</authname><surname>Dembele</surname><given-name>Doulaye</given-name><initials>D.</initials><afid>60000905</afid><afid>60008134</afid><afid>60103368</afid><afid>60017969</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35607400300</author-url><authid>35607400300</authid><authname>Dembele D.</authname><surname>Dembele</surname><given-name>Doulaye</given-name><initials>D.</initials><afid>60000905</afid><afid>60008134</afid><afid>60103368</afid><afid>60017969</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35607400300</author-url><authid>35607400300</authid><authname>Dembele D.</authname><surname>Dembele</surname><given-name>Doulaye</given-name><initials>D.</initials><afid>60000905</afid><afid>60008134</afid><afid>60103368</afid><afid>60017969</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35607400300</author-url><authid>35607400300</authid><authname>Dembele D.</authname><surname>Dembele</surname><given-name>Doulaye</given-name><initials>D.</initials><afid>60000905</afid><afid>60008134</afid><afid>60103368</afid><afid>60017969</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23019285200</author-url><authid>23019285200</authid><authname>Leclere L.</authname><surname>Leclere</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23019285200</author-url><authid>23019285200</authid><authname>Leclere L.</authname><surname>Leclere</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23019285200</author-url><authid>23019285200</authid><authname>Leclere L.</authname><surname>Leclere</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55078229200</author-url><authid>55078229200</authid><authname>Gambert-Nicot S.</authname><surname>Gambert-Nicot</surname><given-name>Ségolène</given-name><initials>S.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55078229200</author-url><authid>55078229200</authid><authname>Gambert-Nicot S.</authname><surname>Gambert-Nicot</surname><given-name>Ségolène</given-name><initials>S.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55078229200</author-url><authid>55078229200</authid><authname>Gambert-Nicot S.</authname><surname>Gambert-Nicot</surname><given-name>Ségolène</given-name><initials>S.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55078229200</author-url><authid>55078229200</authid><authname>Gambert-Nicot S.</authname><surname>Gambert-Nicot</surname><given-name>Ségolène</given-name><initials>S.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003883050</author-url><authid>7003883050</authid><authname>Acar N.</authname><surname>Acar</surname><given-name>Niyazi</given-name><initials>N.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003883050</author-url><authid>7003883050</authid><authname>Acar N.</authname><surname>Acar</surname><given-name>Niyazi</given-name><initials>N.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003883050</author-url><authid>7003883050</authid><authname>Acar N.</authname><surname>Acar</surname><given-name>Niyazi</given-name><initials>N.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56423316500</author-url><authid>56423316500</authid><authname>Bron A.</authname><surname>Bron</surname><given-name>Alain M.</given-name><initials>A.M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56423316500</author-url><authid>56423316500</authid><authname>Bron A.</authname><surname>Bron</surname><given-name>Alain M.</given-name><initials>A.M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56423316500</author-url><authid>56423316500</authid><authname>Bron A.</authname><surname>Bron</surname><given-name>Alain M.</given-name><initials>A.M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56423316500</author-url><authid>56423316500</authid><authname>Bron A.</authname><surname>Bron</surname><given-name>Alain M.</given-name><initials>A.M.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6701311678</author-url><authid>6701311678</authid><authname>Creuzot-Garcher C.</authname><surname>Creuzot-Garcher</surname><given-name>Catherine P.</given-name><initials>C.P.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6701311678</author-url><authid>6701311678</authid><authname>Creuzot-Garcher C.</authname><surname>Creuzot-Garcher</surname><given-name>Catherine P.</given-name><initials>C.P.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6701311678</author-url><authid>6701311678</authid><authname>Creuzot-Garcher C.</authname><surname>Creuzot-Garcher</surname><given-name>Catherine P.</given-name><initials>C.P.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6701311678</author-url><authid>6701311678</authid><authname>Creuzot-Garcher C.</authname><surname>Creuzot-Garcher</surname><given-name>Catherine P.</given-name><initials>C.P.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid><afid>112760311</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603860247</author-url><authid>6603860247</authid><authname>Bretillon L.</authname><surname>Bretillon</surname><given-name>Lionel</given-name><initials>L.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603860247</author-url><authid>6603860247</authid><authname>Bretillon L.</authname><surname>Bretillon</surname><given-name>Lionel</given-name><initials>L.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6603860247</author-url><authid>6603860247</authid><authname>Bretillon L.</authname><surname>Bretillon</surname><given-name>Lionel</given-name><initials>L.</initials><afid>60020315</afid><afid>60008134</afid><afid>60031810</afid></author><authkeywords>Diet | Electroretinography | Fructose | Gene expression | Retina</authkeywords><intid>535814982</intid><source-id>13866</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924249468"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924249468?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924249468&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924249468&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1095643315000379"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924249468</prism:url><dc:identifier>SCOPUS_ID:84924249468</dc:identifier><eid>2-s2.0-84924249468</eid><dc:title>Challenges and opportunities in developmental integrative physiology</dc:title><dc:creator>Mueller C.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology</prism:publicationName><prism:issn>10956433</prism:issn><prism:eIssn>15314332</prism:eIssn><prism:volume>184</prism:volume><prism:pageRange>113-124</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpa.2015.02.013</prism:doi><pii>S1095643315000379</pii><dc:description>© 2015 Elsevier Inc. This review explores challenges and opportunities in developmental physiology outlined by a symposium at the 2014 American Physiological Society Intersociety Meeting: Comparative Approaches to Grand Challenges in Physiology. Across animal taxa, adverse embryonic/fetal environmental conditions can alter morphological and physiological phenotypes in juveniles or adults, and capacities for developmental plasticity are common phenomena. Human neonates with body sizes at the extremes of perinatal growth are at an increased risk of adult disease, particularly hypertension and cardiovascular disease. There are many rewarding areas of current and future research in comparative developmental physiology. We present key mechanisms, models, and experimental designs that can be used across taxa to investigate patterns in, and implications of, the development of animal phenotypes. Intraspecific variation in the timing of developmental events can be increased through developmental plasticity (heterokairy), and could provide the raw material for selection to produce heterochrony - an evolutionary change in the timing of developmental events. Epigenetics and critical windows research recognizes that in ovo or fetal development represent a vulnerable period in the life history of an animal, when the developing organism may be unable to actively mitigate environmental perturbations. 'Critical windows' are periods of susceptibility or vulnerability to environmental or maternal challenges, periods when recovery from challenge is possible, and periods when the phenotype or epigenome has been altered. Developmental plasticity may allow survival in an altered environment, but it also has possible long-term consequences for the animal. "Catch-up growth" in humans after the critical perinatal window has closed elicits adult obesity and exacerbates a programmed hypertensive phenotype (one of many examples of "fetal programing"). Grand challenges for developmental physiology include integrating variation in developmental timing within and across generations, applying multiple stressor dosages and stressor exposure at different developmental timepoints, assessment of epigenetic and parental influences, developing new animal models and techniques, and assessing and implementing these designs and models in human health and development.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024438</affiliation-url><afid>60024438</afid><affilname>University of North Texas</affilname><name-variant>University of North Texas</name-variant><affiliation-city>Denton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024324</affiliation-url><afid>60024324</afid><affilname>University of Iowa</affilname><name-variant>University of Iowa</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024779</affiliation-url><afid>60024779</afid><affilname>University of Plymouth</affilname><name-variant>University of Plymouth</name-variant><affiliation-city>Plymouth</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36716674600</author-url><authid>36716674600</authid><authname>Mueller C.</authname><surname>Mueller</surname><given-name>C. A.</given-name><initials>C.A.</initials><afid>60031828</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:11140288300</author-url><authid>11140288300</authid><authname>Eme J.</authname><surname>Eme</surname><given-name>J.</given-name><initials>J.</initials><afid>60031828</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005365106</author-url><authid>7005365106</authid><authname>Burggren W.</authname><surname>Burggren</surname><given-name>W. W.</given-name><initials>W.W.</initials><afid>60024438</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6508285988</author-url><authid>6508285988</authid><authname>Roghair R.</authname><surname>Roghair</surname><given-name>R. D.</given-name><initials>R.D.</initials><afid>60024324</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004911419</author-url><authid>7004911419</authid><authname>Rundle S.</authname><surname>Rundle</surname><given-name>S. D.</given-name><initials>S.D.</initials><afid>60024779</afid></author><authkeywords>Critical windows | Development | Embryo | Epigenetics | Fetus | Heterochrony | Heterokairy | Leptin | Perinatal</authkeywords><intid>1785104672</intid><source-id>3500148021</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928320426"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928320426?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928320426&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928320426&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0360128514000653"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928320426</prism:url><dc:identifier>SCOPUS_ID:84928320426</dc:identifier><eid>2-s2.0-84928320426</eid><dc:title>Ambient air pollution: An emerging risk factor for diabetes mellitus</dc:title><dc:creator>Rao X.</dc:creator><prism:publicationName>Current Diabetes Reports</prism:publicationName><prism:issn>15344827</prism:issn><prism:eIssn>15390829</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1-11</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11892-015-0603-8</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Growing evidence supports that air pollution has become an important risk factor for developing diabetes mellitus. Understanding the contributing effect of air pollution in population studies, elucidating the potential mechanisms involved, and identifying the most responsible pollutants are all required in order to promulgate successful changes in policy and to help formulate preventive measures in an effort to reduce the risk for diabetes. This review summarizes recent findings from epidemiologic studies and mechanistic insights that provide links between exposure to air pollution and a heightened risk for diabetes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014653</affiliation-url><afid>60014653</afid><affilname>University of Maryland, Baltimore</affilname><name-variant>University of Maryland</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020304</affiliation-url><afid>60020304</afid><affilname>University of Maryland</affilname><name-variant>University of Maryland</name-variant><affiliation-city>College Park</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033182</affiliation-url><afid>60033182</afid><affilname>University of Michigan Medical School</affilname><name-variant>University of Michigan Medical School</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105748910</affiliation-url><afid>105748910</afid><affilname>Division of Cardiovascular Medicine</affilname><name-variant>Division of Cardiovascular Medicine</name-variant><affiliation-city>Ann Arbor</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56498636000</author-url><authid>56498636000</authid><authname>Rao X.</authname><surname>Rao</surname><given-name>Xiaoquan</given-name><initials>X.</initials><afid>60014653</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56514109400</author-url><authid>56514109400</authid><authname>Montresor-Lopez J.</authname><surname>Montresor-Lopez</surname><given-name>Jessica</given-name><initials>J.</initials><afid>60020304</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:24169535400</author-url><authid>24169535400</authid><authname>Puett R.</authname><surname>Puett</surname><given-name>Robin</given-name><initials>R.</initials><afid>60020304</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56550290900</author-url><authid>56550290900</authid><authname>Rajagopalan S.</authname><surname>Rajagopalan</surname><given-name>Sanjay</given-name><initials>S.</initials><afid>60014653</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202129401</author-url><authid>7202129401</authid><authname>Brook R.</authname><surname>Brook</surname><given-name>Robert D.</given-name><initials>R.D.</initials><afid>60033182</afid><afid>105748910</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202129401</author-url><authid>7202129401</authid><authname>Brook R.</authname><surname>Brook</surname><given-name>Robert D.</given-name><initials>R.D.</initials><afid>60033182</afid><afid>105748910</afid></author><authkeywords>Insulin resistance | Metabolic syndrome | Obesity | Particulate matter</authkeywords><intid>35767330</intid><source-id>25465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926345418"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926345418?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926345418&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926345418&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S003193841500178X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926345418</prism:url><dc:identifier>SCOPUS_ID:84926345418</dc:identifier><eid>2-s2.0-84926345418</eid><dc:title>Pain perception and EEG dynamics: Does hypnotizability account for the efficacy of the suggestions of analgesia?</dc:title><dc:creator>Dario M.</dc:creator><prism:publicationName>Physiology and Behavior</prism:publicationName><prism:issn>00319384</prism:issn><prism:eIssn>1873507X</prism:eIssn><prism:volume>145</prism:volume><prism:pageRange>57-63</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physbeh.2015.03.040</prism:doi><pii>S003193841500178X</pii><dc:description>© 2015. We report novel findings concerning the role of hypnotizability, suggestions of analgesia and the activity of the Behavioral Inhibition/Activation System (BIS/BAS) in the modulation of the subjective experience of pain and of the associated EEG dynamics. The EEG of high (. highs) and low hypnotizable participants (. lows) who completed the BIS/BAS questionnaire was recorded during basal conditions, tonic nociceptive stimulation without (PAIN) and with suggestions for analgesia (AN). Participants scored the perceived pain intensity at the end of PAIN and AN. The EEG midline dynamics was characterized by indices indicating the signal predictability (Determinism) and complexity (Entropy) obtained through the Recurrence Quantification Analysis. The reduced pain intensity reported by highs during AN was partially accounted for by the activity of the Behavioral Activation System. The decreased midline cortical Determinism observed during nociceptive stimulation in both groups independently of suggestions remained significantly reduced only in lows after controlling for the activity of the Behavioral Activation System. Finally, controlling for the activity of the Behavioral Inhibition System abolished stimulation, suggestions and hypnotizability-related differences. Results indicate that the BIS/BAS activity may be more important than hypnotizability itself in pain modulation and in the associated EEG dynamics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Department of Information Engineering and Mathematical Sciences</affilname><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002838</affiliation-url><afid>60002838</afid><affilname>Universita degli Studi di Siena</affilname><name-variant>Università di Siena</name-variant><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028868</affiliation-url><afid>60028868</afid><affilname>Universita di Pisa</affilname><name-variant>University of Pisa</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56581937400</author-url><authid>56581937400</authid><authname>Dario M.</authname><surname>Dario</surname><given-name>Madeo</given-name><initials>M.</initials><afid/><afid>60002838</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56581937400</author-url><authid>56581937400</authid><authname>Dario M.</authname><surname>Dario</surname><given-name>Madeo</given-name><initials>M.</initials><afid/><afid>60002838</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56582200400</author-url><authid>56582200400</authid><authname>Eleonora C.</authname><surname>Eleonora</surname><given-name>Castellani</given-name><initials>C.</initials><afid>60028868</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56581778300</author-url><authid>56581778300</authid><authname>Chiara M.</authname><surname>Chiara</surname><given-name>Mocenni</given-name><initials>M.</initials><afid/><afid>60002838</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56581778300</author-url><authid>56581778300</authid><authname>Chiara M.</authname><surname>Chiara</surname><given-name>Mocenni</given-name><initials>M.</initials><afid/><afid>60002838</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56581963300</author-url><authid>56581963300</authid><authname>Laura S.</authname><surname>Laura</surname><given-name>Santarcangelo Enrica</given-name><initials>S.E.</initials><afid>60028868</afid></author><authkeywords>Analgesia | BIS/BAS | EEG dynamics | Hypnotizability | Pain | Suggestions</authkeywords><intid>1785432135</intid><source-id>24007</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928379176"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928379176?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928379176&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928379176&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016524271500080X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928379176</prism:url><dc:identifier>SCOPUS_ID:84928379176</dc:identifier><eid>2-s2.0-84928379176</eid><dc:title>Vulnerable Plaque: Molecular Imaging</dc:title><dc:creator>Lee S.</dc:creator><prism:publicationName>Current Cardiovascular Imaging Reports</prism:publicationName><prism:issn>19419066</prism:issn><prism:eIssn>19419074</prism:eIssn><prism:volume>8</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1-13</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12410-015-9338-9</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Despite the remarkable advances in cardiovascular imaging over the last decade, it is still challenging to identify high-risk atherosclerotic plaques prior to onset of major cardiovascular complications. Accumulating knowledge regarding the pathophysiological properties of vulnerable plaque (VP) has driven the development of molecular imaging technologies that target biologic process to characterize vulnerable plaques. Given the importance of VP detection in vivo, molecular imaging has emerged as an attractive diagnostic tool to more accurately estimate the risk of plaque rupture.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60094642</affiliation-url><afid>60094642</afid><affilname>Korea University Medical Center</affilname><name-variant>Korea University Guro Hospital</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60094642</affiliation-url><afid>60094642</afid><affilname>Korea University Medical Center</affilname><name-variant>Korea University Guro Hospital</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55642622400</author-url><authid>55642622400</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sunki</given-name><initials>S.</initials><afid>60094642</afid><afid>60094642</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55642622400</author-url><authid>55642622400</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sunki</given-name><initials>S.</initials><afid>60094642</afid><afid>60094642</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56018285800</author-url><authid>56018285800</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jin Won</given-name><initials>J.W.</initials><afid>60094642</afid><afid>60094642</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56018285800</author-url><authid>56018285800</authid><authname>Kim J.</authname><surname>Kim</surname><given-name>Jin Won</given-name><initials>J.W.</initials><afid>60094642</afid><afid>60094642</afid></author><authkeywords>Atherosclerosis | Inflammation | Macrophage | Molecular imaging | Vulnerable plaque</authkeywords><intid>1535778783</intid><source-id>19600157307</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928383035"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928383035?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928383035&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928383035&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928383035</prism:url><dc:identifier>SCOPUS_ID:84928383035</dc:identifier><eid>2-s2.0-84928383035</eid><dc:title>Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms</dc:title><dc:creator>Saponaro C.</dc:creator><prism:publicationName>Current Diabetes Reports</prism:publicationName><prism:issn>15344827</prism:issn><prism:eIssn>15390829</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1-13</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11892-015-0607-4</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for advanced liver disease, type 2 diabetes (T2DM), and cardiovascular diseases. The prevalence of NAFLD in the general population is around 30 %, but it is up to three times higher in those with T2DM. Among people with obesity and T2DM, the NAFLD epidemic also is worsening. Therefore, it is important to identify early metabolic alterations and to prevent these diseases and their progression. In this review, we analyze the pathophysiologic mechanisms leading to NAFLD, particularly, those common to T2DM, such as liver and muscle insulin resistance. However, it is mainly adipose tissue insulin resistance that results in increased hepatic de novo lipogenesis, inflammation, and lipotoxicity. Although genetics predispose to NAFLD, an unhealthy lifestyle, including high-fat/high-sugar diets and low physical activity, increases the risk. In addition, alterations in gut microbiota and environmental chemical agents, acting as endocrine disruptors, may play a role.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021199</affiliation-url><afid>60021199</afid><affilname>Consiglio Nazionale delle Ricerche</affilname><name-variant>CNR</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002838</affiliation-url><afid>60002838</afid><affilname>Universita degli Studi di Siena</affilname><name-variant>Università di Siena</name-variant><affiliation-city>Siena</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028868</affiliation-url><afid>60028868</afid><affilname>Universita di Pisa</affilname><name-variant>University of Pisa</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55776189800</author-url><authid>55776189800</authid><authname>Saponaro C.</authname><surname>Saponaro</surname><given-name>Chiara</given-name><initials>C.</initials><afid>60021199</afid><afid>60002838</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55776189800</author-url><authid>55776189800</authid><authname>Saponaro C.</authname><surname>Saponaro</surname><given-name>Chiara</given-name><initials>C.</initials><afid>60021199</afid><afid>60002838</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507456024</author-url><authid>6507456024</authid><authname>Gaggini M.</authname><surname>Gaggini</surname><given-name>Melania</given-name><initials>M.</initials><afid>60021199</afid><afid>60028868</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507456024</author-url><authid>6507456024</authid><authname>Gaggini M.</authname><surname>Gaggini</surname><given-name>Melania</given-name><initials>M.</initials><afid>60021199</afid><afid>60028868</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004210893</author-url><authid>7004210893</authid><authname>Gastaldelli A.</authname><surname>Gastaldelli</surname><given-name>Amalia</given-name><initials>A.</initials><afid>60021199</afid></author><authkeywords>De novo lipogenesis | Endocrine disruptors | Fatty liver | Glucose intolerance | Gut microbiota | Lipotoxicity | NASH</authkeywords><intid>535779944</intid><source-id>25465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922982329"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922982329?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922982329&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922982329&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352250X15000639"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922982329</prism:url><dc:identifier>SCOPUS_ID:84922982329</dc:identifier><eid>2-s2.0-84922982329</eid><dc:title>Explicating the role of emotion dysregulation in risky behaviors: A review and synthesis of the literature with directions for future research and clinical practice</dc:title><dc:creator>Weiss N.</dc:creator><prism:publicationName>Current Opinion in Psychology</prism:publicationName><prism:issn>2352250X</prism:issn><prism:volume>3</prism:volume><prism:pageRange>22-29</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copsyc.2015.01.013</prism:doi><pii>S2352250X15000639</pii><dc:description>© 2015 Elsevier Ltd. Extant literature provides support for emotion dysregulation as a transdiagnostic construct with relevance to the pathogenesis and treatment of numerous psychiatric difficulties and maladaptive behaviors, including risky, self-destructive, and health-compromising behaviors (e.g. substance use, risky sexual behavior). The aim of the present review is to synthesize theory and empirical research on the relationship between emotion dysregulation and risky behaviors. In addition, we highlight cutting-edge approaches for investigating the emotion dysregulation-risky behavior, including examination of the role of positive emotional experiences and inclusion of context-dependent and physiological assessments. Finally, we note the relevance of the emotion dysregulation-risky behavior relation to intervention efforts aimed at reducing risky behaviors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004109</affiliation-url><afid>60004109</afid><affilname>University of Mississippi Medical Center</affilname><name-variant>Univ. of Mississippi Medical Center</name-variant><affiliation-city>Jackson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:43762132500</author-url><authid>43762132500</authid><authname>Weiss N.</authname><surname>Weiss</surname><given-name>Nicole H.</given-name><initials>N.H.</initials><afid>60017994</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8858569300</author-url><authid>8858569300</authid><authname>Sullivan T.</authname><surname>Sullivan</surname><given-name>Tami P.</given-name><initials>T.P.</initials><afid>60017994</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603851453</author-url><authid>6603851453</authid><authname>Tull M.</authname><surname>Tull</surname><given-name>Matthew T.</given-name><initials>M.T.</initials><afid>60004109</afid></author><intid>34908583</intid><source-id>21100372442</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928237811"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928237811?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928237811&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928237811&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928237811</prism:url><dc:identifier>SCOPUS_ID:84928237811</dc:identifier><eid>2-s2.0-84928237811</eid><dc:title>The Changing Meanings of Russian Love: Emotional Socialism and Therapeutic Culture on the Post-Soviet Screen</dc:title><dc:creator>Lerner J.</dc:creator><prism:publicationName>Sexuality and Culture</prism:publicationName><prism:issn>10955143</prism:issn><prism:volume>19</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>349-368</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12119-014-9261-2</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Based on an analysis of post-Soviet Russian cinema and TV productions, this article explores the new emotional culture in post-Soviet Russia and the ways in which it articulates the concept of love. The new emotional style develops through the adoption of popular psychologized therapeutic models and genres of the emotional culture of late capitalism. The article deciphers the encounter of different scenarios of love at the contemporary “therapeutic turn” in Russian culture. I argue that in Russia, the therapeutic script of love meets powerful cultural counterparts, either anchored in the Russian literary tradition, Soviet discursive culture, or constituted in the post-Soviet condition. I use Anna Karenina as a key Russian love scenario, and then refer to contemporary media productions that echo this canonical Russian-Soviet love model and represent its post-Soviet treatments. Some post-Soviet versions differ both from the vantage point of Russian psychological prose and from the global media narrative of therapeutic love. Engaging with the well-established model of “emotional capitalism”, I introduce its contemporary Russian post-Soviet alternative of “emotional socialism” and the moments in which the categories of emotional socialism pose a challenge to the “therapeutic”.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027161</affiliation-url><afid>60027161</afid><affilname>Ben-Gurion University of the Negev</affilname><name-variant>Ben Gurion University of the Negev</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10142654900</author-url><authid>10142654900</authid><authname>Lerner J.</authname><surname>Lerner</surname><given-name>Julia</given-name><initials>J.</initials><afid>60027161</afid></author><authkeywords>Anthropology of media | Emotional socialism | Love cultural script | Post-Soviet condition | Therapeutic culture</authkeywords><intid>1785754550</intid><source-id>145138</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920973857"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920973857?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920973857&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920973857&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214647414000397"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920973857</prism:url><dc:identifier>SCOPUS_ID:84920973857</dc:identifier><eid>2-s2.0-84920973857</eid><dc:title>Genetics of ischaemic stroke in young adults</dc:title><dc:creator>Terni E.</dc:creator><prism:publicationName>BBA Clinical</prism:publicationName><prism:issn>22146474</prism:issn><prism:volume>3</prism:volume><prism:pageRange>96-106</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbacli.2014.12.004</prism:doi><pii>S2214647414000397</pii><dc:description>© 2014. Background: Stroke may be a clinical expression of several inherited disorders in humans. Recognition of the underlined genetic disorders causing stroke is important for a correct diagnosis, for genetic counselling and, even if rarely, for a correct therapeutic management. Moreover, the genetics of complex diseases such the stroke, in which multiple genes interact with environmental risk factors to increase risk, has been revolutionized by the Genome-Wide Association Study (GWAS) approach. Scope of review: Here we review the single-gene causes of ischemic stroke, bringing the reader from the candidate gene method toward the exciting new horizons of genetic technology. Major conclusions: The aetiological diagnosis of ischemic stroke in young adults is more complex than in the elderly. The identification of a genetic cause is important to provide appropriate counseling and to start a correct therapy, when available. The advent of GWAS technology, such as for other complex pathological conditions, has contributed enormously to the understanding of many of these genetic bases. For success large, well phenotyped case cohorts are required, and international collaborations are essential. General significance: This review focuses on the main causes of genetically-based ischemic stroke in young adults, often classified as indeterminate, investigating also the recent findings of the GWAS, in order to improve diagnostic and therapeutic management.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028868</affiliation-url><afid>60028868</afid><affilname>Universita di Pisa</affilname><name-variant>University of Pisa</name-variant><affiliation-city>Pisa</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55227740200</author-url><authid>55227740200</authid><authname>Terni E.</authname><surname>Terni</surname><given-name>Eva</given-name><initials>E.</initials><afid>60028868</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35606804700</author-url><authid>35606804700</authid><authname>Giannini N.</authname><surname>Giannini</surname><given-name>Nicola</given-name><initials>N.</initials><afid>60028868</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56423585100</author-url><authid>56423585100</authid><authname>Brondi M.</authname><surname>Brondi</surname><given-name>Marco</given-name><initials>M.</initials><afid>60028868</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56423555700</author-url><authid>56423555700</authid><authname>Montano V.</authname><surname>Montano</surname><given-name>Vincenzo</given-name><initials>V.</initials><afid>60028868</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55156487000</author-url><authid>55156487000</authid><authname>Bonuccelli U.</authname><surname>Bonuccelli</surname><given-name>Ubaldo</given-name><initials>U.</initials><afid>60028868</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102539755</author-url><authid>7102539755</authid><authname>Mancuso M.</authname><surname>Mancuso</surname><given-name>Michelangelo</given-name><initials>M.</initials><afid>60028868</afid></author><authkeywords>Genetics | GWAS | Stroke</authkeywords><intid>1034560835</intid><source-id>21100317907</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920772132"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920772132?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920772132&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920772132&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920772132</prism:url><dc:identifier>SCOPUS_ID:84920772132</dc:identifier><eid>2-s2.0-84920772132</eid><dc:title>Promotion of astragaloside IV for EA-hy926 cell proliferation and angiogenic activity via ERK1/2 pathway</dc:title><dc:creator>Wang S.</dc:creator><prism:publicationName>Journal of Nanoscience and Nanotechnology</prism:publicationName><prism:issn>15334880</prism:issn><prism:eIssn>15334899</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>4239-4244</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1166/jnn.2015.9785</prism:doi><dc:description>Copyright © 2015 American Scientific Publishers All rights reserved. The aim of this study was to determine the pro-angiogenic effects of Astragaloside IV (AS-IV) in vitro and reveal the potential mechanisms. A kind of human umbilical vein endothelial cells (HUVECs), named EA-hy926 cells, were treated with various dosages of AS-IV. We then utilized Cell Counting Kit-8 (CCK-8), real-time PCR and Western blot to detect EA-hy926 cells' proliferation and proangiogenic effect from AS-IV. Data showed that AS-IV promoted EA-hy926 cells proliferation, as assessed by CCK-8. The AS-IV was also associated with an increased tube formation and upregulation of vascular endothelial growth factor (VEGF) mRNA and protein in a dose-dependent manner. Interestingly, the influence of AS-IV on cell proliferation and angiogenisis could be abolished by inhibitor PD98059 through suppressed extracellular signal regulated protein kinases1/2 (ERK1/2) phosphorylation. These data demonstrated that the AS-IV activated the ERK1/2 pathway to control VEGF synthesis. Our findings conclude that the AS-IV promotes EA-hy926 cells proliferation and angiogenesis through ERK1/2 pathway, and it is also a regulator of VEGF.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005189</affiliation-url><afid>60005189</afid><affilname>Nanjing University of Traditional Chinese Medicine</affilname><name-variant>Nanjing University of Traditional Chinese Medicine</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018310</affiliation-url><afid>60018310</afid><affilname>Nanjing Medical University</affilname><name-variant>Nanjing Medical University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005189</affiliation-url><afid>60005189</afid><affilname>Nanjing University of Traditional Chinese Medicine</affilname><name-variant>Nanjing University of Traditional Chinese Medicine</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56477618100</author-url><authid>56477618100</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Shi</given-name><initials>S.</initials><afid>60005189</afid><afid>60005189</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56477618100</author-url><authid>56477618100</authid><authname>Wang S.</authname><surname>Wang</surname><given-name>Shi</given-name><initials>S.</initials><afid>60005189</afid><afid>60005189</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35247503600</author-url><authid>35247503600</authid><authname>Chen J.</authname><surname>Chen</surname><given-name>Jiandong</given-name><initials>J.</initials><afid>60005189</afid><afid>60018310</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35247503600</author-url><authid>35247503600</authid><authname>Chen J.</authname><surname>Chen</surname><given-name>Jiandong</given-name><initials>J.</initials><afid>60005189</afid><afid>60018310</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56477707900</author-url><authid>56477707900</authid><authname>Fu Y.</authname><surname>Fu</surname><given-name>Yuxuan</given-name><initials>Y.</initials><afid>60018310</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56478374600</author-url><authid>56478374600</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xiaohu</given-name><initials>X.</initials><afid>60005189</afid><afid>60005189</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56478374600</author-url><authid>56478374600</authid><authname>Chen X.</authname><surname>Chen</surname><given-name>Xiaohu</given-name><initials>X.</initials><afid>60005189</afid><afid>60005189</afid></author><authkeywords>Angiogenesis | Astragaloside IV | Extracellular signal regulated protein kinases1/2 | Vascular endothelial growth factor</authkeywords><intid>1534539831</intid><source-id>28546</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930178828"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930178828?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930178828&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930178828&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1878540915000249"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930178828</prism:url><dc:identifier>SCOPUS_ID:84930178828</dc:identifier><eid>2-s2.0-84930178828</eid><dc:title>Editorial: Cibenzoline for left ventricular outflow tract obstruction in tako-tsubo cardiomyopathy and hypertrophic cardiomyopathy</dc:title><dc:creator>Anan R.</dc:creator><prism:publicationName>Journal of Cardiology Cases</prism:publicationName><prism:issn>18785409</prism:issn><prism:eIssn>18785409</prism:eIssn><prism:volume>11</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>158-159</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jccase.2015.03.003</prism:doi><pii>S1878540915000249</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112960775</affiliation-url><afid>112960775</afid><affilname>Miyakonojo National Hospital</affilname><name-variant>Miyakonojo National Hospital</name-variant><affiliation-city>Miyakonojo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603701900</author-url><authid>6603701900</authid><authname>Anan R.</authname><surname>Anan</surname><given-name>Ryuichiro</given-name><initials>R.</initials><afid>112960775</afid></author><authkeywords>Cibenzoline | Hypertrophic cardiomyopathy | Left ventricular outflow tract obstruction | Tako-tsubo cardiomyopathy</authkeywords><intid>1036074541</intid><source-id>19600156852</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926391265"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926391265?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926391265&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926391265&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0531556515001035"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926391265</prism:url><dc:identifier>SCOPUS_ID:84926391265</dc:identifier><eid>2-s2.0-84926391265</eid><dc:title>Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency Vitamin D3 megadose reduces inflammatory markers.</dc:title><dc:creator>Cavalcante I.</dc:creator><prism:publicationName>Experimental Gerontology</prism:publicationName><prism:issn>05315565</prism:issn><prism:eIssn>18736815</prism:eIssn><prism:volume>66</prism:volume><prism:pageRange>10-16</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.exger.2015.03.011</prism:doi><pii>S0531556515001035</pii><dc:description>© 2015 Elsevier Inc. Objective: This study aimed to evaluate the effect of vitamin D3 megadose supplementation and influence of BsmI polymorphism in the VDR gene on the inflammatory profile and oxidative stress in elderly women with vitamin D deficiency. Methods: A double blind, randomized, placebo-controlled trial was conducted with 40 elderly women (aged 68. ±. 6 years) diagnosed with vitamin D insufficiency (24.7 ± 3.1 ng/mL). Participants were distributed into a supplementation group that received 200,000. IU of vitamin D3 (SG; n = 20) and a placebo group (PG; n = 20). Blood samples were collected at baseline and after intervention to analyse the 25(OH)D, parathyroid hormone, serum calcium, ultra-sensitive C-reactive protein (us-CRP), alpha 1-acid glycoprotein (AGP-A), total antioxidant capacity (TAC), and malondialdehyde (MDA) levels, as well as the renal and hepatic function, and genotyping was performed for BsmI polymorphism. Results: Four weeks after supplementation, elderly women in the SG group showed a significant increase in the serum concentration of 25(OH)D (25.29 ± 2.8 to 31.48 ± 6.0; p = 0.0001), which was followed by increased TAC (65.25 ± 15.66 to 71.83 ± 10.71; p = 0.03) and decreased serum PTH (46.32 ± 13.2 to 35.45 ± 11.0; p = 0.009), us-CRP (0.38 ± 0.3 to 0.19 ± 0.1; p = 0.007) and AGP-A levels (75.3 ± 15.4 to 61.1 ± 5.9; p = 0.005). Changes in BP, ANAC and MDA were not observed. The 25(OH)D and PTH, us-CRP and AGP-A levels of participants with the BB/Bb genotype were more responsive to supplementation, but their other markers did not change. Conclusions: Supplementation with a vitamin D3 megadose reduced inflammatory markers and increased the total antioxidant capacity in elderly women with vitamin D insufficiency. The 25(OH)D, PTH, us-CRP and AGP-A levels of elderly patients with the BB/Bb genotype were more responsive to supplementation compared with those with the bb genotype.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011324</affiliation-url><afid>60011324</afid><affilname>Universidade Federal da Paraiba</affilname><name-variant>Universidade Federal da Paraiba</name-variant><affiliation-city>Joao Pessoa</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011324</affiliation-url><afid>60011324</afid><affilname>Universidade Federal da Paraiba</affilname><name-variant>Universidade Federal da Paraiba</name-variant><affiliation-city>Joao Pessoa</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011324</affiliation-url><afid>60011324</afid><affilname>Universidade Federal da Paraiba</affilname><name-variant>Universidade Federal da Paraiba</name-variant><affiliation-city>Joao Pessoa</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011324</affiliation-url><afid>60011324</afid><affilname>Universidade Federal da Paraiba</affilname><name-variant>Universidade Federal da Paraiba</name-variant><affiliation-city>Joao Pessoa</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>João Pessoa City Hall</affilname><affiliation-city>Paraíba</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56581756400</author-url><authid>56581756400</authid><authname>Cavalcante I.</authname><surname>Cavalcante</surname><given-name>Isa Gabriela de Medeiros</given-name><initials>I.G.d.M.</initials><afid>60011324</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35790438200</author-url><authid>35790438200</authid><authname>Silva A.</authname><surname>Silva</surname><given-name>Alexandre Sérgio</given-name><initials>A.S.</initials><afid>60011324</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35202976900</author-url><authid>35202976900</authid><authname>Costa M.</authname><surname>Costa</surname><given-name>Maria José Carvalho</given-name><initials>M.J.C.</initials><afid>60011324</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:14070719400</author-url><authid>14070719400</authid><authname>Persuhn D.</authname><surname>Persuhn</surname><given-name>Darlene Camati</given-name><initials>D.C.</initials><afid>60011324</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56581839800</author-url><authid>56581839800</authid><authname>Issa C.</authname><surname>Issa</surname><given-name>ChariraTahaMad Ibraim</given-name><initials>C.I.</initials><afid>60011324</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56581883200</author-url><authid>56581883200</authid><authname>Freire T.</authname><surname>Freire</surname><given-name>Tiago Lima de Luna</given-name><initials>T.L.d.L.</initials><afid/></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202320523</author-url><authid>7202320523</authid><authname>Gonçalves M.</authname><surname>Gonçalves</surname><given-name>Maria da Conceição Rodrigues</given-name><initials>M.d.C.R.</initials><afid>60011324</afid></author><authkeywords>BsmI polymorphism | Elderly | Inflammation and oxidative stress | Supplementation | Vitamin D3</authkeywords><intid>1035427296</intid><source-id>29003</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928659541"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928659541?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928659541&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928659541&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015002257"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928659541</prism:url><dc:identifier>SCOPUS_ID:84928659541</dc:identifier><eid>2-s2.0-84928659541</eid><dc:title>Quantification of aortic calcification - How and why should we do it?</dc:title><dc:creator>Saboo S.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>469-471</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.007</prism:doi><pii>S0021915015002257</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014739</affiliation-url><afid>60014739</afid><affilname>UT Southwestern Medical School</affilname><name-variant>University of Texas Southwestern Medical Center</name-variant><affiliation-city>Dallas</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016782</affiliation-url><afid>60016782</afid><affilname>Brigham and Women's Hospital</affilname><name-variant>Brigham and Women's Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>no</subtype><subtypeDescription>Note</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:41662183800</author-url><authid>41662183800</authid><authname>Saboo S.</authname><surname>Saboo</surname><given-name>Sachin S.</given-name><initials>S.S.</initials><afid>60014739</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701444307</author-url><authid>6701444307</authid><authname>Abbara S.</authname><surname>Abbara</surname><given-name>Suhny</given-name><initials>S.</initials><afid>60014739</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56638728500</author-url><authid>56638728500</authid><authname>Rybicki F.</authname><surname>Rybicki</surname><given-name>Frank J.</given-name><initials>F.J.</initials><afid>60016782</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:13907765800</author-url><authid>13907765800</authid><authname>Chatzizisis Y.</authname><surname>Chatzizisis</surname><given-name>Yiannis S.</given-name><initials>Y.S.</initials><afid>60016782</afid></author><authkeywords>Aortic calcification | Calcium score | Computed tomography | Volume rendering</authkeywords><intid>1785824897</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928882576"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928882576?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928882576&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928882576&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928882576</prism:url><dc:identifier>SCOPUS_ID:84928882576</dc:identifier><eid>2-s2.0-84928882576</eid><dc:title>Imaging Plaque Inflammation in Higher-Risk Patients: What Do We Know and What Are We Looking For?</dc:title><dc:creator>Ishai A.</dc:creator><prism:publicationName>Current Cardiovascular Risk Reports</prism:publicationName><prism:issn>19329520</prism:issn><prism:eIssn>19329563</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1-8</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s12170-015-0459-0</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Atherosclerosis is a chronic inflammatory condition complicating cholesterol accumulation within the artery wall. Inflammation is believed to play an important role in the formation, progression, and ultimately the rupture of atherosclerotic plaques (the principle event leading to most myocardial infarctions and strokes). An enhanced understanding of the inflammatory process within the atheroma may therefore facilitate risk stratification and treatment strategies. Molecular imaging techniques such as PET/CT have the ability to quantify arterial inflammation and assess the high-risk features of atheromas thus may be useful for identifying patients who are at higher risk for an atherothrombotic event. In this review, we focus on the potential of FDG-PET/CT as a tool to measure arterial inflammation, enhance risk stratification, and to evaluate novel therapies directed against atherosclerotic disease. Additionally, this review will provide a discussion on current challenges as well as future directions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020999</affiliation-url><afid>60020999</afid><affilname>Massachusetts General Hospital and Harvard Medical School</affilname><name-variant>Massachusetts General Hospital and Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020999</affiliation-url><afid>60020999</afid><affilname>Massachusetts General Hospital and Harvard Medical School</affilname><name-variant>Massachusetts General Hospital and Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622852600</author-url><authid>56622852600</authid><authname>Ishai A.</authname><surname>Ishai</surname><given-name>Amorina</given-name><initials>A.</initials><afid>60020999</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603090252</author-url><authid>6603090252</authid><authname>Tawakol A.</authname><surname>Tawakol</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>60020999</afid><afid>60020999</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603090252</author-url><authid>6603090252</authid><authname>Tawakol A.</authname><surname>Tawakol</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>60020999</afid><afid>60020999</afid></author><authkeywords>Atherosclerosis | FDG-PET | Inflammation</authkeywords><intid>1035857261</intid><source-id>19500157062</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928805495"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928805495?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928805495&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928805495&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352154615000522"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928805495</prism:url><dc:identifier>SCOPUS_ID:84928805495</dc:identifier><eid>2-s2.0-84928805495</eid><dc:title>Four promising psychological interventions for reducing reactive aggression</dc:title><dc:creator>Denson T.</dc:creator><prism:publicationName>Current Opinion in Behavioral Sciences</prism:publicationName><prism:eIssn>23521546</prism:eIssn><prism:volume>3</prism:volume><prism:pageRange>136-141</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cobeha.2015.04.003</prism:doi><pii>S2352154615000522</pii><dc:description>© 2015 Elsevier Ltd. Anger-driven aggression is difficult to prevent. This article reviews recent experimental basic science research on four interventions designed to reduce reactive aggression: cognitive reappraisal, self-control training, cognitive control training, and mindfulness. The evidence largely supports the effectiveness of these interventions for reducing anger-driven aggression. However, replication is needed in samples other than university students. Moreover, methodological weaknesses qualify the conclusions that can be drawn. Executive functioning is the putative mechanism through which these interventions reduce reactive aggression. Cognitive reappraisal relies on executive functions, whereas there is some evidence that self-control training, cognitive control training, and mindfulness can improve executive functions. Additional research is warranted. Specifically, researchers may consider testing these interventions as supplementary strategies to existing treatments for reactive aggression.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:105145351</affiliation-url><afid>105145351</afid><affilname>School of Psychology</affilname><name-variant>School of Psychology</name-variant><affiliation-city>Sydney</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603311633</author-url><authid>6603311633</authid><authname>Denson T.</authname><surname>Denson</surname><given-name>Thomas F.</given-name><initials>T.F.</initials><afid>105145351</afid></author><intid>35850791</intid><source-id>21100363813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928994938"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928994938?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928994938&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928994938&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928994938</prism:url><dc:identifier>SCOPUS_ID:84928994938</dc:identifier><eid>2-s2.0-84928994938</eid><dc:title>Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review</dc:title><dc:creator>Moore M.</dc:creator><prism:publicationName>Cell and Tissue Banking</prism:publicationName><prism:issn>13899333</prism:issn><prism:volume>16</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>249-259</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10561-014-9467-4</prism:doi><dc:description>© 2014, The Author(s). Decellularized human dermis has been used for a number of clinical applications including wound healing, soft tissue reconstruction, and sports medicine procedures. A variety of methods exist to prepare this useful class of biomaterial. Here, we describe a decellularization technology (MatrACELL&lt;sup&gt;®&lt;/sup&gt;) utilizing a non-denaturing anionic detergent, N-Lauroyl sarcosinate, and endonuclease, which was developed to remove potentially immunogenic material while retaining biomechanical properties. Effective decellularization was demonstrated by a residual DNA content of ≤4 ng/mg of wet weight which represented &gt;97 % DNA removal compared to unprocessed dermis. Two millimeter thick MatrACELL processed human acellular dermal matrix (MH-ADM) exhibited average ultimate tensile load to failure of 635.4 ± 199.9 N and average suture retention strength of 134.9 ± 55.1 N. Using an in vivo mouse skin excisional model, MH-ADM was shown to be biocompatible and capable of supporting cellular and vascular in-growth. Finally, clinical studies of MH-ADM in variety of applications suggest it can be an appropriate scaffold for wound healing, soft tissue reconstruction, and soft tissue augmentation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109994434</affiliation-url><afid>109994434</afid><affilname>Institute of Regenerative Medicine</affilname><name-variant>Center for Regenerative Medicine</name-variant><affiliation-city>Virginia Beach</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7404470524</author-url><authid>7404470524</authid><authname>Moore M.</authname><surname>Moore</surname><given-name>Mark A.</given-name><initials>M.A.</initials><afid>109994434</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37033055300</author-url><authid>37033055300</authid><authname>Samsell B.</authname><surname>Samsell</surname><given-name>Brian</given-name><initials>B.</initials><afid>109994434</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56335194400</author-url><authid>56335194400</authid><authname>Wallis G.</authname><surname>Wallis</surname><given-name>Glenna</given-name><initials>G.</initials><afid>109994434</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56334890800</author-url><authid>56334890800</authid><authname>Triplett S.</authname><surname>Triplett</surname><given-name>Sherry</given-name><initials>S.</initials><afid>109994434</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56335428700</author-url><authid>56335428700</authid><authname>Chen S.</authname><surname>Chen</surname><given-name>Silvia</given-name><initials>S.</initials><afid>109994434</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55475863700</author-url><authid>55475863700</authid><authname>Jones A.</authname><surname>Jones</surname><given-name>Alyce Linthurst</given-name><initials>A.L.</initials><afid>109994434</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56335485200</author-url><authid>56335485200</authid><authname>Qin X.</authname><surname>Qin</surname><given-name>Xiaofei</given-name><initials>X.</initials><afid>109994434</afid></author><authkeywords>Acellular dermal matrix | Allograft | Decellularized | Dermis | Homograft | MatrACELL</authkeywords><intid>535885693</intid><source-id>18439</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925738585"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925738585?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925738585&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925738585&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515000766"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925738585</prism:url><dc:identifier>SCOPUS_ID:84925738585</dc:identifier><eid>2-s2.0-84925738585</eid><dc:title>Parenting style and obesity risk in children</dc:title><dc:creator>Kakinami L.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>75</prism:volume><prism:pageRange>18-22</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.005</prism:doi><pii>S0091743515000766</pii><dc:description>© 2015 Elsevier Inc. Background: Parents play a critical role in their children's lifestyle habits. The objective was to assess the effect of parenting style on the risk of childhood obesity, and to determine whether poverty was a moderator of the association. Methods: Participants were from the 1994-2008 cross-sectional samples of the National Longitudinal Survey of Children and Youth (NLSCY), a nationally representative survey of Canadian youth. Factor and cluster analyses identified four parenting styles consistent with Baumrind's parenting style prototypes. Multivariable logistic regression assessed the risk of obesity based on parenting style after adjusting for covariates. Analyses were stratified by age (preschool: 2-5. years of age, n = 19,026; school-age: 6-11. years of age, n = 18,551) and the moderating effect of poverty (household income &lt; low income cut-offs adjusted for household size and geographic region) was assessed. Analyses used sampling and bootstrap weights. Results: In multivariable analyses, compared to authoritative parenting, preschool- and school-age children with authoritarian parents were 35% (95% CI: 1.2-1.5) and 41% (CI: 1.1-1.8) more likely to be obese, respectively. In preschool children, poverty moderated this association: authoritarian and negligent parenting was associated with 44% (CI: 1.3-1.7) and 26% (CI: 1.1-1.4) increased likelihood of obesity, respectively, but only among the children not living in poverty. In school-age children, poverty was not a moderator. Conclusions: Parenting style is associated with childhood obesity, but may be moderated by poverty. Successful strategies to combat childhood obesity should reflect the independent and interactive associations of sociodemographic and social-familial influences on health especially in early childhood.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002494</affiliation-url><afid>60002494</afid><affilname>McGill University</affilname><name-variant>McGill University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033154</affiliation-url><afid>60033154</afid><affilname>Universite Concordia</affilname><name-variant>Concordia University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033154</affiliation-url><afid>60033154</afid><affilname>Universite Concordia</affilname><name-variant>Concordia University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015717</affiliation-url><afid>60015717</afid><affilname>INRS-Institut Armand Frappier</affilname><name-variant>Université du Québec</name-variant><affiliation-city>Laval</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033154</affiliation-url><afid>60033154</afid><affilname>Universite Concordia</affilname><name-variant>Concordia University</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005610</affiliation-url><afid>60005610</afid><affilname>Chu Sainte Justine</affilname><name-variant>Chu Sainte Justine ^</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009507</affiliation-url><afid>60009507</afid><affilname>Universite de Montreal</affilname><name-variant>University of Montreal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009507</affiliation-url><afid>60009507</afid><affilname>Universite de Montreal</affilname><name-variant>University of Montreal</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12345298100</author-url><authid>12345298100</authid><authname>Kakinami L.</authname><surname>Kakinami</surname><given-name>Lisa</given-name><initials>L.</initials><afid>60002494</afid><afid>60033154</afid><afid>60033154</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12345298100</author-url><authid>12345298100</authid><authname>Kakinami L.</authname><surname>Kakinami</surname><given-name>Lisa</given-name><initials>L.</initials><afid>60002494</afid><afid>60033154</afid><afid>60033154</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:12345298100</author-url><authid>12345298100</authid><authname>Kakinami L.</authname><surname>Kakinami</surname><given-name>Lisa</given-name><initials>L.</initials><afid>60002494</afid><afid>60033154</afid><afid>60033154</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7101910205</author-url><authid>7101910205</authid><authname>Barnett T.</authname><surname>Barnett</surname><given-name>Tracie A.</given-name><initials>T.A.</initials><afid>60015717</afid><afid>60033154</afid><afid>60005610</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7101910205</author-url><authid>7101910205</authid><authname>Barnett T.</authname><surname>Barnett</surname><given-name>Tracie A.</given-name><initials>T.A.</initials><afid>60015717</afid><afid>60033154</afid><afid>60005610</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7101910205</author-url><authid>7101910205</authid><authname>Barnett T.</authname><surname>Barnett</surname><given-name>Tracie A.</given-name><initials>T.A.</initials><afid>60015717</afid><afid>60033154</afid><afid>60005610</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006696915</author-url><authid>7006696915</authid><authname>Séguin L.</authname><surname>Séguin</surname><given-name>Louise</given-name><initials>L.</initials><afid>60009507</afid><afid>60009507</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006696915</author-url><authid>7006696915</authid><authname>Séguin L.</authname><surname>Séguin</surname><given-name>Louise</given-name><initials>L.</initials><afid>60009507</afid><afid>60009507</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55213081600</author-url><authid>55213081600</authid><authname>Paradis G.</authname><surname>Paradis</surname><given-name>Gilles</given-name><initials>G.</initials><afid>60002494</afid></author><authkeywords>Children and adolescents | Obesity | Parenting style | Poverty</authkeywords><intid>1035342828</intid><source-id>17665</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926354552"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926354552?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926354552&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926354552&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000386"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926354552</prism:url><dc:identifier>SCOPUS_ID:84926354552</dc:identifier><eid>2-s2.0-84926354552</eid><dc:title>Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells</dc:title><dc:creator>Jaramillo M.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>89-100</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.01.031</prism:doi><pii>S0891584915000386</pii><dc:description>© 2015 Elsevier Inc. The manganese porphyrin, manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin (MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt;), acts as a pro-oxidant in the presence of intracellular H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;. Mitochondria are the most prominent source of intracellular ROS and important regulators of the intrinsic apoptotic pathway. Due to the increased oxidants near and within the mitochondria, we hypothesized that the mitochondria are a target of the pro-oxidative activity of MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; and that we could exploit this effect to enhance the chemotherapeutic response in lymphoma. In this study, we demonstrate that MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; modulates the mitochondrial redox environment and sensitizes lymphoma cells to antilymphoma chemotherapeutics. MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; increased dexamethasone-induced mitochondrial ROS and oxidation of the mitochondrial glutathione pool in lymphoma cells. The combination treatment induced glutathionylation of Complexes I, III, and IV in the electron transport chain, and decreased the activity of Complexes I and III, but not the activity of Complex IV. Treatment with the porphyrin and dexamethasone also decreased cellular ATP levels. Rho(0) malignant T-cells with impaired mitochondrial electron transport chain function were less sensitive to the combination treatment than wild-type cells. These findings suggest that mitochondria are important for the porphyrin's ability to enhance cell death. MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; also augmented the effects of 2-deoxy-D-glucose (2DG), an antiglycolytic agent. In combination with 2DG, MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; increased protein glutathionylation, decreased ATP levels more than 2DG treatment alone, and enhanced 2DG-induced cell death in primary B-ALL cells. MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; did not enhance dexamethasone- or 2DG-induced cell death in normal cells. Our findings suggest that MnTE-2-PyP&lt;sup&gt;5+&lt;/sup&gt; has potential as an adjuvant for the treatment of hematologic malignancies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010065</affiliation-url><afid>60010065</afid><affilname>University of Arizona</affilname><name-variant>University of Arizona</name-variant><affiliation-city>Tucson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010065</affiliation-url><afid>60010065</afid><affilname>University of Arizona</affilname><name-variant>University of Arizona</name-variant><affiliation-city>Tucson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14062111600</author-url><authid>14062111600</authid><authname>Jaramillo M.</authname><surname>Jaramillo</surname><given-name>Melba C.</given-name><initials>M.C.</initials><afid>60010065</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56584857600</author-url><authid>56584857600</authid><authname>Briehl M.</authname><surname>Briehl</surname><given-name>Margaret M.</given-name><initials>M.M.</initials><afid>60010065</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003877847</author-url><authid>7003877847</authid><authname>Batinic-Haberle I.</authname><surname>Batinic-Haberle</surname><given-name>Ines</given-name><initials>I.</initials><afid>60005200</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56584877200</author-url><authid>56584877200</authid><authname>Tome M.</authname><surname>Tome</surname><given-name>Margaret E.</given-name><initials>M.E.</initials><afid>60010065</afid></author><authkeywords>Glutathionylation | Lymphoma | Mitochondria | MnTE-2-PyP5 (AEOL10113)</authkeywords><intid>35431063</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930226124"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930226124?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930226124&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930226124&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930226124</prism:url><dc:identifier>SCOPUS_ID:84930226124</dc:identifier><eid>2-s2.0-84930226124</eid><dc:title>A note on the dynamics of two aligned bubbles perpendicular to and above a thin membrane</dc:title><dc:creator>Aghdam A.</dc:creator><prism:publicationName>Fluid Dynamics Research</prism:publicationName><prism:issn>01695983</prism:issn><prism:volume>47</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1088/0169-5983/47/3/035503</prism:doi><dc:description>© 2015 The Japan Society of Fluid Mechanics and IOP Publishing Ltd. The interaction of two perpendicular bubbles of a similar size (upper bubble and lower bubble) and the thin elastic membrane beneath them is studied experimentally. The dynamical behavior of the lower bubble (Bubble1), which is placed between the membrane and upper bubble (Bubble2), is rather complex. Observed phenomena such as the splitting of Bubble1 into the 'mushroom shape' and 'masher shape', the bubble-collapse induced jetting toward Bubble2 and even the coalescence effect are found and systematically categorized by the stated dimensionless parameters.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005010</affiliation-url><afid>60005010</afid><affilname>Arak University</affilname><name-variant>Arak University</name-variant><affiliation-city>Arak</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017161</affiliation-url><afid>60017161</afid><affilname>National University of Singapore</affilname><name-variant>National University of Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26665340700</author-url><authid>26665340700</authid><authname>Aghdam A.</authname><surname>Aghdam</surname><given-name>A. Hajizadeh</given-name><initials>A.H.</initials><afid>60005010</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006437595</author-url><authid>7006437595</authid><authname>Khoo B.</authname><surname>Khoo</surname><given-name>B. C.</given-name><initials>B.C.</initials><afid>60017161</afid></author><authkeywords>biomechanics | membrane | perpendicular bubbles</authkeywords><intid>1536088034</intid><article-number>035503</article-number><source-id>18465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925642571"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925642571?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925642571&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925642571&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115000557"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925642571</prism:url><dc:identifier>SCOPUS_ID:84925642571</dc:identifier><eid>2-s2.0-84925642571</eid><dc:title>Reliability of structure tensors in representing soft tissues structure</dc:title><dc:creator>Lanir Y.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>46</prism:volume><prism:pageRange>222-228</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.02.012</prism:doi><pii>S1751616115000557</pii><dc:description>© 2015 Elsevier Ltd. Structure tensors have been applied as descriptors of tissue morphology for constitutive modeling. Here the reliability of these tensors in representing tissues structure is investigated by model simulations of a few examples of generated and measured planar fiber orientation distributions. Reliability was evaluated by comparing the data with the orientation density distribution recovered from the structure tensor representation, and with a orientation density recovered from an alternative representation by Fourier series of spherical harmonics. The results show that except for the case of uniform or close to uniform orientation distributions, the distributions recovered from the structure tensor fit the data poorly. On the other hand, orientation distributions recovered from Fourier series of spherical harmonics converge to the data distributions provided sufficient terms are included in the truncated series. These results suggest that the structure tensor is a reliable descriptor of tissue structure only under very limited cases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022403</affiliation-url><afid>60022403</afid><affilname>Technion - Israel Institute of Technology</affilname><name-variant>Technion</name-variant><affiliation-city>Haifa</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56231388300</author-url><authid>56231388300</authid><authname>Lanir Y.</authname><surname>Lanir</surname><given-name>Yoram</given-name><initials>Y.</initials><afid>60022403</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:13409903300</author-url><authid>13409903300</authid><authname>Namani R.</authname><surname>Namani</surname><given-name>Ravi</given-name><initials>R.</initials><afid>60022403</afid></author><authkeywords>Constitutive properties | Fourier series | Model simulation | Representation reliability | Structure tensors | Tissue mechanics</authkeywords><intid>1535328552</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924585655"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924585655?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924585655&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924585655&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000720"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924585655</prism:url><dc:identifier>SCOPUS_ID:84924585655</dc:identifier><eid>2-s2.0-84924585655</eid><dc:title>What are the main barriers to healthy eating among families? A qualitative exploration of perceptions and experiences of Tehranian men</dc:title><dc:creator>Farahmand M.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>291-297</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.02.025</prism:doi><pii>S0195666315000720</pii><dc:description>© 2015. Despite women playing a pivotal role in shaping nutritional patterns in their families, it is the men whose ideas and preferences, after children, influence the selection and consumption of daily foods among Iranian families. This study focused on exploring the main barriers to healthy eating as experienced by male participants of the Tehran Lipid Glucose Study (TLGS). A grounded theory approach was used for analyzing participants' experiences and their perceptions regarding these barriers. Participants were 98 men, aged 25-65 years, selected and recruited from the TGLS cohort. Data collection was conducted through fourteen semi-structured focus group discussions, between 2008 and 2009. All interviews and focus group discussions were audio recorded and transcribed verbatim. Constant comparative analysis of the data was conducted manually according to the Strauss and Corbin analysis method. The most important barriers to healthy eating were: (i) Personal factors, which included two subthemes - lack of knowledge and personal taste, (ii) Communication and modeling included two subthemes - other individuals and media/advertisements; (iii) Modernization included two subthemes - nutrition transition and women's role; and (iv) Lack of access to healthy foods, which included four subthemes - Inadequate confidence, perceived risk, high cost and time limitations. Appropriate attention and prioritized policy-making to modify the socio-environmental barriers to healthy eating were explored in the current study, along with effective educational programs that could help to promote healthy eating among Iranian families.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018934</affiliation-url><afid>60018934</afid><affilname>Shahid Beheshti University of Medical Sciences</affilname><name-variant>Shahid Beheshti University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018934</affiliation-url><afid>60018934</afid><affilname>Shahid Beheshti University of Medical Sciences</affilname><name-variant>Shahid Beheshti University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018934</affiliation-url><afid>60018934</afid><affilname>Shahid Beheshti University of Medical Sciences</affilname><name-variant>Shahid Beheshti University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018934</affiliation-url><afid>60018934</afid><affilname>Shahid Beheshti University of Medical Sciences</affilname><name-variant>Shahid Beheshti University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018934</affiliation-url><afid>60018934</afid><affilname>Shahid Beheshti University of Medical Sciences</affilname><name-variant>Shahid Beheshti University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35744463700</author-url><authid>35744463700</authid><authname>Farahmand M.</authname><surname>Farahmand</surname><given-name>Maryam</given-name><initials>M.</initials><afid>60018934</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24176789900</author-url><authid>24176789900</authid><authname>Amiri P.</authname><surname>Amiri</surname><given-name>Parisa</given-name><initials>P.</initials><afid>60018934</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35387059500</author-url><authid>35387059500</authid><authname>Ramezani Tehrani F.</authname><surname>Ramezani Tehrani</surname><given-name>Fahimeh</given-name><initials>F.</initials><afid>60018934</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26423157300</author-url><authid>26423157300</authid><authname>Momenan A.</authname><surname>Momenan</surname><given-name>Amir Abbas</given-name><initials>A.A.</initials><afid>60018934</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602877078</author-url><authid>6602877078</authid><authname>Mirmiran P.</authname><surname>Mirmiran</surname><given-name>Parvin</given-name><initials>P.</initials><afid>60018934</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56174746500</author-url><authid>56174746500</authid><authname>Azizi F.</authname><surname>Azizi</surname><given-name>Fereidoun</given-name><initials>F.</initials><afid>60018934</afid></author><authkeywords>Barriers | Healthy nutrition | Non-communicable diseases | Qualitative study</authkeywords><intid>2035163592</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928920275"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928920275?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928920275&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928920275&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928920275</prism:url><dc:identifier>SCOPUS_ID:84928920275</dc:identifier><eid>2-s2.0-84928920275</eid><dc:title>β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians</dc:title><dc:creator>Yabe D.</dc:creator><prism:publicationName>Current Diabetes Reports</prism:publicationName><prism:issn>15344827</prism:issn><prism:eIssn>15390829</prism:eIssn><prism:volume>15</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11892-015-0602-9</prism:doi><dc:description>© 2015, The Author(s). Type 2 diabetes (T2DM) is one of the most serious global health problems and is mainly a result of the drastic increase in East Asia, which includes over a fourth of the global diabetes population. Lifestyle factors and ethnicity are two determinants in the etiology of T2DM, and lifestyle changes such as higher fat intake and less physical activity link readily to T2DM in East Asians. It is widely recognized that T2DM in East Asians is characterized primarily by β cell dysfunction, which is evident immediately after ingestion of glucose or meal, and less adiposity compared to the disease in Caucasians. These pathophysiological differences have an important impact on therapeutic approaches. Here, we revisit the pathogenesis of T2DM in light of β cell dysfunction versus insulin resistance in East Asians and discuss ethnic differences in the contributions of insulin secretion and insulin resistance, together with incretin secretin and action, to glucose intolerance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032227</affiliation-url><afid>60032227</afid><affilname>Kansai Electric Power</affilname><name-variant>Kansai Electric Power Co., Inc.</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032227</affiliation-url><afid>60032227</afid><affilname>Kansai Electric Power</affilname><name-variant>Kansai Electric Power Co., Inc.</name-variant><affiliation-city>Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026363</affiliation-url><afid>60026363</afid><affilname>Kobe University School of Medicine</affilname><name-variant>Kobe Univ. Sch. Med.</name-variant><affiliation-city>Kobe</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028768</affiliation-url><afid>60028768</afid><affilname>Okayama Prefectural University</affilname><name-variant>Okayama Prefectural University</name-variant><affiliation-city>Soja</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602972745</author-url><authid>6602972745</authid><authname>Yabe D.</authname><surname>Yabe</surname><given-name>Daisuke</given-name><initials>D.</initials><afid>60032227</afid><afid>60032227</afid><afid>60026363</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602972745</author-url><authid>6602972745</authid><authname>Yabe D.</authname><surname>Yabe</surname><given-name>Daisuke</given-name><initials>D.</initials><afid>60032227</afid><afid>60032227</afid><afid>60026363</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602972745</author-url><authid>6602972745</authid><authname>Yabe D.</authname><surname>Yabe</surname><given-name>Daisuke</given-name><initials>D.</initials><afid>60032227</afid><afid>60032227</afid><afid>60026363</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56410449800</author-url><authid>56410449800</authid><authname>Seino Y.</authname><surname>Seino</surname><given-name>Yutaka</given-name><initials>Y.</initials><afid>60032227</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622133200</author-url><authid>56622133200</authid><authname>Fukushima M.</authname><surname>Fukushima</surname><given-name>Mitsuo</given-name><initials>M.</initials><afid>60032227</afid><afid>60026363</afid><afid>60028768</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622133200</author-url><authid>56622133200</authid><authname>Fukushima M.</authname><surname>Fukushima</surname><given-name>Mitsuo</given-name><initials>M.</initials><afid>60032227</afid><afid>60026363</afid><afid>60028768</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56622133200</author-url><authid>56622133200</authid><authname>Fukushima M.</authname><surname>Fukushima</surname><given-name>Mitsuo</given-name><initials>M.</initials><afid>60032227</afid><afid>60026363</afid><afid>60028768</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56622419700</author-url><authid>56622419700</authid><authname>Seino S.</authname><surname>Seino</surname><given-name>Susumu</given-name><initials>S.</initials><afid>60026363</afid></author><authkeywords>East Asian | Incretin | Insulin resistance | Insulin secretion | Type 2 diabetes</authkeywords><intid>1535862037</intid><source-id>25465</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930182280"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930182280?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930182280&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930182280&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1878540915000262"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930182280</prism:url><dc:identifier>SCOPUS_ID:84930182280</dc:identifier><eid>2-s2.0-84930182280</eid><dc:title>Editorial: Silent myocardial ischemia due to coronary artery spasm</dc:title><dc:creator>Kosuge M.</dc:creator><prism:publicationName>Journal of Cardiology Cases</prism:publicationName><prism:issn>18785409</prism:issn><prism:eIssn>18785409</prism:eIssn><prism:volume>11</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>169-170</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jccase.2015.03.005</prism:doi><pii>S1878540915000262</pii><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027130</affiliation-url><afid>60027130</afid><affilname>Yokohama City University Hospital</affilname><name-variant>Yokohama City University Hospital</name-variant><affiliation-city>Yokohama</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ed</subtype><subtypeDescription>Editorial</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005350677</author-url><authid>7005350677</authid><authname>Kosuge M.</authname><surname>Kosuge</surname><given-name>Masami</given-name><initials>M.</initials><afid>60027130</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56579530400</author-url><authid>56579530400</authid><authname>Kimura K.</authname><surname>Kimura</surname><given-name>Kazuo</given-name><initials>K.</initials><afid>60027130</afid></author><authkeywords>Coronary artery spasm | Diagnosis | Silent ischemia</authkeywords><intid>2036074467</intid><source-id>19600156852</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929471882"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929471882?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929471882&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929471882&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352187215300036"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929471882</prism:url><dc:identifier>SCOPUS_ID:84929471882</dc:identifier><eid>2-s2.0-84929471882</eid><dc:title>Sirolimus and tacrolimus rather than cyclosporine A cause bone loss in healthy adult male rats</dc:title><dc:creator>Rubert M.</dc:creator><prism:publicationName>Bone Reports</prism:publicationName><prism:eIssn>23521872</prism:eIssn><prism:volume>2</prism:volume><prism:pageRange>74-81</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bonr.2015.05.003</prism:doi><pii>S2352187215300036</pii><dc:description>© 2015. The aim of this work was to study the effects of cyclosporine (CsA), tacrolimus (FK-506), and rapamycin (RAPA) on bone mass, femoral microstructure, femoral biomechanical properties, and bone remodeling in healthy adult male rats.Forty-eight 5-month-old male Wistar rats were used. CsA (2. mg/kg/day), FK-506 (3. mg/kg/day), RAPA (1.25. mg/kg/day), or water (0.5. ml/rat/day, control group) were administered orally for 3. months.After sacrifice, mean values of immunosuppressants in blood were: CsA (670.4. ng/ml), FK-506 (19.2. ng/ml), and RAPA (4.8. ng/ml). Levels of biochemical parameters were normal in all groups. Femoral BMD was decreased in FK-506 and RAPA groups and lumbar BMD in FK-506 group. Trabecular volume fraction (BV/TV) decreased only in FK-506 group. RAPA and CsA affected femoral cortical structure, but FK-506 did not. FK-506 produced an increase in bone remodeling, and CsA a decrease. FK-506 group showed a decrease in biomechanical parameters relative to all groups. RAPA group showed a decrease in ultimate stress vs control group, and CsA group presented an increase in biomechanical parameters versus control group.We found that administration of both RAPA and FK-506 as monotherapy for healthy rats produced osteopenia. CsA treatment only produces slight damages in the cortical zone of the femur.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019290</affiliation-url><afid>60019290</afid><affilname>Fundacion Jimenez Diaz</affilname><name-variant>Fundacion Jimenez Diaz</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112426262</affiliation-url><afid>112426262</afid><affilname>Technological Park of Galicia</affilname><name-variant>Meat Technological Centre of Galicia</name-variant><affiliation-city>Orense</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002983</affiliation-url><afid>60002983</afid><affilname>Complejo Hospitalario Universitario de Santiago</affilname><name-variant>Hospital Clinico Universitario</name-variant><affiliation-city>Santiago de Compostela</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019290</affiliation-url><afid>60019290</afid><affilname>Fundacion Jimenez Diaz</affilname><name-variant>Fundacion Jimenez Diaz</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55658083500</author-url><authid>55658083500</authid><authname>Rubert M.</authname><surname>Rubert</surname><given-name>Mercedes</given-name><initials>M.</initials><afid>60019290</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55658084400</author-url><authid>55658084400</authid><authname>Montero M.</authname><surname>Montero</surname><given-name>Mercedes</given-name><initials>M.</initials><afid>60019290</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36617372600</author-url><authid>36617372600</authid><authname>Guede D.</authname><surname>Guede</surname><given-name>David</given-name><initials>D.</initials><afid>112426262</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24174023500</author-url><authid>24174023500</authid><authname>Caeiro J.</authname><surname>Caeiro</surname><given-name>Jose Ramón</given-name><initials>J.R.</initials><afid>60002983</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55470267300</author-url><authid>55470267300</authid><authname>Martín-Fernández M.</authname><surname>Martín-Fernández</surname><given-name>Marta</given-name><initials>M.</initials><afid>60019290</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55951265800</author-url><authid>55951265800</authid><authname>Díaz-Curiel M.</authname><surname>Díaz-Curiel</surname><given-name>Manuel</given-name><initials>M.</initials><afid>60019290</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006852587</author-url><authid>7006852587</authid><authname>de la Piedra C.</authname><surname>de la Piedra</surname><given-name>Concepción</given-name><initials>C.</initials><afid>60019290</afid></author><authkeywords>Bone quality | Cyclosporine | Immunosuppressants | Osteopenia | Rapamycin | Tacrolimus</authkeywords><intid>1535963480</intid><source-id>21100386862</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926626505"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926626505?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926626505&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926626505&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0969996115000595"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926626505</prism:url><dc:identifier>SCOPUS_ID:84926626505</dc:identifier><eid>2-s2.0-84926626505</eid><dc:title>D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly</dc:title><dc:creator>Barroso-Chinea P.</dc:creator><prism:publicationName>Neurobiology of Disease</prism:publicationName><prism:issn>09699961</prism:issn><prism:eIssn>1095953X</prism:eIssn><prism:volume>78</prism:volume><prism:pageRange>77-87</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.nbd.2015.02.024</prism:doi><pii>S0969996115000595</pii><dc:description>© 2015 Elsevier Inc. Among the mechanisms underlying the development of L-dopa-induced dyskinesia (LID) in Parkinson's disease, complex alterations in dopamine signaling in D1 receptor (D1R)-expressing medium spiny striatal neurons have been unraveled such as, but not limited to, dysregulation of D1R expression, lateral diffusion, intraneuronal trafficking, subcellular localization and desensitization, leading to a pathological anchorage of D1R at the plasma membrane. Such anchorage is partly due to a decreased proteasomal activity that is specific of the L-dopa-exposed dopamine-depleted striatum, results from D1R activation and feeds-back the D1R exaggerated cell surface abundance. The precise mechanisms by which L-dopa affects striatal proteasome activity remained however unknown. We here show, in a series of in vitro ex vivo and in vivo models, that such rapid modulation of striatal proteasome activity intervenes through D1R-mediated disassembly of the 26S proteasome rather than change in transcription or translation of proteasome or proteasome subunits intraneuronal relocalization.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102125</affiliation-url><afid>60102125</afid><affilname>Universite de Bordeaux</affilname><name-variant>Université de Bordeaux</name-variant><affiliation-city>Bordeaux</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008134</affiliation-url><afid>60008134</afid><affilname>CNRS Centre National de la Recherche Scientifique</affilname><name-variant>CNRS</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8113611800</author-url><authid>8113611800</authid><authname>Barroso-Chinea P.</authname><surname>Barroso-Chinea</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8113611800</author-url><authid>8113611800</authid><authname>Barroso-Chinea P.</authname><surname>Barroso-Chinea</surname><given-name>Pedro</given-name><initials>P.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:40262701200</author-url><authid>40262701200</authid><authname>Thiolat M.</authname><surname>Thiolat</surname><given-name>Marie Laure</given-name><initials>M.L.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:40262701200</author-url><authid>40262701200</authid><authname>Thiolat M.</authname><surname>Thiolat</surname><given-name>Marie Laure</given-name><initials>M.L.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37025502200</author-url><authid>37025502200</authid><authname>Bido S.</authname><surname>Bido</surname><given-name>Simone</given-name><initials>S.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37025502200</author-url><authid>37025502200</authid><authname>Bido S.</authname><surname>Bido</surname><given-name>Simone</given-name><initials>S.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55264090200</author-url><authid>55264090200</authid><authname>Martinez A.</authname><surname>Martinez</surname><given-name>Audrey</given-name><initials>A.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55264090200</author-url><authid>55264090200</authid><authname>Martinez A.</authname><surname>Martinez</surname><given-name>Audrey</given-name><initials>A.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24385252900</author-url><authid>24385252900</authid><authname>Doudnikoff E.</authname><surname>Doudnikoff</surname><given-name>Evelyne</given-name><initials>E.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24385252900</author-url><authid>24385252900</authid><authname>Doudnikoff E.</authname><surname>Doudnikoff</surname><given-name>Evelyne</given-name><initials>E.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6505907151</author-url><authid>6505907151</authid><authname>Baufreton J.</authname><surname>Baufreton</surname><given-name>JérÔme</given-name><initials>J.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6505907151</author-url><authid>6505907151</authid><authname>Baufreton J.</authname><surname>Baufreton</surname><given-name>JérÔme</given-name><initials>J.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55647724000</author-url><authid>55647724000</authid><authname>Bourdenx M.</authname><surname>Bourdenx</surname><given-name>Mathieu</given-name><initials>M.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55647724000</author-url><authid>55647724000</authid><authname>Bourdenx M.</authname><surname>Bourdenx</surname><given-name>Mathieu</given-name><initials>M.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56585512000</author-url><authid>56585512000</authid><authname>Bloch B.</authname><surname>Bloch</surname><given-name>Bertrand</given-name><initials>B.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56585512000</author-url><authid>56585512000</authid><authname>Bloch B.</authname><surname>Bloch</surname><given-name>Bertrand</given-name><initials>B.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003445480</author-url><authid>7003445480</authid><authname>Bezard E.</authname><surname>Bezard</surname><given-name>Erwan</given-name><initials>E.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003445480</author-url><authid>7003445480</authid><authname>Bezard E.</authname><surname>Bezard</surname><given-name>Erwan</given-name><initials>E.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6506170953</author-url><authid>6506170953</authid><authname>Martin-Negrier M.</authname><surname>Martin-Negrier</surname><given-name>Marie Laure</given-name><initials>M.L.</initials><afid>60102125</afid><afid>60008134</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6506170953</author-url><authid>6506170953</authid><authname>Martin-Negrier M.</authname><surname>Martin-Negrier</surname><given-name>Marie Laure</given-name><initials>M.L.</initials><afid>60102125</afid><afid>60008134</afid></author><authkeywords>Catalytic activity | Cellular localization | Dopamine D1 receptor | Dyskinesia | Membrane anchoring | Proteasome | Unit dissociations</authkeywords><intid>1035480886</intid><source-id>17466</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929992435"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929992435?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929992435&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929992435&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929992435</prism:url><dc:identifier>SCOPUS_ID:84929992435</dc:identifier><eid>2-s2.0-84929992435</eid><dc:title>Switching from rivaroxaban to warfarin: An open label pharmacodynamic study in healthy subjects</dc:title><dc:creator>Moore K.</dc:creator><prism:publicationName>British Journal of Clinical Pharmacology</prism:publicationName><prism:issn>03065251</prism:issn><prism:eIssn>13652125</prism:eIssn><prism:volume>79</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>907-917</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bcp.12559</prism:doi><dc:description>© 2014 The Authors. British Journal of Clinical Pharmacology published by John Wiley &amp; Sons Ltd on behalf of The British Pharmacological Society. Aims The primary objective was to explore the pharmacodynamic changes during transition from rivaroxaban to warfarin in healthy subjects. Safety, tolerability and pharmacokinetics were assessed as secondary objectives. Methods An open label, non-randomized, sequential two period study. In treatment period 1 (TP1), subjects received rivaroxaban 20 mg once daily (5 days), followed by co-administration with a warfarin loading dose regimen of 5 or 10 mg (for the 10 mg regimen, the dose could be uptitrated to attain target international normalized ratio [INR] ≥2.0) once daily (2-4 days). When trough INR values ≥2.0 were attained, rivaroxaban was discontinued and warfarin treatment continued as monotherapy (INR 2.0-3.0). During treatment period 2, subjects received the same warfarin regimen as in TP1, but without rivaroxaban. Results During co-administration, maximum INR and prothrombin time (PT) values were higher than with rivaroxaban or warfarin monotherapy. The mean maximum effect (E&lt;inf&gt;max&lt;/inf&gt;) for INR after co-administration was 2.79-4.15 (mean PT E&lt;inf&gt;max&lt;/inf&gt; 41.0-62.7 s), compared with 1.41-1.74 (mean PT E&lt;inf&gt;max&lt;/inf&gt; 20.1-25.2 s) for warfarin alone. However, rivaroxaban had the smallest effect on INR at trough rivaroxaban concentrations. Neither rivaroxaban nor warfarin significantly affected maximum plasma concentrations of the other drug. Conclusions The combined pharmacodynamic effects during co-administration of rivaroxaban and warfarin were greater than additive, but the pharmacokinetics of both drugs were unaffected. Co-administration was well tolerated. When transitioning from rivaroxaban to warfarin, INR monitoring during co-administration should be performed at the trough rivaroxaban concentration to minimize the effect of rivaroxaban on INR.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027736</affiliation-url><afid>60027736</afid><affilname>Janssen</affilname><name-variant>Janssen Research Foundation</name-variant><affiliation-city>Titusville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027736</affiliation-url><afid>60027736</afid><affilname>Janssen</affilname><name-variant>Janssen Research Foundation</name-variant><affiliation-city>Titusville</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112611652</affiliation-url><afid>112611652</afid><affilname>Janssen Research and Development, LLC</affilname><name-variant>Janssen Research and Development, LLC</name-variant><affiliation-city>Malvern</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107029536</affiliation-url><afid>107029536</afid><affilname>Clinical Pharmacology Unit Antwerpen</affilname><name-variant>Clinical Pharmacology Unit</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36626003600</author-url><authid>36626003600</authid><authname>Moore K.</authname><surname>Moore</surname><given-name>Kenneth Todd</given-name><initials>K.T.</initials><afid>60027736</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55274646100</author-url><authid>55274646100</authid><authname>Byra W.</authname><surname>Byra</surname><given-name>William</given-name><initials>W.</initials><afid>60027736</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56161577200</author-url><authid>56161577200</authid><authname>Vaidyanathan S.</authname><surname>Vaidyanathan</surname><given-name>Seema</given-name><initials>S.</initials><afid>112611652</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603669982</author-url><authid>6603669982</authid><authname>Natarajan J.</authname><surname>Natarajan</surname><given-name>Jaya</given-name><initials>J.</initials><afid>60027736</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:36624769100</author-url><authid>36624769100</authid><authname>Ariyawansa J.</authname><surname>Ariyawansa</surname><given-name>Jay</given-name><initials>J.</initials><afid>60027736</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56658417100</author-url><authid>56658417100</authid><authname>Salih H.</authname><surname>Salih</surname><given-name>Hiba</given-name><initials>H.</initials><afid>107029536</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8106104800</author-url><authid>8106104800</authid><authname>Turner K.</authname><surname>Turner</surname><given-name>Kenneth C.</given-name><initials>K.C.</initials><afid>60027736</afid></author><authkeywords>pharmacodynamic | pharmacokinetic | rivaroxaban | switching | warfarin</authkeywords><intid>1036045163</intid><source-id>20082</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930200802"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930200802?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930200802&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930200802&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930200802</prism:url><dc:identifier>SCOPUS_ID:84930200802</dc:identifier><eid>2-s2.0-84930200802</eid><dc:title>Ambient particulate matter air pollution and cardiopulmonary diseases</dc:title><dc:creator>Thurston G.</dc:creator><prism:publicationName>Seminars in Respiratory and Critical Care Medicine</prism:publicationName><prism:issn>10693424</prism:issn><prism:eIssn>10989048</prism:eIssn><prism:volume>36</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>422-432</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1055/s-0035-1549455</prism:doi><dc:description>Copyright © 2015 by Thieme Medical Publishers, Inc. Population exposures to ambient outdoor particulate matter (PM) air pollution have been assessed to represent a major burden on global health. Ambient PM is a diverse class of air pollution, with characteristics and health implications that can vary depending on a host of factors, including a particle's original source of emission or formation. The penetration of inhaled particles into the thorax is dependent on their deposition in the upper respiratory tract during inspiration, which varies with particle size, flow rate and tidal volume, and in vivo airway dimensions. All of these factors can be quite variable from person to person, depending on age, transient illness, cigarette smoke and other short-term toxicant exposures that cause transient bronchoconstriction, and occupational history associated with loss of lung function or cumulative injury. The adverse effects of inhaled PM can result from both short-term (acute) and long-term (chronic) exposures to PM, and can range from relatively minor, such as increased symptoms, to very severe effects, including increased risk of premature mortality and decreased life expectancy from long-term exposure. Control of the most toxic PM components can therefore provide major health benefits, and can help guide the selection of the most human health optimal air quality control and climate change mitigation policy measures. As such, a continued improvement in our understanding of the nature and types of PM that are most dangerous to health, and the mechanism(s) of their respective health effects, is an important public health goal.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021784</affiliation-url><afid>60021784</afid><affilname>New York University</affilname><name-variant>New York University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102270013</author-url><authid>7102270013</authid><authname>Thurston G.</authname><surname>Thurston</surname><given-name>George</given-name><initials>G.</initials><afid>60021784</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56228715800</author-url><authid>56228715800</authid><authname>Lippmann M.</authname><surname>Lippmann</surname><given-name>Morton</given-name><initials>M.</initials><afid>60021784</afid></author><authkeywords>climate co-benefits | lung deposition | morbidity | mortality | particulate matter</authkeywords><intid>1536087595</intid><source-id>19086</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929317924"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929317924?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929317924&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929317924&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0169260715000978"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929317924</prism:url><dc:identifier>SCOPUS_ID:84929317924</dc:identifier><eid>2-s2.0-84929317924</eid><dc:title>An Entropy-Based Noninvasive Cardiac Imaging of Atrial Fibrillation</dc:title><dc:creator>Yang T.</dc:creator><prism:publicationName>Journal of Medical Devices, Transactions of the ASME</prism:publicationName><prism:issn>19326181</prism:issn><prism:eIssn>1932619X</prism:eIssn><prism:volume>9</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>1-2</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4030123</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56488981000</author-url><authid>56488981000</authid><authname>Yang T.</authname><surname>Yang</surname><given-name>Ting</given-name><initials>T.</initials><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56464476300</author-url><authid>56464476300</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Long</given-name><initials>L.</initials><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56376969800</author-url><authid>56376969800</authid><authname>He B.</authname><surname>He</surname><given-name>Bin</given-name><initials>B.</initials><afid>60005745</afid><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56376969800</author-url><authid>56376969800</authid><authname>He B.</authname><surname>He</surname><given-name>Bin</given-name><initials>B.</initials><afid>60005745</afid><afid>60005745</afid></author><intid>1535944052</intid><source-id>11700154387</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929207225"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929207225?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929207225&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929207225&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929207225</prism:url><dc:identifier>SCOPUS_ID:84929207225</dc:identifier><eid>2-s2.0-84929207225</eid><dc:title>Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864</dc:title><dc:creator>Wang Y.</dc:creator><prism:publicationName>British Journal of Pharmacology</prism:publicationName><prism:issn>00071188</prism:issn><prism:eIssn>14765381</prism:eIssn><prism:volume>172</prism:volume><prism:issueIdentifier>11</prism:issueIdentifier><prism:pageRange>2905-2917</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bph.13099</prism:doi><dc:description>© 2015 The British Pharmacological Society. Background and Purpose Medical therapy of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) targets smooth muscle contraction in the prostate, or prostate growth. However, current therapeutic options are insufficient. Here, we investigated the role of Rac in the control of smooth muscle tone in human prostates and growth of prostate stromal cells. Experimental Approach Experiments were performed using human prostate tissues from radical prostatectomy and cultured stromal cells (WPMY-1). Expression of Rac was examined by Western blot and fluorescence staining. Effects of Rac inhibitors (NSC23766 and EHT1864) on contractility were assessed in the organ bath. The effects of Rac inhibitors were assessed by pull-down, cytotoxicity using a cell counting kit, cytoskeletal organization by phalloidin staining and cell growth using an 5-ethynyl-2′-deoxyuridine assay. Key Results Expression of Rac1-3 was observed in prostate samples from each patient. Immunoreactivity for Rac1-3 was observed in the stroma, where it colocalized with the smooth muscle marker, calponin. NSC23766 and EHT1864 significantly reduced contractions of prostate strips induced by noradrenaline, phenylephrine or electrical field stimulation. NSC23766 and EHT1864 inhibited Rac activity in WPMY-1 cells. Survival of WPMY-1 cells ranged between 64 and 81% after incubation with NSC23766 (50 or 100 μM) or EHT1864 (25 μM) for 24 h. NSC23766 and EHT1864 induced cytoskeletal disorganization in WPMY-1 cells. Both inhibitors impaired the growth of WPMY-1 cells. Conclusions and Implications Rac may be a link connecting the control of prostate smooth muscle tone with proliferation of smooth muscle cells. Improvements in LUTS suggestive of BPH by Rac inhibitors appears possible.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028717</affiliation-url><afid>60028717</afid><affilname>Ludwig-Maximilians-Universitat Munchen</affilname><name-variant>University of Munich</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60089929</affiliation-url><afid>60089929</afid><affilname>Zhujiang Hospital</affilname><name-variant>Southern Medical University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101187160</affiliation-url><afid>101187160</afid><affilname>University Hospital for Urology and Andrology</affilname><name-variant>University Clinic of Urology and Andrology</name-variant><affiliation-city>Salzburg</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641364900</author-url><authid>56641364900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60028717</afid><afid>60089929</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641364900</author-url><authid>56641364900</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Y.</given-name><initials>Y.</initials><afid>60028717</afid><afid>60089929</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36711887800</author-url><authid>36711887800</authid><authname>Kunit T.</authname><surname>Kunit</surname><given-name>T.</given-name><initials>T.</initials><afid>60028717</afid><afid>101187160</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36711887800</author-url><authid>36711887800</authid><authname>Kunit T.</authname><surname>Kunit</surname><given-name>T.</given-name><initials>T.</initials><afid>60028717</afid><afid>101187160</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56486071700</author-url><authid>56486071700</authid><authname>Ciotkowska A.</authname><surname>Ciotkowska</surname><given-name>A.</given-name><initials>A.</initials><afid>60028717</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54788342900</author-url><authid>54788342900</authid><authname>Rutz B.</authname><surname>Rutz</surname><given-name>B.</given-name><initials>B.</initials><afid>60028717</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35771555300</author-url><authid>35771555300</authid><authname>Schreiber A.</authname><surname>Schreiber</surname><given-name>A.</given-name><initials>A.</initials><afid>60028717</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:21234554600</author-url><authid>21234554600</authid><authname>Strittmatter F.</authname><surname>Strittmatter</surname><given-name>F.</given-name><initials>F.</initials><afid>60028717</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6701419090</author-url><authid>6701419090</authid><authname>Waidelich R.</authname><surname>Waidelich</surname><given-name>R.</given-name><initials>R.</initials><afid>60028717</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640383800</author-url><authid>56640383800</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>C.</given-name><initials>C.</initials><afid>60089929</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36068591400</author-url><authid>36068591400</authid><authname>Stief C.</authname><surname>Stief</surname><given-name>C. G.</given-name><initials>C.G.</initials><afid>60028717</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:10439205000</author-url><authid>10439205000</authid><authname>Gratzke C.</authname><surname>Gratzke</surname><given-name>C.</given-name><initials>C.</initials><afid>60028717</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8528466400</author-url><authid>8528466400</authid><authname>Hennenberg M.</authname><surname>Hennenberg</surname><given-name>M.</given-name><initials>M.</initials><afid>60028717</afid></author><intid>35917643</intid><source-id>20084</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925342514"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925342514?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925342514&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925342514&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0924424715001016"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925342514</prism:url><dc:identifier>SCOPUS_ID:84925342514</dc:identifier><eid>2-s2.0-84925342514</eid><dc:title>Angled-focused 45 MHz PMN-PT single element transducer for intravascular ultrasound imaging</dc:title><dc:creator>Yoon S.</dc:creator><prism:publicationName>Sensors and Actuators, A: Physical</prism:publicationName><prism:issn>09244247</prism:issn><prism:volume>228</prism:volume><prism:pageRange>16-22</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.sna.2015.02.037</prism:doi><pii>S0924424715001016</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. A transducer with an angled and focused aperture for intravascular ultrasound imaging has been developed. The acoustic stack for the angled-focused transducer was made of PMN-PT single crystal with one matching layer, one protective coating layer, and a highly damped backing layer. It was then press-focused to a desired focal length and inserted into a thin needle housing with an angled tip. A transducer with an angled and unfocused aperture was also made, following the same fabrication procedure, to compare the performance of the two transducers. The focused and unfocused transducers were tested to measure their center frequencies, bandwidths, and spatial resolutions. Lateral resolution of the angled-focused transducer (AFT) improved more than two times compared to that of the angled-unfocused transducer (AUT). A tissue-mimicking phantom in water and a rabbit aorta tissue sample in rabbit blood were scanned using AFT and AUT. Imaging with AFT offered improved contrast, over imaging with AUT, of the tissue-mimicking phantom and the rabbit aorta tissue sample by 23 dB and 8 dB, respectively. The results show that AFT has strong potential to provide morphological and pathological information of coronary arteries with high resolution and high contrast.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029311</affiliation-url><afid>60029311</afid><affilname>University of Southern California</affilname><name-variant>University of Southern California</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009387</affiliation-url><afid>60009387</afid><affilname>Dongguk University, Seoul</affilname><name-variant>Dongguk University-Seoul</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114536123</affiliation-url><afid>114536123</afid><affilname>IBULE Photonics Co., Ltd.</affilname><name-variant>IBULE Photonics Co., Ltd.</name-variant><affiliation-city>Incheon</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60077574</affiliation-url><afid>60077574</afid><affilname>Analogic Corporation</affilname><name-variant>Analogic Corp</name-variant><affiliation-city>Peabody</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56248227000</author-url><authid>56248227000</authid><authname>Yoon S.</authname><surname>Yoon</surname><given-name>Sangpil</given-name><initials>S.</initials><afid>60029311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55728507500</author-url><authid>55728507500</authid><authname>Williams J.</authname><surname>Williams</surname><given-name>Jay</given-name><initials>J.</initials><afid>60029311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55161689500</author-url><authid>55161689500</authid><authname>Kang B.</authname><surname>Kang</surname><given-name>Bong Jin</given-name><initials>B.J.</initials><afid>60029311</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56428470900</author-url><authid>56428470900</authid><authname>Yoon C.</authname><surname>Yoon</surname><given-name>Changhan</given-name><initials>C.</initials><afid>60029311</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55516771000</author-url><authid>55516771000</authid><authname>Cabrera-Munoz N.</authname><surname>Cabrera-Munoz</surname><given-name>Nestor</given-name><initials>N.</initials><afid>60029311</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56564585900</author-url><authid>56564585900</authid><authname>Jeong J.</authname><surname>Jeong</surname><given-name>Jong Seob</given-name><initials>J.S.</initials><afid>60009387</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56564375000</author-url><authid>56564375000</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Sang Goo</given-name><initials>S.G.</initials><afid>114536123</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7102541626</author-url><authid>7102541626</authid><authname>Shung K.</authname><surname>Shung</surname><given-name>K. Kirk</given-name><initials>K.K.</initials><afid>60029311</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56162246100</author-url><authid>56162246100</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Hyung Ham</given-name><initials>H.H.</initials><afid>60029311</afid><afid>60077574</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56162246100</author-url><authid>56162246100</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Hyung Ham</given-name><initials>H.H.</initials><afid>60029311</afid><afid>60077574</afid></author><authkeywords>Angled-focused transducer | Contrast | Coronary stenosis evaluation | High frequency transducer | Intravascular ultrasound (IVUS) imaging | Rabbit aorta</authkeywords><intid>1535280035</intid><source-id>13660</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924674423"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924674423?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924674423&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924674423&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0039914015000983"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924674423</prism:url><dc:identifier>SCOPUS_ID:84924674423</dc:identifier><eid>2-s2.0-84924674423</eid><dc:title>Evaluation of vibrational spectroscopic methods to identify and quantify multiple adulterants in herbal medicines</dc:title><dc:creator>Rooney J.</dc:creator><prism:publicationName>Talanta</prism:publicationName><prism:issn>00399140</prism:issn><prism:volume>138</prism:volume><prism:pageRange>77-85</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.talanta.2015.02.016</prism:doi><pii>S0039914015000983</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. To counter the growth of herbal medicines adulterated with pharmaceuticals crossing borders, rapid, inexpensive and non-destructive analytical techniques, that can handle complex matrices, are required. Since mid-infrared (MIR), near infrared (NIR) and Raman spectroscopic techniques meet these criteria, their performance in identifying adulterants in seized weightloss herbal medicines is definitively determined. Initially a validated high pressure liquid chromatography methodology was used for reference identification and quantification of the adulterants sibutramine H2O·HCl, fenfluramine HCl and phenolphthalein. Of 38 products, only sibutramine and phenolphthalein were detected by HPLC. The spectroscopic measurements showed Raman was ill-suited due to sample burning and emission while NIR lacked adulterant selectivity. Conversely, MIR demonstrated apt identification performance, which manifested as spectrally meaningful separation based on the presence and type of adulterant during principal component analysis (test set validated). Partial least squares regression models were constructed from the MIR training sets for sibutramine and phenolphthalein - both models fitted the training set data well. Average test set prediction errors were 0.8% for sibutramine and 2.2% for phenolphthalein over the respective concentration ranges of 1.7-11.7% and 0.9-34.4%. MIR is apposite for the screening of anorectic and laxative adulterants and is the most viable technique for wider adulterant screening in herbal medicines.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017311</affiliation-url><afid>60017311</afid><affilname>University of Otago</affilname><name-variant>University of Otago</name-variant><affiliation-city>Dunedin</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017311</affiliation-url><afid>60017311</afid><affilname>University of Otago</affilname><name-variant>University of Otago</name-variant><affiliation-city>Dunedin</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002952</affiliation-url><afid>60002952</afid><affilname>Helsingin Yliopisto</affilname><name-variant>University of Helsinki</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56293834500</author-url><authid>56293834500</authid><authname>Rooney J.</authname><surname>Rooney</surname><given-name>Jeremy S.</given-name><initials>J.S.</initials><afid>60017311</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8704157400</author-url><authid>8704157400</authid><authname>McDowell A.</authname><surname>McDowell</surname><given-name>Arlene</given-name><initials>A.</initials><afid>60017311</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005772783</author-url><authid>7005772783</authid><authname>Strachan C.</authname><surname>Strachan</surname><given-name>Clare J.</given-name><initials>C.J.</initials><afid>60017311</afid><afid>60002952</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005772783</author-url><authid>7005772783</authid><authname>Strachan C.</authname><surname>Strachan</surname><given-name>Clare J.</given-name><initials>C.J.</initials><afid>60017311</afid><afid>60002952</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7202357498</author-url><authid>7202357498</authid><authname>Gordon K.</authname><surname>Gordon</surname><given-name>Keith C.</given-name><initials>K.C.</initials><afid>60017311</afid></author><authkeywords>Anorectics | Mid-infrared | Near-infrared | Phenolphthalein | Raman | Sibutramine</authkeywords><intid>535190752</intid><source-id>24555</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925114436"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925114436?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925114436&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925114436&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0920586114006002"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925114436</prism:url><dc:identifier>SCOPUS_ID:84925114436</dc:identifier><eid>2-s2.0-84925114436</eid><dc:title>Catalytic conversions in green aqueous media. Part 8: Partial and full hydrogenation of renewable methyl esters of vegetable oils</dc:title><dc:creator>Bouriazos A.</dc:creator><prism:publicationName>Catalysis Today</prism:publicationName><prism:issn>09205861</prism:issn><prism:volume>247</prism:volume><prism:pageRange>20-32</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cattod.2014.08.021</prism:doi><pii>S0920586114006002</pii><dc:description>© 2014 Elsevier B.V. All rights reserved. This article reviews the partial hydrogenation of renewable polyunsaturated methyl esters of linseed, sunflower, Cynara cardunculus and soybean oils into their monounsaturated counterparts which is upgraded biodiesel fuel employing highly active and selective water-soluble rhodium, ruthenium and palladium TPPTS complexes and by water-dispersible palladium(0) nanoparticles stabilized by water-soluble nitrogen-containing ligands which possess even higher activities than those exhibited by Pd/TPPTS benchmark catalysts in aqueous/organic two-phase systems. Furthermore, this article presents a novel study on the full hydrogenation of polyunsaturated methyl esters of sunflower and palm kernel oils to obtain up to 99.0 mol% methyl stearate (MS) using water-soluble Rh-and Ru-TPPTS catalytic complexes under mild reaction conditions in aqueous/organic two-phase systems. The full hydrogenation reaction of polyunsaturated FAMEs into MS is an interesting catalytic reaction because MS is an industrial feedstock for the manufacture of specialties such as surfactants, emulsifiers, etc., and could also act as a model reaction for studying the full hydrogenation of edible oils to saturated fats to be further subjected to interesterification reactions with liquid edible vegetable oils to yield foodstuffs with zero amounts of trans-fats especially after publication of results of very recent investigations which have questioned whether there really are direct associations between saturated fat consumption and a higher cardiovascular disease risk.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028900</affiliation-url><afid>60028900</afid><affilname>University of Athens</affilname><name-variant>University of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22949934800</author-url><authid>22949934800</authid><authname>Bouriazos A.</authname><surname>Bouriazos</surname><given-name>Achilleas</given-name><initials>A.</initials><afid>60028900</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56168839600</author-url><authid>56168839600</authid><authname>Vasiliou C.</authname><surname>Vasiliou</surname><given-name>Christiana</given-name><initials>C.</initials><afid>60028900</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56168800800</author-url><authid>56168800800</authid><authname>Tsichla A.</authname><surname>Tsichla</surname><given-name>Angeliki</given-name><initials>A.</initials><afid>60028900</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603163703</author-url><authid>6603163703</authid><authname>Papadogianakis G.</authname><surname>Papadogianakis</surname><given-name>Georgios</given-name><initials>G.</initials><afid>60028900</afid></author><authkeywords>Biodiesel | Hydrogenation | Renewable methyl esters of vegetable oils | TPPTS | Water | Zero trans-fats</authkeywords><intid>535269827</intid><source-id>16377</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928902012"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928902012?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928902012&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928902012&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928902012</prism:url><dc:identifier>SCOPUS_ID:84928902012</dc:identifier><eid>2-s2.0-84928902012</eid><dc:title>Upregulation of cytochrome c oxidase subunit 6b1 (Cox6b1) and formation of mitochondrial supercomplexes: implication of Cox6b1 in the effect of calorie restriction</dc:title><dc:creator>Kim S.</dc:creator><prism:publicationName>Age</prism:publicationName><prism:issn>01619152</prism:issn><prism:eIssn>15744647</prism:eIssn><prism:volume>37</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11357-015-9787-8</prism:doi><dc:description>© 2015, American Aging Association. Calorie restriction (CR), a non-genetic intervention that promotes longevity in animals, may exert anti-aging effects by modulating mitochondrial function. Based on our prior mitochondrial proteome analysis, we focused on the potential roles of cytochrome c oxidase (Cox or Complex IV) subunit 6b1 on formation of mitochondrial supercomplexes comprised of Complex I, III, and IV. Blue native polyacrylamide gel electrophoresis followed by immunoblotting showed that the amount of Cox6b1 and the proportion of high molecular weight supercomplexes (SCs) comprised of Complexes I, III, and IV were increased in the liver of mice subjected to 30 % CR, compared with the liver of mice fed ad libitum. In in vitro experiments, in Cox6b1-overexpressing NIH3T3 (Cox6b1-3T3) cells, Cox6b1 was increased in the SC, III&lt;inf&gt;2&lt;/inf&gt;IV&lt;inf&gt;1&lt;/inf&gt;, and III&lt;inf&gt;2&lt;/inf&gt;IV&lt;inf&gt;2&lt;/inf&gt; complexes and Cox was concomitantly recruited abundantly into the SC, compared with control (Con)-3T3 cells. The proportions of III&lt;inf&gt;2&lt;/inf&gt;IV&lt;inf&gt;1&lt;/inf&gt;, and III&lt;inf&gt;2&lt;/inf&gt;IV&lt;inf&gt;2&lt;/inf&gt;, relative to IV monomer were also increased in Cox6b1-3T3 cells. Cox6b1-3T3 cells showed increased oxygen consumption rates, Cox activity, and intracellular ATP concentrations, indicating enhanced mitochondrial respiration, compared with Con-3T3 cells. Despite the increased basal level of mitochondrial reactive oxygen species (ROS), cell viability after inducing oxidative stress was greater in Cox6b1-3T3 cells than in Con-3T3 cells, probably because of prompt activation of protective mechanisms, such as nuclear translocation of nuclear factor E2-related factor-2. These in vivo and in vitro studies show that Cox6b1 is involved in regulation of mitochondrial function by promoting the formation of SC, suggesting that Cox6b1 contributes to the anti-aging effects of CR.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000758</affiliation-url><afid>60000758</afid><affilname>Nagasaki University School of Medicine</affilname><name-variant>Nagasaki University School of Medicine</name-variant><affiliation-city>Nagasaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023462</affiliation-url><afid>60023462</afid><affilname>Waseda University</affilname><name-variant>Waseda University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026245</affiliation-url><afid>60026245</afid><affilname>Charite - Universitatsmedizin Berlin</affilname><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011226</affiliation-url><afid>60011226</afid><affilname>Technische Universitat Darmstadt</affilname><name-variant>Technische Universität Darmstadt</name-variant><affiliation-city>Darmstadt</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622018000</author-url><authid>56622018000</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Sang Eun</given-name><initials>S.E.</initials><afid>60000758</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15762853800</author-url><authid>15762853800</authid><authname>Mori R.</authname><surname>Mori</surname><given-name>Ryoichi</given-name><initials>R.</initials><afid>60000758</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36483180700</author-url><authid>36483180700</authid><authname>Komatsu T.</authname><surname>Komatsu</surname><given-name>Toshimitsu</given-name><initials>T.</initials><afid>60000758</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36119909000</author-url><authid>36119909000</authid><authname>Chiba T.</authname><surname>Chiba</surname><given-name>Takuya</given-name><initials>T.</initials><afid>60000758</afid><afid>60023462</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36119909000</author-url><authid>36119909000</authid><authname>Chiba T.</authname><surname>Chiba</surname><given-name>Takuya</given-name><initials>T.</initials><afid>60000758</afid><afid>60023462</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55753204600</author-url><authid>55753204600</authid><authname>Hayashi H.</authname><surname>Hayashi</surname><given-name>Hiroko</given-name><initials>H.</initials><afid>60000758</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56621626000</author-url><authid>56621626000</authid><authname>Park S.</authname><surname>Park</surname><given-name>Seongjoon</given-name><initials>S.</initials><afid>60000758</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56622624000</author-url><authid>56622624000</authid><authname>Sugawa M.</authname><surname>Sugawa</surname><given-name>Michiru D.</given-name><initials>M.D.</initials><afid>60026245</afid><afid>60011226</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56622624000</author-url><authid>56622624000</authid><authname>Sugawa M.</authname><surname>Sugawa</surname><given-name>Michiru D.</given-name><initials>M.D.</initials><afid>60026245</afid><afid>60011226</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006154420</author-url><authid>7006154420</authid><authname>Dencher N.</authname><surname>Dencher</surname><given-name>Norbert A.</given-name><initials>N.A.</initials><afid>60011226</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7005604036</author-url><authid>7005604036</authid><authname>Shimokawa I.</authname><surname>Shimokawa</surname><given-name>Isao</given-name><initials>I.</initials><afid>60000758</afid></author><authkeywords>Calorie restriction | Cox6b1 | Cytochrome c oxidase | Supercomplex</authkeywords><intid>1785862907</intid><source-id>40283</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927947332"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927947332?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927947332&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927947332&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0367326X15000970"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927947332</prism:url><dc:identifier>SCOPUS_ID:84927947332</dc:identifier><eid>2-s2.0-84927947332</eid><dc:title>New bioactive flavonoid glycosides isolated from the seeds of Lepidium apetalum Willd</dc:title><dc:creator>Shi P.</dc:creator><prism:publicationName>Fitoterapia</prism:publicationName><prism:issn>0367326X</prism:issn><prism:eIssn>18736971</prism:eIssn><prism:volume>103</prism:volume><prism:pageRange>197-205</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.fitote.2015.04.007</prism:doi><pii>S0367326X15000970</pii><dc:description>© 2015 Elsevier B.V. Ten flavonoid glycosides, apetalumosides A (1), B&lt;inf&gt;1&lt;/inf&gt;-B&lt;inf&gt;7&lt;/inf&gt; (2-8), and C (9), quercetin 3-O-(2,6-di-O-β-d-glucopyranosyl)-β-d-glucopyranoside (10), were obtained from the seeds of Lepidium apetalum Willd. Their structures were elucidated by chemical and spectroscopic methods (UV, IR, NMR, and HRESI-TOF-MS). 1-9 were new isolates. The NMR data for 10 was reported here for the first time. On the other hand, activity screening results showed that 1-3 and 10 had triglyceride accumulation inhibitory effects in HepG2 cells. Preliminary structure-activity relationship study revealed that 7-hydroxyl group is an essential moiety.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012594</affiliation-url><afid>60012594</afid><affilname>Tianjin University of Traditional Chinese Medicine</affilname><name-variant>Tianjin University of Traditional Chinese Medicine</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012594</affiliation-url><afid>60012594</afid><affilname>Tianjin University of Traditional Chinese Medicine</affilname><name-variant>Tianjin University of Traditional Chinese Medicine</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55863622300</author-url><authid>55863622300</authid><authname>Shi P.</authname><surname>Shi</surname><given-name>Pingping</given-name><initials>P.</initials><afid>60012594</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56596180900</author-url><authid>56596180900</authid><authname>Chao L.</authname><surname>Chao</surname><given-name>Liping</given-name><initials>L.</initials><afid>60012594</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56595790500</author-url><authid>56595790500</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tingtxing</given-name><initials>T.</initials><afid>60012594</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36671584500</author-url><authid>36671584500</authid><authname>Liu E.</authname><surname>Liu</surname><given-name>Erwei</given-name><initials>E.</initials><afid>60012594</afid><afid>60012594</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36671584500</author-url><authid>36671584500</authid><authname>Liu E.</authname><surname>Liu</surname><given-name>Erwei</given-name><initials>E.</initials><afid>60012594</afid><afid>60012594</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56540457400</author-url><authid>56540457400</authid><authname>Han L.</authname><surname>Han</surname><given-name>Lifeng</given-name><initials>L.</initials><afid>60012594</afid><afid>60012594</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56540457400</author-url><authid>56540457400</authid><authname>Han L.</authname><surname>Han</surname><given-name>Lifeng</given-name><initials>L.</initials><afid>60012594</afid><afid>60012594</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56596302200</author-url><authid>56596302200</authid><authname>Zong Q.</authname><surname>Zong</surname><given-name>Qi</given-name><initials>Q.</initials><afid>60012594</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56374633400</author-url><authid>56374633400</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xiaoxia</given-name><initials>X.</initials><afid>60012594</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56216297700</author-url><authid>56216297700</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60012594</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56215057200</author-url><authid>56215057200</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tao</given-name><initials>T.</initials><afid>60012594</afid><afid>60012594</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56215057200</author-url><authid>56215057200</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tao</given-name><initials>T.</initials><afid>60012594</afid><afid>60012594</afid></author><authkeywords>Flavonoid glycosides | HepG2 cells | Lepidium apetalum | Triglyceride accumulation inhibitory effects</authkeywords><intid>1785702142</intid><source-id>18077</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929998122"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929998122?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929998122&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929998122&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929998122</prism:url><dc:identifier>SCOPUS_ID:84929998122</dc:identifier><eid>2-s2.0-84929998122</eid><dc:title>Comparison of four software packages for CT lung volumetry in healthy individuals</dc:title><dc:creator>Nemec S.</dc:creator><prism:publicationName>European Radiology</prism:publicationName><prism:issn>09387994</prism:issn><prism:eIssn>14321084</prism:eIssn><prism:volume>25</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1588-1597</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00330-014-3557-3</prism:doi><dc:description>© 2015, European Society of Radiology. Objectives: To compare CT lung volumetry (CTLV) measurements provided by different software packages, and to provide normative data for lung densitometric measurements in healthy individuals. Methods: This retrospective study included 51 chest CTs of 17 volunteers (eight men and nine women; mean age, 30 ± 6 years), who underwent spirometrically monitored CT at total lung capacity (TLC), functional residual capacity (FRC), and mean inspiratory capacity (MIC). Volumetric differences assessed by four commercial software packages were compared with analysis of variance (ANOVA) for repeated measurements and benchmarked against the threshold for acceptable variability between spirometric measurements. Mean lung density (MLD) and parenchymal heterogeneity (MLD-SD) were also compared with ANOVA. Results: Volumetric differences ranged from 12 to 213 ml (0.20 % to 6.45 %). Although 16/18 comparisons (among four software packages at TLC, MIC, and FRC) were statistically significant (P &lt; 0.001 to P = 0.004), only 3/18 comparisons, one at MIC and two at FRC, exceeded the spirometry variability threshold. MLD and MLD-SD significantly increased with decreasing volumes, and were significantly larger in lower compared to upper lobes (P &lt; 0.001). Conclusions: Lung volumetric differences provided by different software packages are small. These differences should not be interpreted based on statistical significance alone, but together with absolute volumetric differences. Key Points: • Volumetric differences, assessed by different CTLV software, are small but statistically significant. • Volumetric differences are smaller at TLC than at MIC and FRC. • Volumetric differences rarely exceed spirometric repeatability thresholds at MIC and FRC. • Differences between CTLV measurements should be interpreted based on comparison of absolute differences. • MLD increases with decreasing volumes, and is larger in lower compared to upper lobes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011394</affiliation-url><afid>60011394</afid><affilname>Medizinische Universitat Wien</affilname><name-variant>Medical University of Vienna</name-variant><affiliation-city>Vienna</affiliation-city><affiliation-country>Austria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017724</affiliation-url><afid>60017724</afid><affilname>Centre Hospitalier Regional Universitaire de Lille</affilname><name-variant>CHU</name-variant><affiliation-city>Lille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068606</affiliation-url><afid>60068606</afid><affilname>Centre Hospitalier Universitaire de Charleroi</affilname><name-variant>C.H.U. de Charleroi</name-variant><affiliation-city>Charleroi</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:107422504</affiliation-url><afid>107422504</afid><affilname>CHU Tivoli</affilname><name-variant>CHU Tivoli</name-variant><affiliation-city/><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16203678700</author-url><authid>16203678700</authid><authname>Nemec S.</authname><surname>Nemec</surname><given-name>Stefan F.</given-name><initials>S.F.</initials><afid>60002746</afid><afid>60011394</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16203678700</author-url><authid>16203678700</authid><authname>Nemec S.</authname><surname>Nemec</surname><given-name>Stefan F.</given-name><initials>S.F.</initials><afid>60002746</afid><afid>60011394</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56350545700</author-url><authid>56350545700</authid><authname>Molinari F.</authname><surname>Molinari</surname><given-name>Francesco</given-name><initials>F.</initials><afid>60017724</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:27967736200</author-url><authid>27967736200</authid><authname>Dufresne V.</authname><surname>Dufresne</surname><given-name>Valerie</given-name><initials>V.</initials><afid>60068606</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24173191500</author-url><authid>24173191500</authid><authname>Gosset N.</authname><surname>Gosset</surname><given-name>Natacha</given-name><initials>N.</initials><afid>107422504</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56335785800</author-url><authid>56335785800</authid><authname>Silva M.</authname><surname>Silva</surname><given-name>Mario</given-name><initials>M.</initials><afid>60002746</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55647926700</author-url><authid>55647926700</authid><authname>Bankier A.</authname><surname>Bankier</surname><given-name>Alexander A.</given-name><initials>A.A.</initials><afid>60002746</afid></author><authkeywords>ANOVA | CT lung volumetry | Pulmonary function testing | Software tools | Spirometric repeatability criteria</authkeywords><intid>36048255</intid><source-id>16687</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929603670"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929603670?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929603670&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929603670&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929603670</prism:url><dc:identifier>SCOPUS_ID:84929603670</dc:identifier><eid>2-s2.0-84929603670</eid><dc:title>Treatment planning evaluation and optimization should be biologically and not dose/volume based</dc:title><dc:creator>Deasy J.</dc:creator><prism:publicationName>Medical Physics</prism:publicationName><prism:issn>00942405</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>2753-2756</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1118/1.4916670</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009343</affiliation-url><afid>60009343</afid><affilname>Memorial Sloan-Kettering Cancer Center</affilname><name-variant>Memorial Sloan-Kettering Cancer Center</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005558</affiliation-url><afid>60005558</afid><affilname>Mayo Clinic</affilname><name-variant>Mayo Clinic</name-variant><affiliation-city>Rochester</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>sh</subtype><subtypeDescription>Short Survey</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7003361779</author-url><authid>7003361779</authid><authname>Deasy J.</authname><surname>Deasy</surname><given-name>Joseph O.</given-name><initials>J.O.</initials><afid>60009343</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006680076</author-url><authid>7006680076</authid><authname>Mayo C.</authname><surname>Mayo</surname><given-name>Charles S.</given-name><initials>C.S.</initials><afid>60005558</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56366611600</author-url><authid>56366611600</authid><authname>Orton C.</authname><surname>Orton</surname><given-name>Colin G.</given-name><initials>C.G.</initials></author><intid>535982420</intid><source-id>17871</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930210250"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930210250?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930210250&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930210250&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930210250</prism:url><dc:identifier>SCOPUS_ID:84930210250</dc:identifier><eid>2-s2.0-84930210250</eid><dc:title>Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension</dc:title><dc:creator>Hernanz R.</dc:creator><prism:publicationName>British Journal of Pharmacology</prism:publicationName><prism:issn>00071188</prism:issn><prism:eIssn>14765381</prism:eIssn><prism:volume>172</prism:volume><prism:issueIdentifier>12</prism:issueIdentifier><prism:pageRange>3159-3176</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bph.13117</prism:doi><dc:description>© 2015 The British Pharmacological Society. Background and Purpose Toll-like receptor 4 (TLR4) signalling contributes to inflammatory cardiovascular diseases, but its role in hypertension and the associated vascular damage is not known. We investigated whether TLR4 activation contributed to angiotensin II (AngII)-induced hypertension and the associated vascular structural, mechanical and functional alterations. Experimental Approach AngII was infused (1.44 mg·kg&lt;sup&gt;-1&lt;/sup&gt;·day&lt;sup&gt;-1&lt;/sup&gt;, s.c.) for 2 weeks in C57BL6 mice, treated with a neutralizing anti-TLR4 antibody or IgG (1 μg·day&lt;sup&gt;-1&lt;/sup&gt;); systolic BP (SBP) and aortic cytokine levels were measured. Structural, mechanical and contractile properties of aortic and mesenteric arterial segments were measured with myography and histology. RT-PCR and Western blotting were used to analyse these tissues and cultured vascular smooth muscle cells (VSMC) from hypertensive rats (SHR). Key Results Aortic TLR4 mRNA levels were raised by AngII infusion. Anti-TLR4 antibody treatment of AngII-treated mice normalised: (i) increased SBP and TNF-α, IL-6 and CCL2 levels; (ii) vascular structural and mechanical changes; (iii) altered aortic phenylephrine- and ACh-induced responses; (iv) increased NOX-1 mRNA levels, superoxide anion production and NAD(P)H oxidase activity and effects of catalase, apocynin, ML-171 and Mito-TEMPO on vascular responses; and (v) reduced NO release and effects of L-NAME on phenylephrine-induced contraction. In VSMC, the MyD88 inhibitor ST-2825 reduced AngII-induced NAD(P)H oxidase activity. The TLR4 inhibitor CLI-095 reduced AngII-induced increased phospho-JNK1/2 and p65 NF-κB subunit nuclear protein expression. Conclusions and Implications TLR4 up-regulation by AngII contributed to the inflammation, endothelial dysfunction, vascular remodelling and stiffness associated with hypertension by mechanisms involving oxidative stress. MyD88-dependent activation and JNK/NF-κB signalling pathways participated in these alterations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018940</affiliation-url><afid>60018940</afid><affilname>Universidad Rey Juan Carlos</affilname><name-variant>Rey Juan Carlos University</name-variant><affiliation-city>Mostoles</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028162</affiliation-url><afid>60028162</afid><affilname>Hospital Universitario La Paz</affilname><name-variant>Hospital Universitario La Paz</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026796</affiliation-url><afid>60026796</afid><affilname>Universidad Autonoma de Madrid</affilname><name-variant>Universidad Autónoma de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">21</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602961465</author-url><authid>6602961465</authid><authname>Hernanz R.</authname><surname>Hernanz</surname><given-name>R.</given-name><initials>R.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602961465</author-url><authid>6602961465</authid><authname>Hernanz R.</authname><surname>Hernanz</surname><given-name>R.</given-name><initials>R.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9037327900</author-url><authid>9037327900</authid><authname>Martínez-Revelles S.</authname><surname>Martínez-Revelles</surname><given-name>S.</given-name><initials>S.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9037327900</author-url><authid>9037327900</authid><authname>Martínez-Revelles S.</authname><surname>Martínez-Revelles</surname><given-name>S.</given-name><initials>S.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54783285000</author-url><authid>54783285000</authid><authname>Palacios R.</authname><surname>Palacios</surname><given-name>R.</given-name><initials>R.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54783285000</author-url><authid>54783285000</authid><authname>Palacios R.</authname><surname>Palacios</surname><given-name>R.</given-name><initials>R.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7404932572</author-url><authid>7404932572</authid><authname>Martín A.</authname><surname>Martín</surname><given-name>A.</given-name><initials>A.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7404932572</author-url><authid>7404932572</authid><authname>Martín A.</authname><surname>Martín</surname><given-name>A.</given-name><initials>A.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004845644</author-url><authid>7004845644</authid><authname>Cachofeiro V.</authname><surname>Cachofeiro</surname><given-name>V.</given-name><initials>V.</initials><afid>60027282</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35083136100</author-url><authid>35083136100</authid><authname>Aguado A.</authname><surname>Aguado</surname><given-name>A.</given-name><initials>A.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35083136100</author-url><authid>35083136100</authid><authname>Aguado A.</authname><surname>Aguado</surname><given-name>A.</given-name><initials>A.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55510363800</author-url><authid>55510363800</authid><authname>García-Redondo L.</authname><surname>García-Redondo</surname><given-name>L.</given-name><initials>L.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55510363800</author-url><authid>55510363800</authid><authname>García-Redondo L.</authname><surname>García-Redondo</surname><given-name>L.</given-name><initials>L.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6506139164</author-url><authid>6506139164</authid><authname>Barrús M.</authname><surname>Barrús</surname><given-name>M. T.</given-name><initials>M.T.</initials><afid>60018940</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:41861256500</author-url><authid>41861256500</authid><authname>De Batista P.</authname><surname>De Batista</surname><given-name>P. R.</given-name><initials>P.R.</initials><afid>60018940</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004606732</author-url><authid>7004606732</authid><authname>Briones A.</authname><surname>Briones</surname><given-name>A. M.</given-name><initials>A.M.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004606732</author-url><authid>7004606732</authid><authname>Briones A.</authname><surname>Briones</surname><given-name>A. M.</given-name><initials>A.M.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005739080</author-url><authid>7005739080</authid><authname>Salaices M.</authname><surname>Salaices</surname><given-name>M.</given-name><initials>M.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005739080</author-url><authid>7005739080</authid><authname>Salaices M.</authname><surname>Salaices</surname><given-name>M.</given-name><initials>M.</initials><afid>60028162</afid><afid>60026796</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7401659495</author-url><authid>7401659495</authid><authname>Alonso M.</authname><surname>Alonso</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>60018940</afid><afid>60028162</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7401659495</author-url><authid>7401659495</authid><authname>Alonso M.</authname><surname>Alonso</surname><given-name>M. J.</given-name><initials>M.J.</initials><afid>60018940</afid><afid>60028162</afid></author><intid>1536088078</intid><source-id>20084</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927152746"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927152746?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927152746&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927152746&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015001963"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927152746</prism:url><dc:identifier>SCOPUS_ID:84927152746</dc:identifier><eid>2-s2.0-84927152746</eid><dc:title>Retinol binding protein 4 induces mitochondrial dysfunction and vascular oxidative damage</dc:title><dc:creator>Wang J.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>335-344</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.03.036</prism:doi><pii>S0021915015001963</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objectives: Mitochondrial dysfunction has been implicated in cardiovascular diseases. Elevation of serum retinol binding protein 4 (RBP4) in patients has been linked to cardiovascular disease. However, the role of RBP4 on mitochondrial oxidative stress and vascular oxidative damage is not well demonstrated. Therefore, we evaluated the impact of RBP4 on the mitochondrial reactive oxygen species (ROS) and dynamics in the pathogenesis of cardiovascular diseases. Methods and results: RBP4 treatment increased mitochondrial superoxide generation in a dose-dependent manner in human aortic endothelial cells (HAECs). Exposure to RBP4 also promoted mitochondrial dysfunction as determined by decreased mitochondrial content and integrity as well as membrane potential in HAECs. Incubation with RBP4 suppressed mitofusin (Mfn)-1 protein expression, but enhanced dynamin-related protein-1 (Drp1) and fission-1 (Fis1) protein expression in HAECs, suggesting an impairment of mitochondrial fusion and fission dynamics. Moreover, RBP4 treatment significantly induced endothelial apoptosis, increased the expression of Cytochrome C and Bax, but decreased the expression of Bcl-2. Furthermore, RBP4 stimulation suppressed phosphatidyl inositol 3-kinase (PI3K)/Akt signaling in HAECs. Finally, RBP4-Tg mice exhibited severe mitochondrial dysfunction and vascular oxidative damage in aorta compared with wide-type C57BL/6J mice. Conclusion: The present study uncovers a novel mechanism through which RBP4 induces vascular oxidative damage and accelerates the development of atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109728498</affiliation-url><afid>109728498</afid><affilname>Guangdong Provincial Key Laboratory of Food</affilname><name-variant>Guangdong Provincial Key Laboratory of smart grid technology</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021182</affiliation-url><afid>60021182</afid><affilname>Sun Yat-Sen University</affilname><name-variant>Sun Yat-Sen University</name-variant><affiliation-city>Guangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56587207700</author-url><authid>56587207700</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jingjing</given-name><initials>J.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56587207700</author-url><authid>56587207700</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jingjing</given-name><initials>J.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56428175800</author-url><authid>56428175800</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hongen</given-name><initials>H.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56428175800</author-url><authid>56428175800</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hongen</given-name><initials>H.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56032546900</author-url><authid>56032546900</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yan</given-name><initials>Y.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56032546900</author-url><authid>56032546900</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yan</given-name><initials>Y.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56587126800</author-url><authid>56587126800</authid><authname>Zhou W.</authname><surname>Zhou</surname><given-name>Wenjing</given-name><initials>W.</initials><afid>60021182</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56031672700</author-url><authid>56031672700</authid><authname>Sun R.</authname><surname>Sun</surname><given-name>Ruifang</given-name><initials>R.</initials><afid>60021182</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35303869600</author-url><authid>35303869600</authid><authname>Xia M.</authname><surname>Xia</surname><given-name>Min</given-name><initials>M.</initials><afid>109728498</afid><afid>60021182</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35303869600</author-url><authid>35303869600</authid><authname>Xia M.</authname><surname>Xia</surname><given-name>Min</given-name><initials>M.</initials><afid>109728498</afid><afid>60021182</afid></author><authkeywords>Endothelial cells | Mitochondrial dysfunction | Retinol binding protein 4 | ROS</authkeywords><intid>1785570599</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930199777"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930199777?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930199777&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930199777&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2352431615000449"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930199777</prism:url><dc:identifier>SCOPUS_ID:84930199777</dc:identifier><eid>2-s2.0-84930199777</eid><dc:title>Balloon catheters with integrated stretchable electronics for electrical stimulation, ablation and blood flow monitoring</dc:title><dc:creator>Klinker L.</dc:creator><prism:publicationName>Extreme Mechanics Letters</prism:publicationName><prism:eIssn>23524316</prism:eIssn><prism:volume>3</prism:volume><prism:pageRange>45-54</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.eml.2015.02.005</prism:doi><pii>S2352431615000449</pii><dc:description>© 2015 Elsevier Ltd. Balloon catheter-based techniques that apply mechanical force to blood vessel walls have dramatically advanced the standard of care for patients with vascular disease. But balloons are limited in their therapeutic potential because they rely on mechanics alone and lack electronically active materials. Recent advances in balloon catheters with integrated electrodes have offered additional treatment capabilities through the application of both mechanical contact force and radio frequency electromotive force. However, these smart balloons remain limited in their mechanics and their ability to provide diagnostic information about local vessel hemodynamics and tissue health near treatment zones. Here, we demonstrate a novel instrumented balloon catheter system that contains stretchable electrodes and thermal-based blood flow sensors, providing hemodynamic information, electrical stimulation, and ablation therapy on a single device. This system accommodates high inflation pressure (~2 atm) and twisting and bending over a broad range of vascular diameters and geometries. Finite element and analytical modeling capture the anisotropic mechanical and thermal properties of the device during cycles of inflation and deflation in a simulated biological environment. Bench-top ablation and in vivo blood flow measurements highlight the utility of this technology for clinical application.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:109593557</affiliation-url><afid>109593557</afid><affilname>MC10 Inc.</affilname><name-variant>MC10 Inc.</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025278</affiliation-url><afid>60025278</afid><affilname>Tsinghua University</affilname><name-variant>Tsinghua University</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007363</affiliation-url><afid>60007363</afid><affilname>Northwestern University</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Evanston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029929</affiliation-url><afid>60029929</afid><affilname>Massachusetts General Hospital</affilname><name-variant>Massachusetts General Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005290</affiliation-url><afid>60005290</afid><affilname>University of Illinois</affilname><name-variant>University of Illinois</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname/><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">20</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55512351600</author-url><authid>55512351600</authid><authname>Klinker L.</authname><surname>Klinker</surname><given-name>Lauren</given-name><initials>L.</initials><afid>109593557</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37079213400</author-url><authid>37079213400</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Stephen</given-name><initials>S.</initials><afid>109593557</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55843280200</author-url><authid>55843280200</authid><authname>Work J.</authname><surname>Work</surname><given-name>John</given-name><initials>J.</initials><afid>109593557</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56662618000</author-url><authid>56662618000</authid><authname>Wright J.</authname><surname>Wright</surname><given-name>John</given-name><initials>J.</initials><afid>109593557</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56480885500</author-url><authid>56480885500</authid><authname>Ma Y.</authname><surname>Ma</surname><given-name>Yinji</given-name><initials>Y.</initials><afid>60025278</afid><afid>60007363</afid><afid>60007363</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56480885500</author-url><authid>56480885500</authid><authname>Ma Y.</authname><surname>Ma</surname><given-name>Yinji</given-name><initials>Y.</initials><afid>60025278</afid><afid>60007363</afid><afid>60007363</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56480885500</author-url><authid>56480885500</authid><authname>Ma Y.</authname><surname>Ma</surname><given-name>Yinji</given-name><initials>Y.</initials><afid>60025278</afid><afid>60007363</afid><afid>60007363</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36057047500</author-url><authid>36057047500</authid><authname>Ptaszek L.</authname><surname>Ptaszek</surname><given-name>Leon</given-name><initials>L.</initials><afid>60029929</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56289252100</author-url><authid>56289252100</authid><authname>Webb R.</authname><surname>Webb</surname><given-name>Richard C.</given-name><initials>R.C.</initials><afid>60005290</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56662559300</author-url><authid>56662559300</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Cliff</given-name><initials>C.</initials><afid>109593557</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56662826300</author-url><authid>56662826300</authid><authname>Sheth N.</authname><surname>Sheth</surname><given-name>Nirav</given-name><initials>N.</initials><afid>109593557</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7202600315</author-url><authid>7202600315</authid><authname>Mansour M.</authname><surname>Mansour</surname><given-name>Moussa</given-name><initials>M.</initials><afid>60029929</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7404269624</author-url><authid>7404269624</authid><authname>Rogers J.</authname><surname>Rogers</surname><given-name>John A.</given-name><initials>J.A.</initials><afid>60005290</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56307825300</author-url><authid>56307825300</authid><authname>Huang Y.</authname><surname>Huang</surname><given-name>Yonggang</given-name><initials>Y.</initials><afid>60007363</afid><afid>60007363</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56307825300</author-url><authid>56307825300</authid><authname>Huang Y.</authname><surname>Huang</surname><given-name>Yonggang</given-name><initials>Y.</initials><afid>60007363</afid><afid>60007363</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55660890500</author-url><authid>55660890500</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hang</given-name><initials>H.</initials><afid>60025278</afid><afid>60007363</afid><afid>60007363</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55660890500</author-url><authid>55660890500</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hang</given-name><initials>H.</initials><afid>60025278</afid><afid>60007363</afid><afid>60007363</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55660890500</author-url><authid>55660890500</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Hang</given-name><initials>H.</initials><afid>60025278</afid><afid>60007363</afid><afid>60007363</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:55258653200</author-url><authid>55258653200</authid><authname>Ghaffari R.</authname><surname>Ghaffari</surname><given-name>Roozbeh</given-name><initials>R.</initials><afid>109593557</afid><afid/></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:55258653200</author-url><authid>55258653200</authid><authname>Ghaffari R.</authname><surname>Ghaffari</surname><given-name>Roozbeh</given-name><initials>R.</initials><afid>109593557</afid><afid/></author><authkeywords>Ablation | Angioplasty | Balloon catheters | Hemodynamics | Mechanics | Stretchable electronics</authkeywords><intid>1536086984</intid><source-id>21100376821</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923085262"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923085262?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923085262&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923085262&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0301008215000246"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923085262</prism:url><dc:identifier>SCOPUS_ID:84923085262</dc:identifier><eid>2-s2.0-84923085262</eid><dc:title>Voltage-gated calcium channels: Determinants of channel function and modulation by inorganic cations</dc:title><dc:creator>Neumaier F.</dc:creator><prism:publicationName>Progress in Neurobiology</prism:publicationName><prism:issn>03010082</prism:issn><prism:eIssn>18735118</prism:eIssn><prism:volume>129</prism:volume><prism:pageRange>1-36</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pneurobio.2014.12.003</prism:doi><pii>S0301008215000246</pii><dc:description>© 2015 Elsevier Ltd. Voltage-gated calcium channels (VGCCs) represent a key link between electrical signals and non-electrical processes, such as contraction, secretion and transcription. Evolved to achieve high rates of Ca&lt;sup&gt;2+&lt;/sup&gt;-selective flux, they possess an elaborate mechanism for selection of Ca&lt;sup&gt;2+&lt;/sup&gt; over foreign ions. It has been convincingly linked to competitive binding in the pore, but the fundamental question of how this is reconcilable with high rates of Ca&lt;sup&gt;2+&lt;/sup&gt; transfer remains unanswered. By virtue of their similarity to Ca&lt;sup&gt;2+&lt;/sup&gt;, polyvalent cations can interfere with the function of VGCCs and have proven instrumental in probing the mechanisms underlying selective permeation. Recent emergence of crystallographic data on a set of Ca&lt;sup&gt;2+&lt;/sup&gt;-selective model channels provides a structural framework for permeation in VGCCs, and warrants a reconsideration of their diverse modulation by polyvalent cations, which can be roughly separated into three general mechanisms: (I) long-range interactions with charged regions on the surface, affecting the local potential sensed by the channel or influencing voltage-sensor movement by repulsive forces (electrostatic effects), (II) short-range interactions with sites in the ion-conducting pathway, leading to physical obstruction of the channel (pore block), and in some cases (III) short-range interactions with extracellular binding sites, leading to non-electrostatic modifications of channel gating (allosteric effects). These effects, together with the underlying molecular modifications, provide valuable insights into the function of VGCCs, and have important physiological and pathophysiological implications. Allosteric suppression of some of the pore-forming Ca&lt;inf&gt;v&lt;/inf&gt;α&lt;inf&gt;1&lt;/inf&gt;-subunits (Ca&lt;inf&gt;v&lt;/inf&gt;2.3, Ca&lt;inf&gt;v&lt;/inf&gt;3.2) by Zn&lt;sup&gt;2+&lt;/sup&gt; and Cu&lt;sup&gt;2+&lt;/sup&gt; may play a major role for the regulation of excitability by endogenous transition metal ions. The fact that these ions can often traverse VGCCs can contribute to the detrimental intracellular accumulation of metal ions following excessive release of endogenous Cu&lt;sup&gt;2+&lt;/sup&gt; and Zn&lt;sup&gt;2+&lt;/sup&gt; or exposure to non-physiological toxic metal ions.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024025</affiliation-url><afid>60024025</afid><affilname>Universitat zu Koln</affilname><name-variant>Universität zu Köln</name-variant><affiliation-city>Koln</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025310</affiliation-url><afid>60025310</afid><affilname>Heinrich Heine Universitat</affilname><affiliation-city>Dusseldorf</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113191211</affiliation-url><afid>113191211</afid><affilname>Center for Molecular Medicine</affilname><name-variant>Center of Molecular Medicine</name-variant><affiliation-city>Koln</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56062330900</author-url><authid>56062330900</authid><authname>Neumaier F.</authname><surname>Neumaier</surname><given-name>Felix</given-name><initials>F.</initials><afid>60024025</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56463048500</author-url><authid>56463048500</authid><authname>Dibué-Adjei M.</authname><surname>Dibué-Adjei</surname><given-name>Maxine</given-name><initials>M.</initials><afid>60024025</afid><afid>60025310</afid><afid>113191211</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56463048500</author-url><authid>56463048500</authid><authname>Dibué-Adjei M.</authname><surname>Dibué-Adjei</surname><given-name>Maxine</given-name><initials>M.</initials><afid>60024025</afid><afid>60025310</afid><afid>113191211</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56463048500</author-url><authid>56463048500</authid><authname>Dibué-Adjei M.</authname><surname>Dibué-Adjei</surname><given-name>Maxine</given-name><initials>M.</initials><afid>60024025</afid><afid>60025310</afid><afid>113191211</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:16452898500</author-url><authid>16452898500</authid><authname>Hescheler J.</authname><surname>Hescheler</surname><given-name>Jürgen</given-name><initials>J.</initials><afid>60024025</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:22972981100</author-url><authid>22972981100</authid><authname>Schneider T.</authname><surname>Schneider</surname><given-name>Toni</given-name><initials>T.</initials><afid>60024025</afid></author><authkeywords>Allosteric modulation | Electrostatic interactions | Endogenous transition metal ions | Pore block | Selective permeation | Voltage-gated Ca&lt;sup&gt;2+&lt;/sup&gt;-channels</authkeywords><intid>1784914804</intid><source-id>24025</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927644444"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927644444?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927644444&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927644444&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0149763415000858"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927644444</prism:url><dc:identifier>SCOPUS_ID:84927644444</dc:identifier><eid>2-s2.0-84927644444</eid><dc:title>Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: A systematic review and meta-analysis</dc:title><dc:creator>van Sloten T.</dc:creator><prism:publicationName>Neuroscience and Biobehavioral Reviews</prism:publicationName><prism:issn>01497634</prism:issn><prism:eIssn>18737528</prism:eIssn><prism:volume>53</prism:volume><prism:pageRange>121-130</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neubiorev.2015.03.011</prism:doi><pii>S0149763415000858</pii><dc:description>© 2015 Elsevier Ltd. Arterial stiffness may be a cause of cerebral small vessel disease and cognitive impairment. We therefore performed a systematic review and meta-analysis of studies on the association between stiffness, cerebral small vessel disease and cognitive impairment. For the associations between stiffness (i.e. carotid-femoral pulse wave velocity (cfPWV), brachial-ankle PWV (baPWV), carotid stiffness and pulse pressure) on the one hand and cerebral small vessel disease and cognitive impairment on the other, we identified 23 (n= 15,666/20 cross-sectional; 1 longitudinal; 2 combined cross-sectional/longitudinal) and 41 studies (n= 57,671/26 cross-sectional; 11 longitudinal; 4 combined cross-sectional/longitudinal), respectively. Pooled analyses of cross-sectional studies showed that greater stiffness was associated with markers of cerebral small vessel disease with odds ratios, per +1 SD, of 1.29-1.32 (P&lt;. .001). Studies on cognitive impairment could not be pooled due to large heterogeneity. Some (but not all) studies showed an association between greater stiffness and cognitive impairment, and the strength of this association was relatively weak. The present study supports the hypothesis that greater arterial stiffness is a contributor to microvascular brain disease.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017252</affiliation-url><afid>60017252</afid><affilname>National Institute on Aging</affilname><name-variant>National Institute on Aging</name-variant><affiliation-city>Bethesda</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:25642215100</author-url><authid>25642215100</authid><authname>van Sloten T.</authname><surname>van Sloten</surname><given-name>Thomas T.</given-name><initials>T.T.</initials><afid>60018869</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602651260</author-url><authid>6602651260</authid><authname>Protogerou A.</authname><surname>Protogerou</surname><given-name>Athanase D.</given-name><initials>A.D.</initials><afid>60018869</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7401911647</author-url><authid>7401911647</authid><authname>Henry R.</authname><surname>Henry</surname><given-name>Ronald M A</given-name><initials>R.M.A.</initials><afid>60018869</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603799463</author-url><authid>6603799463</authid><authname>Schram M.</authname><surname>Schram</surname><given-name>Miranda T.</given-name><initials>M.T.</initials><afid>60018869</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7006392362</author-url><authid>7006392362</authid><authname>Launer L.</authname><surname>Launer</surname><given-name>Lenore J.</given-name><initials>L.J.</initials><afid>60017252</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36051195700</author-url><authid>36051195700</authid><authname>Stehouwer C.</authname><surname>Stehouwer</surname><given-name>Coen D A</given-name><initials>C.D.A.</initials><afid>60018869</afid></author><authkeywords>Arterial stiffness | Cerebral infarcts | Cerebral microbleeds | Cerebral small vessel disease | Cognitive impairment | Dementia | Meta-analysis | Systematic review | White matter hyperintensities</authkeywords><intid>1035641448</intid><source-id>18045</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927702909"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927702909?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927702909&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927702909&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0024320515001708"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927702909</prism:url><dc:identifier>SCOPUS_ID:84927702909</dc:identifier><eid>2-s2.0-84927702909</eid><dc:title>The role of 17β-estradiol in the regulation of antioxidant enzymes via the Nrf2-Keap1 pathway in the livers of CBA/H mice</dc:title><dc:creator>Sobočanec S.</dc:creator><prism:publicationName>Life Sciences</prism:publicationName><prism:issn>00243205</prism:issn><prism:eIssn>18790631</prism:eIssn><prism:volume>130</prism:volume><prism:pageRange>57-65</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.lfs.2015.03.014</prism:doi><pii>S0024320515001708</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Abstract Aims We aimed to explore the impact of surgical 17β-estradiol (E&lt;inf&gt;2&lt;/inf&gt;) deprivation/administration on the expression of antioxidant enzymes with an emphasis on the alteration of the NF-E&lt;inf&gt;2&lt;/inf&gt;-related factor 2/Kelch-like ECH-associated protein 1 (Nrf2/Keap1) pathway under physiological conditions in the livers of CBA/H mice of both sexes. Main methods Hepatic oxidative stress markers were determined by measuring lipid peroxidation and DNA damage using the comet assay. The expression and activities of two isoforms of superoxide dismutase (Sod-1, Sod-2) and catalase (Cat) were studied using real-time PCR, Western blot and spectrophotometrical analyses. The effect of E&lt;inf&gt;2&lt;/inf&gt; on Nrf2/Keap1 protein levels and localization was assessed using cytosolic and nuclear fractions. Key findings We demonstrate the E&lt;inf&gt;2&lt;/inf&gt;-mediated repression of the antioxidant enzymes Sod-1, Sod-2 and Cat in the livers of ovariectomized mice treated with E&lt;inf&gt;2&lt;/inf&gt; and its association with a decreased level of Nrf2/Keap1 proteins in the nucleus. We observed beneficial effects of long-term E&lt;inf&gt;2&lt;/inf&gt; administration on lipid peroxidation but not on DNA damage in the livers of ovariectomized mice. Significance The results of this study may additionally confirm the protective ability of E&lt;inf&gt;2&lt;/inf&gt; in prolonging the onset of age-related disease in females that ultimately contributes to their longer lifespan.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000961</affiliation-url><afid>60000961</afid><affilname>Institute Ruder Boskovic</affilname><name-variant>Ruder Bošković Institute</name-variant><affiliation-city>Zagreb</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000961</affiliation-url><afid>60000961</afid><affilname>Institute Ruder Boskovic</affilname><name-variant>Ruder Bošković Institute</name-variant><affiliation-city>Zagreb</affiliation-city><affiliation-country>Croatia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602254157</author-url><authid>6602254157</authid><authname>Sobočanec S.</authname><surname>Sobočanec</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60000961</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15133194600</author-url><authid>15133194600</authid><authname>Šarić A.</authname><surname>Šarić</surname><given-name>Ana</given-name><initials>A.</initials><afid>60000961</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35746661700</author-url><authid>35746661700</authid><authname>Mačak Šafranko Ž.</authname><surname>Mačak Šafranko</surname><given-name>Željka</given-name><initials>Ž.</initials><afid>60000961</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6505859289</author-url><authid>6505859289</authid><authname>Popović Hadžija M.</authname><surname>Popović Hadžija</surname><given-name>Marijana</given-name><initials>M.</initials><afid>60000961</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56010486600</author-url><authid>56010486600</authid><authname>Abramić M.</authname><surname>Abramić</surname><given-name>Marija</given-name><initials>M.</initials><afid>60000961</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602080418</author-url><authid>6602080418</authid><authname>Balog T.</authname><surname>Balog</surname><given-name>Tihomir</given-name><initials>T.</initials><afid>60000961</afid></author><authkeywords>17β-estradiol | Cat | Keap1 | Nrf2 | ROS | Sex-related | Sod-1 | Sod-2</authkeywords><intid>2035662064</intid><article-number>14340</article-number><source-id>20473</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923923759"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923923759?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923923759&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923923759&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000525"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923923759</prism:url><dc:identifier>SCOPUS_ID:84923923759</dc:identifier><eid>2-s2.0-84923923759</eid><dc:title>Effects of an acute bout of aerobic exercise on immediate and subsequent three-day food intake and energy expenditure in active and inactive pre-menopausal women taking oral contraceptives</dc:title><dc:creator>Rocha J.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>183-191</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.02.005</prism:doi><pii>S0195666315000525</pii><dc:description>© 2015 Elsevier Ltd. This study examined the effects of an acute bout of exercise of low-intensity on food intake and energy expenditure over four days in women taking oral contraceptives. Twenty healthy, active (n=10) and inactive (n=10) pre-menopausal women taking oral contraceptives completed two conditions (exercise and control), in a randomised, crossover fashion. The exercise experimental day involved cycling for one hour at an intensity equivalent to 50% of maximum oxygen uptake and two hours of rest. The control condition comprised three hours of rest. Participants arrived at the laboratory fasted overnight; breakfast was standardised and an ad libitum pasta lunch was consumed on each experimental day. Participants kept a food diary to measure food intake and wore an Actiheart to measure energy expenditure for the remainder of the experimental days and over the subsequent 3 days. There was a condition effect for absolute energy intake (exercise vs. control: 3363±668kJ vs. 3035±752kJ; p=0.033, d=0.49) and relative energy intake (exercise vs. control: 2019±746kJ vs. 2710±712kJ; p&lt;. 0.001, d=-1.00) at the ad libitum lunch. There were no significant differences in energy intake over the four days in active participants and there was a suppression of energy intake on the first day after the exercise experimental day compared with the same day of the control condition in inactive participants (mean difference=-1974kJ; 95% CI -1048 to -2900kJ, p=0.002, d=-0.89). There was a group effect (. p=0.001, d=1.63) for free-living energy expenditure, indicating that active participants expended more energy than inactive participants during this period. However, there were no compensatory changes in daily physical activity energy expenditure. These results support the use of low-intensity aerobic exercise as a method to induce a short-term negative energy balance in inactive women taking oral contraceptives.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011149</affiliation-url><afid>60011149</afid><affilname>Trinity College Dublin</affilname><name-variant>Trinity College Dublin</name-variant><affiliation-city>Dublin</affiliation-city><affiliation-country>Ireland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032204</affiliation-url><afid>60032204</afid><affilname>Sheffield Hallam University</affilname><name-variant>Sheffield Hallam University</name-variant><affiliation-city>Sheffield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032204</affiliation-url><afid>60032204</afid><affilname>Sheffield Hallam University</affilname><name-variant>Sheffield Hallam University</name-variant><affiliation-city>Sheffield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032204</affiliation-url><afid>60032204</afid><affilname>Sheffield Hallam University</affilname><name-variant>Sheffield Hallam University</name-variant><affiliation-city>Sheffield</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55873639700</author-url><authid>55873639700</authid><authname>Rocha J.</authname><surname>Rocha</surname><given-name>Joel</given-name><initials>J.</initials><afid>60011149</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:24484025800</author-url><authid>24484025800</authid><authname>Paxman J.</authname><surname>Paxman</surname><given-name>Jenny</given-name><initials>J.</initials><afid>60032204</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35338794300</author-url><authid>35338794300</authid><authname>Dalton C.</authname><surname>Dalton</surname><given-name>Caroline</given-name><initials>C.</initials><afid>60032204</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102040748</author-url><authid>7102040748</authid><authname>Winter E.</authname><surname>Winter</surname><given-name>Edward</given-name><initials>E.</initials><afid>60032204</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:12773550200</author-url><authid>12773550200</authid><authname>Broom D.</authname><surname>Broom</surname><given-name>David</given-name><initials>D.</initials><afid>60032204</afid></author><authkeywords>Active | Appetite | Exercise | Food intake | Inactive | Oral contraceptives</authkeywords><intid>35077999</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925355461"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925355461?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925355461&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925355461&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0967063715000540"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925355461</prism:url><dc:identifier>SCOPUS_ID:84925355461</dc:identifier><eid>2-s2.0-84925355461</eid><dc:title>Enzyme activities of demersal fishes from the shelf to the abyssal plain</dc:title><dc:creator>Drazen J.</dc:creator><prism:publicationName>Deep-Sea Research Part I: Oceanographic Research Papers</prism:publicationName><prism:issn>09670637</prism:issn><prism:volume>100</prism:volume><prism:pageRange>117-126</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.dsr.2015.02.013</prism:doi><pii>S0967063715000540</pii><dc:description>© 2015 Elsevier Ltd. The present study examined metabolic enzyme activities of 61 species of demersal fishes (331 individuals) trawled from a 3000. m depth range. Citrate synthase, lactate dehydrogenase, malate dehydrogenase, and pyruvate kinase activities were measured as proxies for aerobic and anaerobic activity and metabolic rate. Fishes were classified according to locomotory mode, either benthic or benthopelagic. Fishes with these two locomotory modes were found to exhibit differences in metabolic enzyme activity. This was particularly clear in the overall activity of citrate synthase, which had higher activity in benthopelagic fishes. Confirming earlier, less comprehensive studies, enzyme activities declined with depth in benthopelagic fishes. For the first time, patterns in benthic species could be explored and these fishes also exhibited depth-related declines in enzyme activity, contrary to expectations of the visual interactions hypothesis. Trends were significant when using depth parameters taken from the literature as well as from the present trawl information, suggesting a robust pattern regardless of the depth metric used. Potential explanations for the depth trends are discussed, but clearly metabolic rate does not vary simply as a function of mass and habitat temperature in fishes as shown by the substantial depth-related changes in enzymatic activities.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029042</affiliation-url><afid>60029042</afid><affilname>University of Hawaii System</affilname><name-variant>Univ. Hawaii</name-variant><affiliation-city>Honolulu</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020873</affiliation-url><afid>60020873</afid><affilname>NOAA National Marine Fisheries Service Northwest Regional Office</affilname><name-variant>National Marine Fisheries Service</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7202121266</author-url><authid>7202121266</authid><authname>Drazen J.</authname><surname>Drazen</surname><given-name>Jeffrey C.</given-name><initials>J.C.</initials><afid>60029042</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55425001000</author-url><authid>55425001000</authid><authname>Friedman J.</authname><surname>Friedman</surname><given-name>Jason R.</given-name><initials>J.R.</initials><afid>60029042</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:47960898700</author-url><authid>47960898700</authid><authname>Condon N.</authname><surname>Condon</surname><given-name>Nicole E.</given-name><initials>N.E.</initials><afid>60029042</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56566675800</author-url><authid>56566675800</authid><authname>Aus E.</authname><surname>Aus</surname><given-name>Erica J.</given-name><initials>E.J.</initials><afid>60029042</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56085400200</author-url><authid>56085400200</authid><authname>Gerringer M.</authname><surname>Gerringer</surname><given-name>Mackenzie E.</given-name><initials>M.E.</initials><afid>60029042</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7401737636</author-url><authid>7401737636</authid><authname>Keller A.</authname><surname>Keller</surname><given-name>Aimee A.</given-name><initials>A.A.</initials><afid>60020873</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55233692700</author-url><authid>55233692700</authid><authname>Elizabeth Clarke M.</authname><surname>Elizabeth Clarke</surname><given-name>M.</given-name><initials>M.</initials><afid>60020873</afid></author><authkeywords>Enzymes | Locomotory mode | Metabolism | Visual interactions hypothesis</authkeywords><intid>1035284840</intid><source-id>26830</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925595971"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925595971?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925595971&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925595971&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115000521"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925595971</prism:url><dc:identifier>SCOPUS_ID:84925595971</dc:identifier><eid>2-s2.0-84925595971</eid><dc:title>Effects of aneurysm on the directional, regional, and layer distribution of residual strains in ascending thoracic aorta</dc:title><dc:creator>Sokolis D.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>46</prism:volume><prism:pageRange>229-243</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.01.024</prism:doi><pii>S1751616115000521</pii><dc:description>© 2015 Elsevier Ltd. Stress analyses in ascending thoracic aortic aneurysms require measurement of the stress-free state of tissue, for which there is limited information. The true reference configuration can also be difficult to delineate with opening angle measurements, due to (a) the variability in aneurysmal shape and (b) layered wall structure, suggesting spatial dependency of the residual strain field, and (c) the non-consideration of axial residual strains. The present study was designed to overcome these difficulties, by providing extensive data about the consequences of aneurysm on the directional, regional, and layer distribution of residual strains in the ascending thoracic aorta. We demonstrate that the opening angle of rings cut-open anteriorly correlated positively with age, diameter, degree of atherosclerosis, and circumferential residual strain at the external wall and negatively with that at the internal wall. As anticipated from the highly curved and non-axisymmetric geometry, the opening angle of ascending thoracic aortic aneurysms from tricuspid aortic valve patients declined notably, from ~240 to 190 deg, along a relatively short vessel length and residual strains varied strongly from one layer to another, being compressive in the intima and tensile in the media and adventitia, and depended also on circumferential position and direction. Smaller opening angles were found in aneurysms from bicuspid aortic valve patients and non-aneurysmal aorta, but differences were only significant for the latter that also showed less pronounced axial decline and smaller layer-specific residual strains. Dimensional data of the aortic layers obtained via histology support the association between opening angle change and non-uniform tissue remodeling, with the greater cross-sectional area of the intima and media in the wall of tricuspid aortic valve aneurysms explaining the increase of opening angle in this patient class compared to control.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003185</affiliation-url><afid>60003185</afid><affilname>Academy of Athens</affilname><name-variant>Biomedical Research Foundation of the Academy of Athens</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55922625400</author-url><authid>55922625400</authid><authname>Sokolis D.</authname><surname>Sokolis</surname><given-name>Dimitrios P.</given-name><initials>D.P.</initials><afid>60003185</afid></author><authkeywords>Aortic dissection | Heterogeneity | Opening angle | Stress distribution | Vascular remodeling | Zero-stress state</authkeywords><intid>1035323656</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929950720"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929950720?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929950720&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929950720&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0301008215000350"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929950720</prism:url><dc:identifier>SCOPUS_ID:84929950720</dc:identifier><eid>2-s2.0-84929950720</eid><dc:title>The brain acid-base homeostasis and serotonin: A perspective on the use of carbon dioxide as human and rodent experimental model of panic</dc:title><dc:creator>Leibold N.</dc:creator><prism:publicationName>Progress in Neurobiology</prism:publicationName><prism:issn>03010082</prism:issn><prism:eIssn>18735118</prism:eIssn><prism:volume>129</prism:volume><prism:pageRange>58-78</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pneurobio.2015.04.001</prism:doi><pii>S0301008215000350</pii><dc:description>© 2015 Elsevier Ltd. Panic attacks (PAs), the core feature of panic disorder, represent a common phenomenon in the general adult population and are associated with a considerable decrease in quality of life and high health care costs. To date, the underlying pathophysiology of PAs is not well understood. A unique feature of PAs is that they represent a rare example of a psychopathological phenomenon that can be reliably modeled in the laboratory in panic disorder patients and healthy volunteers. The most effective techniques to experimentally trigger PAs are those that acutely disturb the acid-base homeostasis in the brain: inhalation of carbon dioxide (CO&lt;inf&gt;2&lt;/inf&gt;), hyperventilation, and lactate infusion. This review particularly focuses on the use of CO&lt;inf&gt;2&lt;/inf&gt; inhalation in humans and rodents as an experimental model of panic. Besides highlighting the different methodological approaches, the cardio-respiratory and the endocrine responses to CO&lt;inf&gt;2&lt;/inf&gt; inhalation are summarized. In addition, the relationships between CO&lt;inf&gt;2&lt;/inf&gt; level, changes in brain pH, the serotonergic system, and adaptive physiological and behavioral responses to CO&lt;inf&gt;2&lt;/inf&gt; exposure are presented. We aim to present an integrated psychological and neurobiological perspective. Remaining gaps in the literature and future perspectives are discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018869</affiliation-url><afid>60018869</afid><affilname>Maastricht University</affilname><name-variant>University of Limburg</name-variant><affiliation-city>Maastricht</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012689</affiliation-url><afid>60012689</afid><affilname>Julius-Maximilians-Universitat Wurzburg</affilname><name-variant>University of Würzburg</name-variant><affiliation-city>Wurzburg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025063</affiliation-url><afid>60025063</afid><affilname>Katholieke Universiteit Leuven</affilname><name-variant>University of Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025063</affiliation-url><afid>60025063</afid><affilname>Katholieke Universiteit Leuven</affilname><name-variant>University of Leuven</name-variant><affiliation-city>Leuven</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">21</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55835063200</author-url><authid>55835063200</authid><authname>Leibold N.</authname><surname>Leibold</surname><given-name>N. K.</given-name><initials>N.K.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55835063200</author-url><authid>55835063200</authid><authname>Leibold N.</authname><surname>Leibold</surname><given-name>N. K.</given-name><initials>N.K.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55835063200</author-url><authid>55835063200</authid><authname>Leibold N.</authname><surname>Leibold</surname><given-name>N. K.</given-name><initials>N.K.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56410729200</author-url><authid>56410729200</authid><authname>van den Hove D.</authname><surname>van den Hove</surname><given-name>D. L A</given-name><initials>D.L.A.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56410729200</author-url><authid>56410729200</authid><authname>van den Hove D.</authname><surname>van den Hove</surname><given-name>D. L A</given-name><initials>D.L.A.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56410729200</author-url><authid>56410729200</authid><authname>van den Hove D.</authname><surname>van den Hove</surname><given-name>D. L A</given-name><initials>D.L.A.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23570357300</author-url><authid>23570357300</authid><authname>Esquivel G.</authname><surname>Esquivel</surname><given-name>G.</given-name><initials>G.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23570357300</author-url><authid>23570357300</authid><authname>Esquivel G.</authname><surname>Esquivel</surname><given-name>G.</given-name><initials>G.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6505951546</author-url><authid>6505951546</authid><authname>De Cort K.</authname><surname>De Cort</surname><given-name>K.</given-name><initials>K.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6505951546</author-url><authid>6505951546</authid><authname>De Cort K.</authname><surname>De Cort</surname><given-name>K.</given-name><initials>K.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:22950517500</author-url><authid>22950517500</authid><authname>Goossens L.</authname><surname>Goossens</surname><given-name>L.</given-name><initials>L.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:22950517500</author-url><authid>22950517500</authid><authname>Goossens L.</authname><surname>Goossens</surname><given-name>L.</given-name><initials>L.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:25628928400</author-url><authid>25628928400</authid><authname>Strackx E.</authname><surname>Strackx</surname><given-name>E.</given-name><initials>E.</initials><afid>60025063</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35978342100</author-url><authid>35978342100</authid><authname>Buchanan G.</authname><surname>Buchanan</surname><given-name>G. F.</given-name><initials>G.F.</initials><afid>60017994</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006557041</author-url><authid>7006557041</authid><authname>Steinbusch H.</authname><surname>Steinbusch</surname><given-name>H. W M</given-name><initials>H.W.M.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006557041</author-url><authid>7006557041</authid><authname>Steinbusch H.</authname><surname>Steinbusch</surname><given-name>H. W M</given-name><initials>H.W.M.</initials><afid>60018869</afid><afid>60018869</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:19735689200</author-url><authid>19735689200</authid><authname>Lesch K.</authname><surname>Lesch</surname><given-name>K. P.</given-name><initials>K.P.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:19735689200</author-url><authid>19735689200</authid><authname>Lesch K.</authname><surname>Lesch</surname><given-name>K. P.</given-name><initials>K.P.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:19735689200</author-url><authid>19735689200</authid><authname>Lesch K.</authname><surname>Lesch</surname><given-name>K. P.</given-name><initials>K.P.</initials><afid>60018869</afid><afid>60018869</afid><afid>60012689</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004118960</author-url><authid>7004118960</authid><authname>Schruers K.</authname><surname>Schruers</surname><given-name>K. R J</given-name><initials>K.R.J.</initials><afid>60018869</afid><afid>60025063</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004118960</author-url><authid>7004118960</authid><authname>Schruers K.</authname><surname>Schruers</surname><given-name>K. R J</given-name><initials>K.R.J.</initials><afid>60018869</afid><afid>60025063</afid></author><authkeywords>Animal models | Brain pH | CO&lt;inf&gt;2&lt;/inf&gt; | Human models | Panic disorder | Serotonin</authkeywords><intid>1536041917</intid><source-id>24025</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929161195"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929161195?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929161195&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929161195&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929161195</prism:url><dc:identifier>SCOPUS_ID:84929161195</dc:identifier><eid>2-s2.0-84929161195</eid><dc:title>Platelet activation is a key event in the pathogenesis of streptococcal infections</dc:title><dc:creator>Jia M.</dc:creator><prism:publicationName>Frontiers in Bioscience - Landmark</prism:publicationName><prism:issn>10939946</prism:issn><prism:eIssn>10934715</prism:eIssn><prism:volume>20</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>910-918</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><dc:description>© 2015, Frontiers in Bioscience. All rights reserved. Diverse Streptococcus species including Streptococcus Pneumoniae, Sanguis, Gordonii, Mitis and Mutans cause life-threatening conditions including pneumonia, bacteremia and meningitis. These diseases bear a high morbidity and mortality and for this reason, understanding the key events in the pathogenesis of these infections have a great significance in their prevention and/or treatment. Here, we describe as how the activation of the platelets and their affinity to bind to bacterial proteins act as early key events in the pathogenesis of Streptococcal infections.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023797</affiliation-url><afid>60023797</afid><affilname>Third Military Medical University</affilname><name-variant>Third Military Medical University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023797</affiliation-url><afid>60023797</afid><affilname>Third Military Medical University</affilname><name-variant>Third Military Medical University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640618500</author-url><authid>56640618500</authid><authname>Jia M.</authname><surname>Jia</surname><given-name>Ming</given-name><initials>M.</initials><afid>60023797</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640378700</author-url><authid>56640378700</authid><authname>Xiong Y.</authname><surname>Xiong</surname><given-name>Yuling</given-name><initials>Y.</initials><afid>60023797</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56477649400</author-url><authid>56477649400</authid><authname>Lu H.</authname><surname>Lu</surname><given-name>Hua</given-name><initials>H.</initials><afid>60023797</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55491365400</author-url><authid>55491365400</authid><authname>Li R.</authname><surname>Li</surname><given-name>Ruqing</given-name><initials>R.</initials><afid>60023797</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640069700</author-url><authid>56640069700</authid><authname>Wang T.</authname><surname>Wang</surname><given-name>Tiantian</given-name><initials>T.</initials><afid>60023797</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640352100</author-url><authid>56640352100</authid><authname>Ye Y.</authname><surname>Ye</surname><given-name>Yanyao</given-name><initials>Y.</initials><afid>60023797</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56640348000</author-url><authid>56640348000</authid><authname>Song M.</authname><surname>Song</surname><given-name>Min</given-name><initials>M.</initials><afid>60023797</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640110500</author-url><authid>56640110500</authid><authname>Li B.</authname><surname>Li</surname><given-name>Bing</given-name><initials>B.</initials><afid>60023797</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56477946400</author-url><authid>56477946400</authid><authname>Jiang T.</authname><surname>Jiang</surname><given-name>Tianlun</given-name><initials>T.</initials><afid>60023797</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56565812700</author-url><authid>56565812700</authid><authname>Zhao S.</authname><surname>Zhao</surname><given-name>Shuming</given-name><initials>S.</initials><afid>60023797</afid></author><authkeywords>Infection | Platelets | Review | Streptococcus</authkeywords><intid>1035912053</intid><source-id>27974</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928139669"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928139669?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928139669&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928139669&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0379073815001310"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928139669</prism:url><dc:identifier>SCOPUS_ID:84928139669</dc:identifier><eid>2-s2.0-84928139669</eid><dc:title>Simple protocol for extracting diatoms from lung tissues of suspected drowning cases within 3h: First practical application</dc:title><dc:creator>Kakizaki E.</dc:creator><prism:publicationName>Forensic Science International</prism:publicationName><prism:issn>03790738</prism:issn><prism:eIssn>18726283</prism:eIssn><prism:volume>251</prism:volume><prism:pageRange>179-185</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.forsciint.2015.03.025</prism:doi><pii>S0379073815001310</pii><dc:description>© 2015 Elsevier Ireland Ltd. Conventional acid digestion of tissues for analyzing diatoms obtained from suspected drowning cases is time-consuming, laborious and potentially dangerous. We propose a new protocol for solubilizing lung tissue using only Qiagen Proteinase K, Qiagen Buffer ATL, and 5N hydrochloric acid that can accelerate and simplify diatom extraction from suspected drowning cases. The lower lobe of the right lung (1. g, inner region) and the upper lobe of the left lung (1. g, peripheral region) of ten immersed victims were digested in 15-mL conical centrifuge tubes containing 9. mL of Buffer ATL and 1. mL of 20. mg/mL Proteinase K solution at 56. °C for 15-60. min. The digest was washed with ultrapure water and then heated at 70. °C for 15. min in 5N hydrochloric acid. The acid residue was washed with ultrapure water followed by ethanol. The identification of 60-23,000 valves in 20 lung samples from the ten victims suggested that they had aspirated water before death. The proposed digestive protocol required only a low-speed centrifuge and a block incubator (or water bath) and diatoms could usually be extracted from lung samples within about 3. h. Informative results of lung diatom tests were very helpful to confirm drowning as a cause of death. Therefore, the proposed protocol can be useful as a simple minimal test to support or challenge a diagnosis of death by drowning when characteristic autopsy findings of drowning are obvious and the probability of drowning is very high, when characteristic autopsy findings of drowning are absent and the probability of drowning is very low, and when conventional diatom testing is not performed due to logistic, personnel or budgetary limitations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001580</affiliation-url><afid>60001580</afid><affilname>University of Miyazaki</affilname><name-variant>Miyazaki University</name-variant><affiliation-city>Miyazaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56194660700</author-url><authid>56194660700</authid><authname>Kakizaki E.</authname><surname>Kakizaki</surname><given-name>Eiji</given-name><initials>E.</initials><afid>60001580</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005953788</author-url><authid>7005953788</authid><authname>Yukawa N.</authname><surname>Yukawa</surname><given-name>Nobuhiro</given-name><initials>N.</initials><afid>60001580</afid></author><authkeywords>Diatom test | Drowning | Enzymatic digestion | Hydrochloric acid | Proteinase K | Tissue solubilization</authkeywords><intid>1035728999</intid><source-id>27743</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924560120"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924560120?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924560120&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924560120&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0952791515000370"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924560120</prism:url><dc:identifier>SCOPUS_ID:84924560120</dc:identifier><eid>2-s2.0-84924560120</eid><dc:title>The IL-6/gp130/STAT3 signaling axis: Recent advances towards specific inhibition</dc:title><dc:creator>Garbers C.</dc:creator><prism:publicationName>Current Opinion in Immunology</prism:publicationName><prism:issn>09527915</prism:issn><prism:eIssn>18790372</prism:eIssn><prism:volume>34</prism:volume><prism:pageRange>75-82</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.coi.2015.02.008</prism:doi><pii>S0952791515000370</pii><dc:description>© 2015 Elsevier Ltd. Interleukin-6 has long been recognized as a prototypic pro-inflammatory cytokine that is involved in the pathogenesis of all inflammatory diseases. Activation of the gp130 homodimer by IL-6 leads to the initiation of Jak/STAT signaling, a pathway that is often constitutively switched on in inflammatory malignancies. However, a plethora of studies in the last decade has convincingly shown that only signaling via the soluble IL-6R (trans-signaling) accounts for the deleterious effects of IL-6, whereas classic signaling via the membrane-bound receptor is essential for the regenerative and anti-bacterial effects of IL-6 (classic signaling). In this review, we highlight recent developments in the field of IL-6 research, and specifically focus on advances towards a safe and specific inhibition of IL-6 trans-signaling.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012345</affiliation-url><afid>60012345</afid><affilname>Christian-Albrechts-Universitat zu Kiel</affilname><name-variant>University of Kiel</name-variant><affiliation-city>Kiel</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36657260000</author-url><authid>36657260000</authid><authname>Garbers C.</authname><surname>Garbers</surname><given-name>Christoph</given-name><initials>C.</initials><afid>60012345</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55587932300</author-url><authid>55587932300</authid><authname>Aparicio-Siegmund S.</authname><surname>Aparicio-Siegmund</surname><given-name>Samadhi</given-name><initials>S.</initials><afid>60012345</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005838522</author-url><authid>7005838522</authid><authname>Rose-John S.</authname><surname>Rose-John</surname><given-name>Stefan</given-name><initials>S.</initials><afid>60012345</afid></author><intid>1535166930</intid><source-id>18797</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928633595"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928633595?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928633595&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928633595&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928633595</prism:url><dc:identifier>SCOPUS_ID:84928633595</dc:identifier><eid>2-s2.0-84928633595</eid><dc:title>Novel Antiplatelet Agents in Cardiovascular Medicine</dc:title><dc:creator>Rafeedheen R.</dc:creator><prism:publicationName>Current Treatment Options in Cardiovascular Medicine</prism:publicationName><prism:issn>10928464</prism:issn><prism:eIssn>15343189</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11936-015-0383-0</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Dual antiplatelet therapy with aspirin and a P2Y&lt;inf&gt;12&lt;/inf&gt; receptor blocker, particularly clopidogrel, has been the standard of therapy for secondary prevention in patients with acute coronary syndromes and patients treated with percutaneous coronary intervention. More potent P2Y&lt;inf&gt;12&lt;/inf&gt; inhibitors such as ticagrelor and prasugrel are associated with better pharmacodynamic effect and improved clinical outcomes but are associated with an increased risk of bleeding compared to clopidogrel. In addition, the observation of treatment failure in ~10 % of high-risk patients treated with aspirin and a potent P2Y&lt;inf&gt;12&lt;/inf&gt; inhibitor is another major concern. Personalized antiplatelet therapy based on therapeutic winnow concept for P2Y&lt;inf&gt;12&lt;/inf&gt; receptor blocker may facilitate the balance between reducing ischemic events and avoiding bleeding events, thereby improving net clinical outcome. New class of agents like vorapaxar has been approved by the FDA to reduce thrombotic events in patients with a history of myocardial infarction or with peripheral arterial disease. In addition, new P2Y&lt;inf&gt;12&lt;/inf&gt; receptor and protease-activated receptor (PAR)-1 receptor antagonists and agents targeting intracellular signaling downstream from G protein-coupled receptors are among the novel strategies under investigation to prevent arterial ischemic event occurrences.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001995</affiliation-url><afid>60001995</afid><affilname>Sinai Center for Thrombosis Research</affilname><name-variant>Sinai Center for Thrombosis Research</name-variant><affiliation-city>Baltimore</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56133197400</author-url><authid>56133197400</authid><authname>Rafeedheen R.</authname><surname>Rafeedheen</surname><given-name>Rahil</given-name><initials>R.</initials><afid>60001995</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603318898</author-url><authid>6603318898</authid><authname>Bliden K.</authname><surname>Bliden</surname><given-name>Kevin P.</given-name><initials>K.P.</initials><afid>60001995</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56565743700</author-url><authid>56565743700</authid><authname>Liu F.</authname><surname>Liu</surname><given-name>Fang</given-name><initials>F.</initials><afid>60001995</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602488679</author-url><authid>6602488679</authid><authname>Tantry U.</authname><surname>Tantry</surname><given-name>Udaya S.</given-name><initials>U.S.</initials><afid>60001995</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004969189</author-url><authid>7004969189</authid><authname>Gurbel P.</authname><surname>Gurbel</surname><given-name>Paul A.</given-name><initials>P.A.</initials><afid>60001995</afid></author><authkeywords>Antiplatelet therapy | Aspirin | Intracellular signaling | P2Y12 receptor inhibitor | PAR-1 inhibitors | Thrombin receptor</authkeywords><intid>35814320</intid><source-id>23154</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929352937"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929352937?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929352937&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929352937&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214540015000092"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929352937</prism:url><dc:identifier>SCOPUS_ID:84929352937</dc:identifier><eid>2-s2.0-84929352937</eid><dc:title>Association of novel SNPs in the candidate genes affecting caprine milk fatty acids related to human health</dc:title><dc:creator>Dixit S.</dc:creator><prism:publicationName>Meta Gene</prism:publicationName><prism:issn>22145400</prism:issn><prism:eIssn>22145400</prism:eIssn><prism:volume>4</prism:volume><prism:pageRange>45-56</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mgene.2015.01.004</prism:doi><pii>S2214540015000092</pii><dc:description>© 2015 Published by Elsevier B.V.. In the present investigation, 618 milk samples of Sirohi breed of goat were collected, and analyzed for conjugated linoleic acid (CLA, C18:2) and other fatty acids. The CLA in studied goat milk samples was 4.87. mg/g of milk fat and C18:2 cis-9, trans-11 contributes 2.9. mg/g of milk fat and trans10 cis12 contributes 0.82. mg/g of milk fat. The saturated fatty acids in the milk accounted for 69.55% and unsaturated fatty acid accounted for 28.50%. The unsaturated fatty acid was constituted by monounsaturated fatty acid (24.57%) and polyunsaturated fatty acids (3.96%.). The major contribution (45.56%) in total fatty acid was of C12:0, C14:0 and C16:0. C18:0 and short chain ones (C4:0, C6:0, C8:0, and C10:0) have a neutral or cholesterol-decreasing effect. The DNA sequence analysis of the genes (DGAT1, SCAP, PPARG, OLR, FABP3 and PRL) in a random panel of 8 Sirohi goats revealed 38 SNPs across the targeted regions. Out of the studied SNPs (38) across these genes, 22 SNPs had significant effect on one or a group of fatty acids including CLA. The genotypes at these loci showed significant differences in the least square means of a particular fatty acid or a group of fatty acids including CLA and its isomers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60050145</affiliation-url><afid>60050145</afid><affilname>National Bureau of Animal Genetic Resources India</affilname><name-variant>National Bureau of Animal Genetic Resources</name-variant><affiliation-city>Karnal</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012257</affiliation-url><afid>60012257</afid><affilname>National Dairy Research Institute India</affilname><name-variant>National Dairy Research Institute</name-variant><affiliation-city>Karnal</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026966</affiliation-url><afid>60026966</afid><affilname>Rajasthan Vidyapeeth University</affilname><name-variant>Rajasthan University</name-variant><affiliation-city>Udaipur</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201965872</author-url><authid>7201965872</authid><authname>Dixit S.</authname><surname>Dixit</surname><given-name>S. P.</given-name><initials>S.P.</initials><afid>60050145</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55905570000</author-url><authid>55905570000</authid><authname>Sivalingam J.</authname><surname>Sivalingam</surname><given-name>Jayakumar</given-name><initials>J.</initials><afid>60050145</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202520267</author-url><authid>7202520267</authid><authname>Tyagi A.</authname><surname>Tyagi</surname><given-name>A. K.</given-name><initials>A.K.</initials><afid>60012257</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55808397800</author-url><authid>55808397800</authid><authname>Saroha V.</authname><surname>Saroha</surname><given-name>V.</given-name><initials>V.</initials><afid>60050145</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7404970782</author-url><authid>7404970782</authid><authname>Sharma A.</authname><surname>Sharma</surname><given-name>A.</given-name><initials>A.</initials><afid>60050145</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56644693000</author-url><authid>56644693000</authid><authname>Nagda R.</authname><surname>Nagda</surname><given-name>R. K.</given-name><initials>R.K.</initials><afid>60026966</afid></author><authkeywords>Association | DGAT1 | FABP3 | Goat | Milk fatty acids | OLR | PPARG | PRL | SCAP | SNP</authkeywords><intid>1785945518</intid><source-id>21100283722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929176133"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929176133?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929176133&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929176133&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929176133</prism:url><dc:identifier>SCOPUS_ID:84929176133</dc:identifier><eid>2-s2.0-84929176133</eid><dc:title>Systemic inflammation and multiple organ injury in traumatic hemorrhagic shock</dc:title><dc:creator>Liu H.</dc:creator><prism:publicationName>Frontiers in Bioscience - Landmark</prism:publicationName><prism:issn>10939946</prism:issn><prism:eIssn>10934715</prism:eIssn><prism:volume>20</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>927-933</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><dc:description>© 2015, Frontiers in Bioscience. All rights reserved. Traumatic hemorrhagic shock (HS) is a severe outcome of traumatic injury that accounts for numerous traumatic deaths. In the process of traumatic HS, both hemorrhage and trauma can trigger a complex cascade of posttraumatic events that are related to inflammatory and immune responses, which may lead to multiple organ injury or even death. From a mechanistic perspective, systemic inflammation and organ injury are involved coagulation, the complement system, impaired microcirculation and inflammatory signaling pathways. In this review, we discuss the systemic inflammation and multiple organ injury in post-traumatic HS.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017060</affiliation-url><afid>60017060</afid><affilname>Central South University China</affilname><name-variant>Central South University</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56640053700</author-url><authid>56640053700</authid><authname>Liu H.</authname><surname>Liu</surname><given-name>Huaizheng</given-name><initials>H.</initials><afid>60017060</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56493725900</author-url><authid>56493725900</authid><authname>Xiao X.</authname><surname>Xiao</surname><given-name>Xuefei</given-name><initials>X.</initials><afid>60017060</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640192200</author-url><authid>56640192200</authid><authname>Sun C.</authname><surname>Sun</surname><given-name>Chuanzheng</given-name><initials>C.</initials><afid>60017060</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55185111000</author-url><authid>55185111000</authid><authname>Sun D.</authname><surname>Sun</surname><given-name>Dao</given-name><initials>D.</initials><afid>60017060</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56641934900</author-url><authid>56641934900</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yayong</given-name><initials>Y.</initials><afid>60017060</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56640130700</author-url><authid>56640130700</authid><authname>Yang M.</authname><surname>Yang</surname><given-name>Mingshi</given-name><initials>M.</initials><afid>60017060</afid></author><authkeywords>Hemorrhagic shock | Multiple organ injury | Review | Systemic inflammation</authkeywords><intid>1035911662</intid><source-id>27974</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924778603"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924778603?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924778603&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924778603&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304389415001776"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924778603</prism:url><dc:identifier>SCOPUS_ID:84924778603</dc:identifier><eid>2-s2.0-84924778603</eid><dc:title>Bisphenol A removal by a Pseudomonas aeruginosa immobilized on granular activated carbon and operating in a fluidized bed reactor</dc:title><dc:creator>Mita L.</dc:creator><prism:publicationName>Journal of Hazardous Materials</prism:publicationName><prism:issn>03043894</prism:issn><prism:eIssn>18733336</prism:eIssn><prism:volume>291</prism:volume><prism:pageRange>129-135</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jhazmat.2015.02.072</prism:doi><pii>S0304389415001776</pii><dc:description>© 2015 Elsevier B.V. Serratia rubidiae, Pseudomonas aeruginosa and Escherichia coli K12 have been studied for their ability of Bisphenol A removal from aqueous systems and biofilm formation on activated granule carbon. Mathematical equations for biodegradation process have been elaborated and discussed. P. aeruginosa was found the best strain to be employed in the process of Bisphenol A removal. The yield in BPA removal of a P. aeruginosa biofilm grown on GAC and operating in a fluidized bed reactor has been evaluated. The results confirm the usefulness in using biological activated carbon (BAC process) to remove phenol compounds from aqueous systems.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60082163</affiliation-url><afid>60082163</afid><affilname>Istituto Nazionale di Biostrutture e Biosistemi</affilname><name-variant>INBB</name-variant><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025668</affiliation-url><afid>60025668</afid><affilname>Institute of Genetics and Biophysics Adriano Buzzati Traverso</affilname><name-variant>CNR</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114479232</affiliation-url><afid>114479232</afid><affilname>Institute of Biosciences and BioResources</affilname><name-variant>Institute of Biosciences and Bioresources</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60083734</affiliation-url><afid>60083734</afid><affilname>Istituto Zooprofilattico Sperimentale del Mezzogiorno</affilname><name-variant>Istituto Zooprofilattico Sperimentale del Mezzogiorno</name-variant><affiliation-city>Portici</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026777</affiliation-url><afid>60026777</afid><affilname>Seconda Universita degli Studi di Napoli</affilname><name-variant>Second University of Naples</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:20433892300</author-url><authid>20433892300</authid><authname>Mita L.</authname><surname>Mita</surname><given-name>Luigi</given-name><initials>L.</initials><afid>60082163</afid><afid>60025668</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:20433892300</author-url><authid>20433892300</authid><authname>Mita L.</authname><surname>Mita</surname><given-name>Luigi</given-name><initials>L.</initials><afid>60082163</afid><afid>60025668</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54792907300</author-url><authid>54792907300</authid><authname>Grumiro L.</authname><surname>Grumiro</surname><given-name>Laura</given-name><initials>L.</initials><afid>60082163</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56549485700</author-url><authid>56549485700</authid><authname>Rossi S.</authname><surname>Rossi</surname><given-name>Sergio</given-name><initials>S.</initials><afid>60025668</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005433945</author-url><authid>7005433945</authid><authname>Bianco C.</authname><surname>Bianco</surname><given-name>Carmen</given-name><initials>C.</initials><afid>114479232</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701673938</author-url><authid>6701673938</authid><authname>Defez R.</authname><surname>Defez</surname><given-name>Roberto</given-name><initials>R.</initials><afid>114479232</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55960710500</author-url><authid>55960710500</authid><authname>Gallo P.</authname><surname>Gallo</surname><given-name>Pasquale</given-name><initials>P.</initials><afid>60083734</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006472919</author-url><authid>7006472919</authid><authname>Mita D.</authname><surname>Mita</surname><given-name>Damiano Gustavo</given-name><initials>D.G.</initials><afid>60082163</afid><afid>60025668</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7006472919</author-url><authid>7006472919</authid><authname>Mita D.</authname><surname>Mita</surname><given-name>Damiano Gustavo</given-name><initials>D.G.</initials><afid>60082163</afid><afid>60025668</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603192762</author-url><authid>6603192762</authid><authname>Diano N.</authname><surname>Diano</surname><given-name>Nadia</given-name><initials>N.</initials><afid>60082163</afid><afid>60026777</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6603192762</author-url><authid>6603192762</authid><authname>Diano N.</authname><surname>Diano</surname><given-name>Nadia</given-name><initials>N.</initials><afid>60082163</afid><afid>60026777</afid></author><authkeywords>BAC process | Bacterial biofilm | Bioremediation | Bisphenol A removal | Fluidized bed reactor</authkeywords><intid>35198551</intid><source-id>25858</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928382328"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928382328?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928382328&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928382328&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928382328</prism:url><dc:identifier>SCOPUS_ID:84928382328</dc:identifier><eid>2-s2.0-84928382328</eid><dc:title>Are SGLT2 Inhibitors Reasonable Antihypertensive Drugs and Renoprotective?</dc:title><dc:creator>Lovshin J.</dc:creator><prism:publicationName>Current Hypertension Reports</prism:publicationName><prism:issn>15226417</prism:issn><prism:eIssn>15343111</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11906-015-0551-3</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. By eliminating glucose in the urine, the sodium-glucose-linked cotransporter-2 (SGLT2) inhibitors act as osmotic diuretics to lower blood pressure in addition to reducing plasma glucose and assisting with weight loss. While not approved as antihypertensive agents, the ability of this new class of antihyperglycemic agents to lower blood pressure is not insubstantial, and while not used primarily for this indication, they may assist diabetic individuals in attaining currently recommended blood pressure targets. In addition to lowering systemic pressure, preclinical and exploratory human studies suggest that SGLT2 inhibitors may also lower intraglomerular pressure, potentially reducing the rate of GFR decline in patients with diabetic nephropathy. However, given the lack of clinically meaningful endpoint data, the use of SGLT2 inhibitors, primarily, as either antihypertensive or renoprotective agents would, at present, be premature. Fortunately, further insight will be garnered from large, randomized controlled trials that will assess the effects of various SGLT2 inhibitors on cardiovascular and renal outcomes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016849</affiliation-url><afid>60016849</afid><affilname>University of Toronto</affilname><name-variant>University of Toronto</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085801</affiliation-url><afid>60085801</afid><affilname>Li Ka Shing Knowledge Institute</affilname><name-variant>St. Michael's Hospital</name-variant><affiliation-city>Toronto</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507160037</author-url><authid>6507160037</authid><authname>Lovshin J.</authname><surname>Lovshin</surname><given-name>J. A.</given-name><initials>J.A.</initials><afid>60016849</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7401931892</author-url><authid>7401931892</authid><authname>Gilbert R.</authname><surname>Gilbert</surname><given-name>R. E.</given-name><initials>R.E.</initials><afid>60085801</afid></author><authkeywords>Blood pressure | Diabetes mellitus | Diabetic nephropathy | Sodium-glucose-linked cotransporter-2 | Tubuloglomerular Feedback</authkeywords><intid>35778507</intid><source-id>23135</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930212051"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930212051?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930212051&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930212051&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930212051</prism:url><dc:identifier>SCOPUS_ID:84930212051</dc:identifier><eid>2-s2.0-84930212051</eid><dc:title>Lightning Rods in the Local Moral Economy: Debating Unauthorized Migrants' Deservingness in Israel</dc:title><dc:creator>Willen S.</dc:creator><prism:publicationName>International Migration</prism:publicationName><prism:issn>00207985</prism:issn><prism:eIssn>14682435</prism:eIssn><prism:volume>53</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>70-86</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1111/imig.12173</prism:doi><dc:description>© 2014 The Author. International Migration © 2014 IOM. Localized debates about who unauthorized migrants are and what they do, or do not, deserve unfold in a culturally specific register that is deeply charged with emotion and moral valuation. Structuring such debates are vernacular discursive frames that emerge from, and reflect, a common "local moral economy." Taking Israel as case study, this article examines six elements of the country's local moral economy - biopolitical logic, historical memory, political emotion, popularized religion, an ideology of "fruitful multiplication," and hasbara ("public diplomacy"/propaganda) - and explores their impact on public debates about unauthorized and irregular forms of migration. Here, as elsewhere, conventionalized distinctions that frame much migration scholarship - e.g. "economic" vs. "political" migrants, "migrant workers" vs. "refugees," even the terms "authorized" and "unauthorized" themselves - bear but limited salience. Migration researchers who hope to influence local policy debates must recognize the weight and influence of local moral economies, and the chasms that divide vernacular from conventionalized frames. Achieving this sort of nuanced understanding is, at root, an ethnographic challenge.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022659</affiliation-url><afid>60022659</afid><affilname>University of Connecticut</affilname><name-variant>University of Connecticut</name-variant><affiliation-city>Storrs</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:17344391100</author-url><authid>17344391100</authid><authname>Willen S.</authname><surname>Willen</surname><given-name>Sarah S.</given-name><initials>S.S.</initials><afid>60022659</afid></author><intid>1036082701</intid><source-id>26855</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928743466"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928743466?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928743466&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928743466&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S187439001500021X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928743466</prism:url><dc:identifier>SCOPUS_ID:84928743466</dc:identifier><eid>2-s2.0-84928743466</eid><dc:title>The social dilemma of bribery in emerging economies: A dynamic model of emotion, social value, and institutional uncertainty</dc:title><dc:creator>Li Y.</dc:creator><prism:publicationName>Asia Pacific Journal of Management</prism:publicationName><prism:issn>02174561</prism:issn><prism:eIssn>15729958</prism:eIssn><prism:volume>32</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>311-334</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s10490-014-9406-8</prism:doi><dc:description>© 2014, Springer Science+Business Media New York. Corruption dampens social justice and can hurt consumer welfare through increases in transaction costs and perceived unfairness in resource distribution. This study examines the particular corruption practice of bribery. It conceptualizes bribery decisions in terms of social dilemmas, that is, the acquisition of valuable assets for personal good vs. maintaining a fair and open mechanism for the collective common good. To better understand this social dilemma, institutional uncertainty was incorporated to contextualize the decision situation. Combining both cognitive and emotional mechanisms, the proposed model deliberates the psychological process of the social dilemma, particularly the contradiction between social values and selfinterests as well as their influences on ethical emotions such as shame and fear. A double loop model is further proposed to elucidate the societal dynamics of bribery decisions, which suggests a solution to reduce the likelihood of the social dilemma by governing the social consequences of bribery, enhancing social value, decreasing the uncertainty level of institutions, and intensifying emotional inhibition, where managing the levels of institutional uncertainty center the dynamics.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016835</affiliation-url><afid>60016835</afid><affilname>Beijing Institute of Technology</affilname><name-variant>Beijing Institute of Technology</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000745</affiliation-url><afid>60000745</afid><affilname>University of Illinois at Urbana-Champaign</affilname><name-variant>University of Illinois</name-variant><affiliation-city>Urbana</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36668614700</author-url><authid>36668614700</authid><authname>Li Y.</authname><surname>Li</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60016835</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35772777100</author-url><authid>35772777100</authid><authname>Yao F.</authname><surname>Yao</surname><given-name>Fiona Kun</given-name><initials>F.K.</initials><afid>60000745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56525447800</author-url><authid>56525447800</authid><authname>Ahlstrom D.</authname><surname>Ahlstrom</surname><given-name>David</given-name><initials>D.</initials><afid>60002798</afid></author><authkeywords>Bribery | Corruption | Dynamic | Emotion | Institutional theory | Social dilemma</authkeywords><intid>1035835603</intid><source-id>145211</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929087829"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929087829?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929087829&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929087829&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929087829</prism:url><dc:identifier>SCOPUS_ID:84929087829</dc:identifier><eid>2-s2.0-84929087829</eid><dc:title>Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?</dc:title><dc:creator>Mizerska-Dudka M.</dc:creator><prism:publicationName>Archivum Immunologiae et Therapiae Experimentalis</prism:publicationName><prism:issn>0004069X</prism:issn><prism:eIssn>16614917</prism:eIssn><prism:volume>63</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>197-205</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00005-014-0311-0</prism:doi><dc:description>© 2014, The Author(s). The role of endogenous animal opioids in the biology of cancer is widely recognized but poorly understood. This is, among others, because of the short half-life of these peptides, which are quickly inactivated by endopeptidases, e.g., neutral endopeptidase (NEP, CD10). It has been established that NEP is engaged in the modulation of the tumor microenvironment, among others that of colon cancer, by exerting influence on cell growth factors, the extracellular matrix and other biologically active substances. Although there are some discrepancies among the findings on the role of both opioids and NEP in cancer development, authors agree that their role seems to depend on the origin, stage and grade of tumor, and even on the method of examination. Moreover, recently, natural inhibitors of NEP, such as sialorphin, opiorphin and spinorphin have been detected. Their analgesic activity has been established. It is interesting to ask whether there is a relationship among opioid peptides, tumor-associated NEP and its inhibitors.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011685</affiliation-url><afid>60011685</afid><affilname>Uniwersytet Marii Curie-Sklodowskiej w Lublinie</affilname><name-variant>Maria Curie-Sklodowska University</name-variant><affiliation-city>Lublin</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24332616000</author-url><authid>24332616000</authid><authname>Mizerska-Dudka M.</authname><surname>Mizerska-Dudka</surname><given-name>Magdalena</given-name><initials>M.</initials><afid>60011685</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006348736</author-url><authid>7006348736</authid><authname>Kandefer-Szerszeń M.</authname><surname>Kandefer-Szerszeń</surname><given-name>Martyna</given-name><initials>M.</initials><afid>60011685</afid></author><authkeywords>CD10 | Colon cancer | Neutral endopeptidase | OGF | Opioid peptides</authkeywords><intid>1535901743</intid><source-id>20652</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925780905"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925780905?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925780905&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925780905&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S2214647415000185"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925780905</prism:url><dc:identifier>SCOPUS_ID:84925780905</dc:identifier><eid>2-s2.0-84925780905</eid><dc:title>Calcitriol/calcifediol ratio: An indicator of vitamin D hydroxylation efficiency?</dc:title><dc:creator>Pasquali M.</dc:creator><prism:publicationName>BBA Clinical</prism:publicationName><prism:issn>22146474</prism:issn><prism:volume>3</prism:volume><prism:pageRange>251-256</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbacli.2015.03.004</prism:doi><pii>S2214647415000185</pii><dc:description>© 2015. Background: Calcifediol (25D) availability is crucial for calcitriol (1,25D) synthesis, but regulation of vitamin D hydroxylases is majorly responsible for 1,25D synthesis. The net efficiency of vitamin D hydroxylases might be informative. We assume that the ratio between calcitriol and calcifediol (25D/1,25D) serum concentrations could suggest the vitamin D hydroxylation efficiency. Methods: We evaluated 25D/1,25D in different patient populations: hemodialysis (HD, n. =. 76), CKD stage 2-5 (n. =. 111), renal transplant (TX, n. =. 135), patients with no renal disease (No-CKD, n. =. 290), and primary hyperparathyroidism (PHP, n. =. 20). Results: The geometric mean of 1,25D/25D (pg/ng) averaged 1.11 (HD), 1.36 (CKD), 1.77 (TX), 2.22 (No-CKD), and 4.11 (PHP), with a progressive increment from HD to PHP (p-value for the trend &lt;0.001). Each clinical condition elicited a significant effect on 25D/1,25D (p&lt;0.0001) and adjusted multivariate analysis indicated levels of Cas, Ps, PTH, and 25D as predictors of 25D/1,25D. Both in vitamin D deficient and replete subjects (25D&lt; or ≥20ng/ml) 25D/1,25D associated with each clinical condition (p&lt;0.0001) and mean values increased progressively from HD to PHP (p-values for the trend &lt;0.0001). Regression analysis between 25D (substrate) and 25D/1,25D (efficiency) revealed an exponential negative correlation in No-CKD (r2Exp=0.53, p&lt;0.001) with sharp increments of 25D/1,25D when 25D values are &lt;20ng/ml. At variance, in CKD (r2lin=0.19) and in TX (r2lin=0.32) the regression was linear as if, in case of deficit, some inhibition of the system were operating. Conclusion and General significance: In conclusion 1,25D/25D can reflect the efficiency of vitamin D hydroxylases more than separate evaluation of 25D and 1,25D and can facilitate the therapeutic choices in different patient populations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009636</affiliation-url><afid>60009636</afid><affilname>Ospedale Mauriziano Umberto I</affilname><name-variant>Ospedale Mauriziano</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56470874200</author-url><authid>56470874200</authid><authname>Pasquali M.</authname><surname>Pasquali</surname><given-name>Marzia</given-name><initials>M.</initials><afid>60032350</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36673965500</author-url><authid>36673965500</authid><authname>Tartaglione L.</authname><surname>Tartaglione</surname><given-name>Lida</given-name><initials>L.</initials><afid>60032350</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36180150600</author-url><authid>36180150600</authid><authname>Rotondi S.</authname><surname>Rotondi</surname><given-name>Silverio</given-name><initials>S.</initials><afid>60032350</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:26635601300</author-url><authid>26635601300</authid><authname>Muci M.</authname><surname>Muci</surname><given-name>Maria Luisa</given-name><initials>M.L.</initials><afid>60032350</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56574124100</author-url><authid>56574124100</authid><authname>Mandanici G.</authname><surname>Mandanici</surname><given-name>Giusi</given-name><initials>G.</initials><afid>60032350</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:17434161200</author-url><authid>17434161200</authid><authname>Farcomeni A.</authname><surname>Farcomeni</surname><given-name>Alessio</given-name><initials>A.</initials><afid>60032350</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005466164</author-url><authid>7005466164</authid><authname>Marangella M.</authname><surname>Marangella</surname><given-name>Martino</given-name><initials>M.</initials><afid>60009636</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003416740</author-url><authid>7003416740</authid><authname>Mazzaferro S.</authname><surname>Mazzaferro</surname><given-name>Sandro</given-name><initials>S.</initials><afid>60032350</afid></author><authkeywords>Calcifediol | Calcitriol | Chronic renal failure | Renal transplantation | Vitamin D | Vitamin D hydroxylation</authkeywords><intid>535350812</intid><source-id>21100317907</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924984759"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924984759?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924984759&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924984759&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0887233315000284"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924984759</prism:url><dc:identifier>SCOPUS_ID:84924984759</dc:identifier><eid>2-s2.0-84924984759</eid><dc:title>The utility of HepG2 cells to identify direct mitochondrial dysfunction in the absence of cell death</dc:title><dc:creator>Kamalian L.</dc:creator><prism:publicationName>Toxicology in Vitro</prism:publicationName><prism:issn>08872333</prism:issn><prism:eIssn>18793177</prism:eIssn><prism:volume>29</prism:volume><prism:issueIdentifier>4</prism:issueIdentifier><prism:pageRange>732-740</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tiv.2015.02.011</prism:doi><pii>S0887233315000284</pii><dc:description>© 2015 The Authors. Drug-induced mitochondrial dysfunction has been hypothesized to be an important determining factor in the onset of drug-induced liver injury. It is essential to develop robust screens with which to identify drug-induced mitochondrial toxicity and to dissect its role in hepatotoxicity. In this study we have characterised a mechanistically refined HepG2 model, using a panel of selected hepatotoxicants and non-hepatotoxicants. We have demonstrated that acute metabolic modification, via glucose-deprivation over a 4. h period immediately prior to compound addition, is sufficient to allow the identification of drugs which induce mitochondrial dysfunction, in the absence of cell death over a short exposure (2-8. h) using a plate-based screen to measure cellular ATP content and cytotoxicity. These effects were verified by measuring changes in cellular respiration, via oxygen consumption and extracellular acidification rates. Overall, these studies demonstrate the utility of HepG2 cells for the identification of mitochondrial toxins which act directly on the electron transport chain and that the dual assessment of ATP content alongside cytotoxicity provides an enhanced mechanistic understanding of the causes of toxicity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020661</affiliation-url><afid>60020661</afid><affilname>University of Liverpool</affilname><name-variant>University of Liverpool</name-variant><affiliation-city>Liverpool</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112442095</affiliation-url><afid>112442095</afid><affilname>Drug Metabolism and Pharmacokinetics</affilname><name-variant>Drug Metabolism and Pharmacokinetics</name-variant><affiliation-city>Beerse</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24073575500</author-url><authid>24073575500</authid><authname>Kamalian L.</authname><surname>Kamalian</surname><given-name>Laleh</given-name><initials>L.</initials><afid>60020661</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56556165000</author-url><authid>56556165000</authid><authname>Chadwick A.</authname><surname>Chadwick</surname><given-name>Amy E.</given-name><initials>A.E.</initials><afid>60020661</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56556236200</author-url><authid>56556236200</authid><authname>Bayliss M.</authname><surname>Bayliss</surname><given-name>Mark</given-name><initials>M.</initials><afid>60020661</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:34975060700</author-url><authid>34975060700</authid><authname>French N.</authname><surname>French</surname><given-name>Neil S.</given-name><initials>N.S.</initials><afid>60020661</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701401084</author-url><authid>6701401084</authid><authname>Monshouwer M.</authname><surname>Monshouwer</surname><given-name>Mario</given-name><initials>M.</initials><afid>112442095</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:10140797500</author-url><authid>10140797500</authid><authname>Snoeys J.</authname><surname>Snoeys</surname><given-name>Jan</given-name><initials>J.</initials><afid>112442095</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56457101800</author-url><authid>56457101800</authid><authname>Park B.</authname><surname>Park</surname><given-name>B. Kevin</given-name><initials>B.K.</initials><afid>60020661</afid></author><authkeywords>Drug-induced liver injury | Dysfunction | HepG2 | Mitochondria | Toxicity</authkeywords><intid>1785233938</intid><source-id>25224</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84923224685"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84923224685?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84923224685&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84923224685&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715001990"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84923224685</prism:url><dc:identifier>SCOPUS_ID:84923224685</dc:identifier><eid>2-s2.0-84923224685</eid><dc:title>Exposure to metals and congenital anomalies: A biomonitoring study of pregnant Bedouin-Arab women</dc:title><dc:creator>Karakis I.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>517</prism:volume><prism:pageRange>106-112</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.02.056</prism:doi><pii>S0048969715001990</pii><dc:description>© 2015. The Bedouin-Arab population in Israel comprises a low socio-economic society in transition. Smoking among males and consanguineous marriages are frequent. A previous study showed elevated rates of major malformations within groups from this population residing near an industrial park, where high ambient values of arsenic (As) and nickel (Ni) were detected, compared to groups living in remote localities. Objectives: We estimated the extent of exposure to metals in pregnant Bedouin-Arab women in relation to congenital malformations. Methods: We collected maternal urine samples from 140 Bedouin women who gave birth in a local hospital. Patient medical history, type of marriage (consanguineous or non-consanguineous), and parental exposure history were collected by interview and medical records. Results: Aluminum (Al) was detected in 37 women (26.4%), cadmium (Cd) in 2 (1.4%), As in 10 (7.1%), and Ni in 1 woman (0.7%). The detected rate of Cd exposure was low, though more than 92% of the fathers reported smoking. Concentrations of Al were higher for women residing within 10 km of the local industrial park (Prevalence Ratio (PR). = 1.12, p-value. = 0.012) or who reported using a wood burning stove (PR. = 1.37, p-value. = 0.011) and cooking over an open fire (PR. = 1.16, p-value. = 0.076).Exposure to Al was adversely associated with minor anomalies (OR. = 3.8, p-value. = 0.046) after adjusting for history of abortions (OR. = 6.1, p-value. = 0.007). Fetuses prenatally exposed to As were born prematurely (p-value. = 0.001) and at lower weights (pv. = 0.023). Conclusions: The study population of pregnant women is exposed to high levels of metals mainly of household origin. Our findings may be generalized to similar populations in developing countries.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002021</affiliation-url><afid>60002021</afid><affilname>Israel Ministry of Health</affilname><name-variant>Ministry of Health</name-variant><affiliation-city>Jerusalem</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027161</affiliation-url><afid>60027161</afid><affilname>Ben-Gurion University of the Negev</affilname><name-variant>Ben Gurion University of the Negev</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030184</affiliation-url><afid>60030184</afid><affilname>Soroka University Medical Center</affilname><name-variant>Soroka University Medical Center</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030184</affiliation-url><afid>60030184</afid><affilname>Soroka University Medical Center</affilname><name-variant>Soroka University Medical Center</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011766</affiliation-url><afid>60011766</afid><affilname>Chaim Sheba Medical Center Israel</affilname><name-variant>Chaim Sheba Medical Center</name-variant><affiliation-city>Tel Aviv-Yafo</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002021</affiliation-url><afid>60002021</afid><affilname>Israel Ministry of Health</affilname><name-variant>Ministry of Health</name-variant><affiliation-city>Jerusalem</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103928</affiliation-url><afid>60103928</afid><affilname>Ashkelon Academic College</affilname><name-variant>Ashkelon Academic College</name-variant><affiliation-city>Ashkelon</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030184</affiliation-url><afid>60030184</afid><affilname>Soroka University Medical Center</affilname><name-variant>Soroka University Medical Center</name-variant><affiliation-city>Beer Sheba</affiliation-city><affiliation-country>Israel</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508167710</author-url><authid>6508167710</authid><authname>Karakis I.</authname><surname>Karakis</surname><given-name>Isabella</given-name><initials>I.</initials><afid>60002021</afid><afid>60027161</afid><afid>60103928</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508167710</author-url><authid>6508167710</authid><authname>Karakis I.</authname><surname>Karakis</surname><given-name>Isabella</given-name><initials>I.</initials><afid>60002021</afid><afid>60027161</afid><afid>60103928</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6508167710</author-url><authid>6508167710</authid><authname>Karakis I.</authname><surname>Karakis</surname><given-name>Isabella</given-name><initials>I.</initials><afid>60002021</afid><afid>60027161</afid><afid>60103928</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55188685700</author-url><authid>55188685700</authid><authname>Landau D.</authname><surname>Landau</surname><given-name>Daniella</given-name><initials>D.</initials><afid>60027161</afid><afid>60030184</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55188685700</author-url><authid>55188685700</authid><authname>Landau D.</authname><surname>Landau</surname><given-name>Daniella</given-name><initials>D.</initials><afid>60027161</afid><afid>60030184</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56416385900</author-url><authid>56416385900</authid><authname>Yitshak-Sade M.</authname><surname>Yitshak-Sade</surname><given-name>Maayan</given-name><initials>M.</initials><afid>60027161</afid><afid>60030184</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56416385900</author-url><authid>56416385900</authid><authname>Yitshak-Sade M.</authname><surname>Yitshak-Sade</surname><given-name>Maayan</given-name><initials>M.</initials><afid>60027161</afid><afid>60030184</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603859864</author-url><authid>6603859864</authid><authname>Hershkovitz R.</authname><surname>Hershkovitz</surname><given-name>Reli</given-name><initials>R.</initials><afid>60027161</afid><afid>60030184</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603859864</author-url><authid>6603859864</authid><authname>Hershkovitz R.</authname><surname>Hershkovitz</surname><given-name>Reli</given-name><initials>R.</initials><afid>60027161</afid><afid>60030184</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56416116100</author-url><authid>56416116100</authid><authname>Rotenberg M.</authname><surname>Rotenberg</surname><given-name>Michal</given-name><initials>M.</initials><afid>60011766</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004085810</author-url><authid>7004085810</authid><authname>Sarov B.</authname><surname>Sarov</surname><given-name>Batia</given-name><initials>B.</initials><afid>60027161</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004310151</author-url><authid>7004310151</authid><authname>Grotto I.</authname><surname>Grotto</surname><given-name>Itamar</given-name><initials>I.</initials><afid>60002021</afid><afid>60027161</afid><afid>60002021</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004310151</author-url><authid>7004310151</authid><authname>Grotto I.</authname><surname>Grotto</surname><given-name>Itamar</given-name><initials>I.</initials><afid>60002021</afid><afid>60027161</afid><afid>60002021</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004310151</author-url><authid>7004310151</authid><authname>Grotto I.</authname><surname>Grotto</surname><given-name>Itamar</given-name><initials>I.</initials><afid>60002021</afid><afid>60027161</afid><afid>60002021</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:14066362100</author-url><authid>14066362100</authid><authname>Novack L.</authname><surname>Novack</surname><given-name>Lena</given-name><initials>L.</initials><afid>60027161</afid></author><authkeywords>Biomonitoring | Household environment | Malformations | Metals | Prenatal exposure</authkeywords><intid>34940544</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930195399"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930195399?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930195399&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930195399&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930195399</prism:url><dc:identifier>SCOPUS_ID:84930195399</dc:identifier><eid>2-s2.0-84930195399</eid><dc:title>Stem cells and differentiation-A synoptic review of patents granted since 2009</dc:title><dc:creator>Sureshkumar P.</dc:creator><prism:publicationName>Expert Opinion on Therapeutic Patents</prism:publicationName><prism:issn>13543776</prism:issn><prism:eIssn>17447674</prism:eIssn><prism:volume>25</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>663-673</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1517/13543776.2015.1021334</prism:doi><dc:description>© 2015 Informa UK, Ltd. Introduction: Innovations in human pluripotent stem cell research and their application in therapeutics have seen a giant leap in the past decade. Patent applications related to human pluripotent stem cell generation, culture and differentiation show an ever-increasing trend worldwide with hundreds of patents being applied for every year. With the turn of the second decade in stem cell patenting, a review of the latest patents issued will be significant.Areas covered: The growing need in healthcare sector has revolutionized stem cell application in clinical therapeutics by extending in unprecedented dimensions. With the potential of being able to differentiate into any desired adult cell lineage, human pluripotent stem cells find a wide range of applicability in clinical as well as cosmetic therapy. Moreover, the recent innovation of isolating a disease-specific pluripotent stem cell has opened new horizons to stem cell application in cell therapy. This review gives an overview of significant international patents granted on innovations in human pluripotent stem cell differentiation methodologies between 2009 and 2014.Expert opinion: The discovery of human pluripotent stem cells and their immense potential in clinical therapeutics has increasingly channeled scientific research in their orientation. Although being widely used to fathom human physiology, the trend in stem cell application is slowly shifting toward disease-modeling, drug safety evaluation and toxicity-testing. And in order to probe those unexplored realms of stem cell applications, a unified approach from the scientific community is imperative.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024025</affiliation-url><afid>60024025</afid><affilname>Universitat zu Koln</affilname><name-variant>Universität zu Köln</name-variant><affiliation-city>Koln</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662882900</author-url><authid>56662882900</authid><authname>Sureshkumar P.</authname><surname>Sureshkumar</surname><given-name>Poornima</given-name><initials>P.</initials><afid>60024025</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56442009100</author-url><authid>56442009100</authid><authname>Srinivasan S.</authname><surname>Srinivasan</surname><given-name>Sureshkumar Perumal</given-name><initials>S.P.</initials><afid>60024025</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55488578600</author-url><authid>55488578600</authid><authname>Natarajan K.</authname><surname>Natarajan</surname><given-name>Karthick</given-name><initials>K.</initials><afid>60024025</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006015465</author-url><authid>7006015465</authid><authname>Gaspar J.</authname><surname>Gaspar</surname><given-name>John Antonydas</given-name><initials>J.A.</initials><afid>60024025</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16452898500</author-url><authid>16452898500</authid><authname>Hescheler J.</authname><surname>Hescheler</surname><given-name>Jürgen</given-name><initials>J.</initials><afid>60024025</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56273462100</author-url><authid>56273462100</authid><authname>Sachinidis A.</authname><surname>Sachinidis</surname><given-name>Agapios</given-name><initials>A.</initials><afid>60024025</afid></author><authkeywords>Alternative testing strategies | Cellular therapy | Differentiation | Human embryonic stem cells | Human induced pluripotent stem cells</authkeywords><intid>536087958</intid><source-id>21353</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928029397"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928029397?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928029397&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928029397&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0005272815000614"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928029397</prism:url><dc:identifier>SCOPUS_ID:84928029397</dc:identifier><eid>2-s2.0-84928029397</eid><dc:title>Uncoupling, metabolic inhibition and induction of mitochondrial permeability transition in rat liver mitochondria caused by the major long-chain hydroxyl monocarboxylic fatty acids accumulating in LCHAD deficiency</dc:title><dc:creator>Hickmann F.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Bioenergetics</prism:publicationName><prism:issn>00052728</prism:issn><prism:eIssn>18792650</prism:eIssn><prism:volume>1847</prism:volume><prism:issueIdentifier>6-7</prism:issueIdentifier><prism:pageRange>620-628</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbabio.2015.04.003</prism:doi><pii>S0005272815000614</pii><dc:description>© 2015 Elsevier B.V. Patients with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency commonly present liver dysfunction whose pathogenesis is unknown. We studied the effects of long-chain 3-hydroxylated fatty acids (LCHFA) that accumulate in LCHAD deficiency on liver bioenergetics using mitochondrial preparations from young rats. We provide strong evidence that 3-hydroxytetradecanoic (3HTA) and 3-hydroxypalmitic (3HPA) acids, the monocarboxylic acids that are found at the highest tissue concentrations in this disorder, act as metabolic inhibitors and uncouplers of oxidative phosphorylation. These conclusions are based on the findings that these fatty acids decreased ADP-stimulated (state 3) and uncoupled respiration, mitochondrial membrane potential and NAD(P)H content, and, in contrast, increased resting (state 4) respiration. We also verified that 3HTA and 3HPA markedly reduced Ca&lt;sup&gt;2 +&lt;/sup&gt; retention capacity and induced swelling in Ca&lt;sup&gt;2 +&lt;/sup&gt;-loaded mitochondria. These effects were mediated by mitochondrial permeability transition (MPT) induction since they were totally prevented by the classical MPT inhibitors cyclosporin A and ADP, as well as by ruthenium red, a Ca&lt;sup&gt;2 +&lt;/sup&gt; uptake blocker. Taken together, our data demonstrate that the major monocarboxylic LCHFA accumulating in LCHAD deficiency disrupt energy mitochondrial homeostasis in the liver. It is proposed that this pathomechanism may explain at least in part the hepatic alterations characteristic of the affected patients.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006726</affiliation-url><afid>60006726</afid><affilname>Universidade Federal do Rio Grande do Sul</affilname><name-variant>Universidade Federal do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014120</affiliation-url><afid>60014120</afid><affilname>Hospital de Clinicas de Porto Alegre</affilname><name-variant>Universidade Federal do Rio Grande do Sul</name-variant><affiliation-city>Porto Alegre</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029570</affiliation-url><afid>60029570</afid><affilname>Universidade Estadual de Campinas</affilname><name-variant>State University of Campinas</name-variant><affiliation-city>Campinas</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37090771800</author-url><authid>37090771800</authid><authname>Hickmann F.</authname><surname>Hickmann</surname><given-name>Fernanda Hermes</given-name><initials>F.H.</initials><afid>60006726</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54406690900</author-url><authid>54406690900</authid><authname>Cecatto C.</authname><surname>Cecatto</surname><given-name>Cristiane</given-name><initials>C.</initials><afid>60006726</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56506883600</author-url><authid>56506883600</authid><authname>Kleemann D.</authname><surname>Kleemann</surname><given-name>Daniele</given-name><initials>D.</initials><afid>60006726</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56151526400</author-url><authid>56151526400</authid><authname>Monteiro W.</authname><surname>Monteiro</surname><given-name>Wagner Oliveira</given-name><initials>W.O.</initials><afid>60006726</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005844374</author-url><authid>7005844374</authid><authname>Castilho R.</authname><surname>Castilho</surname><given-name>Roger Frigério</given-name><initials>R.F.</initials><afid>60029570</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23484109200</author-url><authid>23484109200</authid><authname>Amaral A.</authname><surname>Amaral</surname><given-name>Alexandre Umpierrez</given-name><initials>A.U.</initials><afid>60006726</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005044422</author-url><authid>7005044422</authid><authname>Wajner M.</authname><surname>Wajner</surname><given-name>Moacir</given-name><initials>M.</initials><afid>60006726</afid><afid>60014120</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005044422</author-url><authid>7005044422</authid><authname>Wajner M.</authname><surname>Wajner</surname><given-name>Moacir</given-name><initials>M.</initials><afid>60006726</afid><afid>60014120</afid></author><authkeywords>Calcium | dehydrogenase deficiency | Liver mitochondrial bioenergetics | Long-chain 3-hydroxy-acyl-CoA | Mitochondrial permeability transition</authkeywords><intid>535716565</intid><source-id>16791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928008470"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928008470?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928008470&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928008470&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928008470</prism:url><dc:identifier>SCOPUS_ID:84928008470</dc:identifier><eid>2-s2.0-84928008470</eid><dc:title>G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells</dc:title><dc:creator>Altmann J.</dc:creator><prism:publicationName>Journal of Neurochemistry</prism:publicationName><prism:issn>00223042</prism:issn><prism:eIssn>14714159</prism:eIssn><prism:volume>133</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>629-639</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/jnc.13066</prism:doi><dc:description>© 2015 International Society for Neurochemistry. G protein-coupled estrogen receptor (GPER) is a relatively recently identified non-nuclear estrogen receptor, expressed in several tissues, including brain and blood vessels. The mechanisms elicited by GPER activation in brain microvascular endothelial cells are incompletely understood. The purpose of this work was to assess the effects of GPER activation on cytosolic Ca&lt;sup&gt;2+&lt;/sup&gt; concentration, [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt;, nitric oxide production, membrane potential and cell nanomechanics in rat brain microvascular endothelial cells (RBMVEC). Extracellular but not intracellular administration of G-1, a selective GPER agonist, or extracellular administration of 17-β-estradiol and tamoxifen, increased [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; in RBMVEC. The effect of G-1 on [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; was abolished in Ca&lt;sup&gt;2+&lt;/sup&gt;-free saline or in the presence of a L-type Ca&lt;sup&gt;2+&lt;/sup&gt; channel blocker. G-1 increased nitric oxide production in RBMVEC; the effect was prevented by NG-nitro-l-arginine methyl ester. G-1 elicited membrane hyperpolarization that was abolished by the antagonists of small and intermediate-conductance Ca&lt;sup&gt;2+&lt;/sup&gt;-activated K&lt;sup&gt;+&lt;/sup&gt; channels, apamin, and charibdotoxin. GPER-mediated responses were sensitive to G-36, a GPER antagonist. In addition, atomic force microscopy studies revealed that G-1 increased the modulus of elasticity, indicative of cytoskeletal changes and increase in RBMVEC stiffness. Our results unravel the mechanisms underlying GPER-mediated effects in RBMVEC with implications for the effect of estrogen on cerebral microvasculature. Activation of the G protein-coupled estrogen receptor (GPER) in rat brain microvascular endothelial cells (RBMVEC) increases [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; by promoting Ca&lt;sup&gt;2+&lt;/sup&gt; influx. The increase in [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; leads to membrane hyperpolarization, nitric oxide (NO) production, and to cytoskeletal changes and increased cell stiffness. Our results unravel the mechanisms underlying GPER-mediated effects in RBMVEC with implications for the effect of estrogen on cerebral microvasculature. Activation of the G protein-coupled estrogen receptor (GPER) in rat brain microvascular endothelial cells (RBMVEC) increases [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; by promoting Ca&lt;sup&gt;2+&lt;/sup&gt; influx. The increase in [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; leads to membrane hyperpolarization, nitric oxide (NO) production, and to cytoskeletal changes and increased cell stiffness. Our results unravel the mechanisms underlying GPER-mediated effects in RBMVEC with implications for the effect of estrogen on cerebral microvasculature.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015277</affiliation-url><afid>60015277</afid><affilname>Thomas Jefferson University</affilname><name-variant>Thomas Jefferson University</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013936</affiliation-url><afid>60013936</afid><affilname>Temple University School of Medicine</affilname><name-variant>Temple Univ. Sch. Med.</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013936</affiliation-url><afid>60013936</afid><affilname>Temple University School of Medicine</affilname><name-variant>Temple Univ. Sch. Med.</name-variant><affiliation-city>Philadelphia</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56183914000</author-url><authid>56183914000</authid><authname>Altmann J.</authname><surname>Altmann</surname><given-name>Joseph B.</given-name><initials>J.B.</initials><afid>60015277</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56530047500</author-url><authid>56530047500</authid><authname>Yan G.</authname><surname>Yan</surname><given-name>Guang</given-name><initials>G.</initials><afid>60015277</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56530364400</author-url><authid>56530364400</authid><authname>Meeks J.</authname><surname>Meeks</surname><given-name>Jeffrey F.</given-name><initials>J.F.</initials><afid>60015277</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004337080</author-url><authid>7004337080</authid><authname>Abood M.</authname><surname>Abood</surname><given-name>Mary E.</given-name><initials>M.E.</initials><afid>60013936</afid><afid>60013936</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004337080</author-url><authid>7004337080</authid><authname>Abood M.</authname><surname>Abood</surname><given-name>Mary E.</given-name><initials>M.E.</initials><afid>60013936</afid><afid>60013936</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603936682</author-url><authid>6603936682</authid><authname>Brailoiu E.</authname><surname>Brailoiu</surname><given-name>Eugen</given-name><initials>E.</initials><afid>60013936</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:14040168400</author-url><authid>14040168400</authid><authname>Cristina Brailoiu G.</authname><surname>Cristina Brailoiu</surname><given-name>G.</given-name><initials>G.</initials><afid>60015277</afid></author><authkeywords>atomic force microscopy | blood-brain barrier | calcium signaling | cerebral microvasculature | GPER</authkeywords><intid>1035712296</intid><source-id>17620</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921328674"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921328674?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921328674&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921328674&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814614019918"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921328674</prism:url><dc:identifier>SCOPUS_ID:84921328674</dc:identifier><eid>2-s2.0-84921328674</eid><dc:title>Characterisation of extra virgin olive oils from Galician autochthonous varieties and their co-crushings with Arbequina and Picual cv.</dc:title><dc:creator>Reboredo-Rodríguez P.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>176</prism:volume><prism:pageRange>493-503</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2014.12.078</prism:doi><pii>S0308814614019918</pii><dc:description>© 2014 Elsevier Ltd. All rights reserved. The current trend of the olive oil market is the production of high quality extra from traditional minor olive varieties with peculiar and differentiated characteristics (especially with respect to the aromatic and phenolic composition). In this way, the interest of Galician oil producers (NW Spain) in recovering old autochthonous Local olive fruits has increased substantially in recent years. In order to investigate the potential of the Local olives by either producing high quality monovarietal oils or mixing with the most widespread olives in Galicia (Arbequina and Picual cv.), quality indices, and fatty acid composition as well as volatile and phenolic profiles were determined and compared. All EVOOs studied in this work can be considered as "extra virgin olive oil" due to quality indices fell within the ranges established in legislation. Picual and Local olive oils as well as those resulting from their co-crushing reach values which are required by EU legislation to add the specific health claim on the oil label. Co-crushing Picual:Local (80:20) provided a significant enhancement of grass and apple nuances and a decrease of banana notes with respect to Picual oils. The co-crushing process improved sensory and health properties of Picual extra virgin olive oils. The effect of co-crushing on phenolics, ester volatiles and banana nuances cannot be easily modulated, contrary to quality indices and fatty acid composition, both changing linearly in strict correlation with the fruit mass ratio.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026134</affiliation-url><afid>60026134</afid><affilname>Universidad de Vigo</affilname><name-variant>University of Vigo</name-variant><affiliation-city>Vigo</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000823</affiliation-url><afid>60000823</afid><affilname>Universidad de Castilla-La Mancha</affilname><name-variant>University of Castilla-La Mancha</name-variant><affiliation-city>Ciudad Real</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54420943000</author-url><authid>54420943000</authid><authname>Reboredo-Rodríguez P.</authname><surname>Reboredo-Rodríguez</surname><given-name>P.</given-name><initials>P.</initials><afid>60026134</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506161093</author-url><authid>6506161093</authid><authname>González-Barreiro C.</authname><surname>González-Barreiro</surname><given-name>C.</given-name><initials>C.</initials><afid>60026134</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603425031</author-url><authid>6603425031</authid><authname>Cancho-Grande B.</authname><surname>Cancho-Grande</surname><given-name>B.</given-name><initials>B.</initials><afid>60026134</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603767267</author-url><authid>6603767267</authid><authname>Fregapane G.</authname><surname>Fregapane</surname><given-name>G.</given-name><initials>G.</initials><afid>60000823</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103310884</author-url><authid>7103310884</authid><authname>Salvador M.</authname><surname>Salvador</surname><given-name>M. D.</given-name><initials>M.D.</initials><afid>60000823</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004118440</author-url><authid>7004118440</authid><authname>Simal-Gándara J.</authname><surname>Simal-Gándara</surname><given-name>J.</given-name><initials>J.</initials><afid>60026134</afid></author><authkeywords>Fatty acids | Odour activity value (OAV) | Olive co-crushing | Phenolic compounds | Quality-related indices | Volatile compounds</authkeywords><intid>2034665851</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929957840"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929957840?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929957840&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929957840&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0009912015000715"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929957840</prism:url><dc:identifier>SCOPUS_ID:84929957840</dc:identifier><eid>2-s2.0-84929957840</eid><dc:title>Inflammation, coagulation, endothelial dysfunction and oxidative stress in prediabetes - Biomarkers as a possible tool for early disease detection for rural screening</dc:title><dc:creator>Maschirow L.</dc:creator><prism:publicationName>Clinical Biochemistry</prism:publicationName><prism:issn>00099120</prism:issn><prism:eIssn>18732933</prism:eIssn><prism:volume>48</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>581-585</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clinbiochem.2015.02.015</prism:doi><pii>S0009912015000715</pii><dc:description>© 2015 . Objectives: This study aims to increase understanding of the connection between oxidative stress and inflammation in diabetes disease progression to provide a basis for investigating improved diagnostic possibilities, treatment and prevention of prediabetes. Design and methods: Differences in the level of biochemical markers of oxidative stress (erythrocyte GSH/GSSG and urinary 8-isoprostane), inflammation (CRP, IL-6), endothelial dysfunction (plasma homocysteine, urinary 8-hydroxy-2-deoxy-guanosine) and coagulation/fibrinolysis (C5a, D-Dimer) were determined in prediabetes and control subjects. Results: While no difference was found in the 8-isoprostane levels between the two groups, the erythrocyte GSH/GSSG ratio was significantly reduced in the prediabetes group compared to control, indicating increased oxidative stress in the prediabetic state. Both urinary 8-OHdG and surprisingly also plasma homocysteine were significantly elevated in the prediabetes group, indicating endothelial dysfunction. The inflammation markers were slightly elevated in the prediabetic subjects and the same trend was found for the coagulation/fibrinolysis markers C5a and D-Dimer. These results were however not significant. Conclusions: The small elevation of blood glucose levels in the prediabetic state may have a detectable influence on endothelial function as indicated by changes to 8-OHdG, indicating an increased DNA-damage and homocysteine release from endothelial cells. Increased oxidative stress as indicated by the reduced GSH/GSSG ratio is likely to be the link between the moderate hyperglycaemia in prediabetes and pathological changes in endothelial function, which in the long-term may promote atherogenesis and result in the development of cardiovascular disease. Early detection of prediabetes is essential to avoid diabetes development and the associated complications like cardiovascular disease. The GSH/GSSG ratio and biomarkers like urinary 8-OHdG and plasma homocysteine offer a possible tool for the assessment of prediabetes in prevention screenings.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021763</affiliation-url><afid>60021763</afid><affilname>Universitat Potsdam</affilname><name-variant>University of Potsdam</name-variant><affiliation-city>Potsdam</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104134</affiliation-url><afid>60104134</afid><affilname>Khalifa University</affilname><name-variant>Khalifa University</name-variant><affiliation-city>Abu Dhabi</affiliation-city><affiliation-country>United Arab Emirates</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015356</affiliation-url><afid>60015356</afid><affilname>University of Tasmania</affilname><name-variant>University of Tasmania</name-variant><affiliation-city>Hobart</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60088314</affiliation-url><afid>60088314</afid><affilname>Macquarie University, Australian School of Advanced Medicine</affilname><name-variant>Macquarie University</name-variant><affiliation-city/><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001248</affiliation-url><afid>60001248</afid><affilname>Charles Sturt University</affilname><name-variant>Charles Sturt University</name-variant><affiliation-city>Bathurst</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56574406800</author-url><authid>56574406800</authid><authname>Maschirow L.</authname><surname>Maschirow</surname><given-name>L.</given-name><initials>L.</initials><afid>60021763</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603998219</author-url><authid>6603998219</authid><authname>Khalaf K.</authname><surname>Khalaf</surname><given-name>K.</given-name><initials>K.</initials><afid>60104134</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:36645610900</author-url><authid>36645610900</authid><authname>Al-Aubaidy H.</authname><surname>Al-Aubaidy</surname><given-name>H. A.</given-name><initials>H.A.</initials><afid>60015356</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701411651</author-url><authid>6701411651</authid><authname>Jelinek H.</authname><surname>Jelinek</surname><given-name>H. F.</given-name><initials>H.F.</initials><afid>60088314</afid><afid>60001248</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6701411651</author-url><authid>6701411651</authid><authname>Jelinek H.</authname><surname>Jelinek</surname><given-name>H. F.</given-name><initials>H.F.</initials><afid>60088314</afid><afid>60001248</afid></author><authkeywords>Coagulation | Endothelial dysfunction | Inflammation | Oxidative stress | Prediabetes</authkeywords><intid>1536042489</intid><source-id>16954</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929573547"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929573547?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929573547&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929573547&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929573547</prism:url><dc:identifier>SCOPUS_ID:84929573547</dc:identifier><eid>2-s2.0-84929573547</eid><dc:title>Validating FMEA output against incident learning data: A study in stereotactic body radiation therapy</dc:title><dc:creator>Yang F.</dc:creator><prism:publicationName>Medical Physics</prism:publicationName><prism:issn>00942405</prism:issn><prism:volume>42</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>2777-2785</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1118/1.4919440</prism:doi><dc:description>© 2015 American Association of Physicists in Medicine. Purpose: Though failure mode and effects analysis (FMEA) is becoming more widely adopted for risk assessment in radiation therapy, to our knowledge, its output has never been validated against data on errors that actually occur. The objective of this study was to perform FMEA of a stereotactic body radiation therapy (SBRT) treatment planning process and validate the results against data recorded within an incident learning system. Methods: FMEA on the SBRT treatment planning process was carried out by a multidisciplinary group including radiation oncologists, medical physicists, dosimetrists, and IT technologists. Potential failure modes were identified through a systematic review of the process map. Failure modes were rated for severity, occurrence, and detectability on a scale of one to ten and risk priority number (RPN) was computed. Failure modes were then compared with historical reports identified as relevant to SBRT planning within a departmental incident learning system that has been active for two and a half years. Differences between FMEA anticipated failure modes and existing incidents were identified. Results: FMEA identified 63 failure modes. RPN values for the top 25% of failure modes ranged from 60 to 336. Analysis of the incident learning database identified 33 reported near-miss events related to SBRT planning. Combining both methods yielded a total of 76 possible process failures, of which 13 (17%) were missed by FMEA while 43 (57%) identified by FMEA only. When scored for RPN, the 13 events missed by FMEA ranked within the lower half of all failure modes and exhibited significantly lower severity relative to those identified by FMEA (p = 0.02). Conclusions: FMEA, though valuable, is subject to certain limitations. In this study, FMEA failed to identify 17% of actual failure modes, though these were of lower risk. Similarly, an incident learning system alone fails to identify a large number of potentially high-severity process errors. Using FMEA in combination with incident learning may render an improved overview of risks within a process.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033293</affiliation-url><afid>60033293</afid><affilname>University of Washington Medical Center</affilname><name-variant>University of Washington Medical Center</name-variant><affiliation-city>Seattle</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55741580900</author-url><authid>55741580900</authid><authname>Yang F.</authname><surname>Yang</surname><given-name>F.</given-name><initials>F.</initials><afid>60033293</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56070951500</author-url><authid>56070951500</authid><authname>Cao N.</authname><surname>Cao</surname><given-name>N.</given-name><initials>N.</initials><afid>60033293</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56650489000</author-url><authid>56650489000</authid><authname>Young L.</authname><surname>Young</surname><given-name>L.</given-name><initials>L.</initials><afid>60033293</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650490500</author-url><authid>56650490500</authid><authname>Howard J.</authname><surname>Howard</surname><given-name>J.</given-name><initials>J.</initials><afid>60033293</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650711800</author-url><authid>56650711800</authid><authname>Logan W.</authname><surname>Logan</surname><given-name>W.</given-name><initials>W.</initials><afid>60033293</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56650786800</author-url><authid>56650786800</authid><authname>Arbuckle T.</authname><surname>Arbuckle</surname><given-name>T.</given-name><initials>T.</initials><afid>60033293</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55523494600</author-url><authid>55523494600</authid><authname>Sponseller P.</authname><surname>Sponseller</surname><given-name>P.</given-name><initials>P.</initials><afid>60033293</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7801652938</author-url><authid>7801652938</authid><authname>Korssjoen T.</authname><surname>Korssjoen</surname><given-name>T.</given-name><initials>T.</initials><afid>60033293</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35403191100</author-url><authid>35403191100</authid><authname>Meyer J.</authname><surname>Meyer</surname><given-name>J.</given-name><initials>J.</initials><afid>60033293</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56564293000</author-url><authid>56564293000</authid><authname>Ford E.</authname><surname>Ford</surname><given-name>E.</given-name><initials>E.</initials><afid>60033293</afid></author><authkeywords>FMEA | incident learning | patient safety | risk assessment | SBRT planning</authkeywords><intid>1535981878</intid><source-id>17871</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84922376668"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84922376668?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84922376668&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84922376668&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0195666315000288"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84922376668</prism:url><dc:identifier>SCOPUS_ID:84922376668</dc:identifier><eid>2-s2.0-84922376668</eid><dc:title>Development and validation of a measure of food choice values</dc:title><dc:creator>Lyerly J.</dc:creator><prism:publicationName>Appetite</prism:publicationName><prism:issn>01956663</prism:issn><prism:eIssn>10958304</prism:eIssn><prism:volume>89</prism:volume><prism:pageRange>47-55</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.appet.2015.01.019</prism:doi><pii>S0195666315000288</pii><dc:description>© 2015 Elsevier Ltd. Food choice values (FCVs) are factors that individuals consider when deciding which foods to purchase and/or consume. Given the potentially important implications for health, it is critical for researchers to have access to a validated measure of FCV. Though there is an existing measure of FCV, this measure was developed 20 years ago and recent research suggests additional FCVs exist that are not included in this measure. A series of four studies was conducted to develop a new expanded measure of FCV. An eight-factor model of FCV was supported and confirmed. In aggregate, results from the four studies indicate that the measure is content valid, and has internally consistent scales that also demonstrated acceptable temporal stability and convergent validity. In addition, the eight scales of the measures were independent of social desirability, met criteria for measurement invariance across income groups, and predicted dietary intake. The development of this new measure of FCV may be useful for researchers examining FCVs (FCVs) in the future, as well as for use in intervention and prevention efforts targeting dietary choices.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006951</affiliation-url><afid>60006951</afid><affilname>The University of North Carolina at Charlotte</affilname><name-variant>University of North Carolina</name-variant><affiliation-city>Charlotte</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55436911100</author-url><authid>55436911100</authid><authname>Lyerly J.</authname><surname>Lyerly</surname><given-name>Jordan E.</given-name><initials>J.E.</initials><afid>60006951</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006953405</author-url><authid>7006953405</authid><authname>Reeve C.</authname><surname>Reeve</surname><given-name>Charlie L.</given-name><initials>C.L.</initials><afid>60006951</afid></author><authkeywords>Food choice values | Measure | Reliability | Scale development | Validity</authkeywords><intid>534797505</intid><source-id>29994</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928387996"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928387996?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928387996&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928387996&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915001100"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928387996</prism:url><dc:identifier>SCOPUS_ID:84928387996</dc:identifier><eid>2-s2.0-84928387996</eid><dc:title>Lycopene bioavailability is associated with a combination of genetic variants</dc:title><dc:creator>Borel P.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>238-244</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.02.033</prism:doi><pii>S0891584915001100</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. The intake of tomatoes and tomato products, which constitute the main dietary source of the red pigment lycopene (LYC), has been associated with a reduced risk of prostate cancer and cardiovascular disease, suggesting a protective role of this carotenoid. However, LYC bioavailability displays high interindividual variability. This variability may lead to varying biological effects following LYC consumption. Based on recent results obtained with two other carotenoids, we assumed that this variability was due, at least in part, to several single nucleotide polymorphisms (SNPs) in genes involved in LYC and lipid metabolism. Thus, we aimed at identifying a combination of SNPs significantly associated with the variability in LYC bioavailability. In a postprandial study, 33 healthy male volunteers consumed a test meal containing 100 g tomato puree, which provided 9.7 mg all-trans LYC. LYC concentrations were measured in plasma chylomicrons (CM) isolated at regular time intervals over 8 h postprandially. For the study 1885 SNPs in 49 candidate genes, i.e., genes assumed to play a role in LYC bioavailability, were selected. Multivariate statistical analysis (partial least squares regression) was used to identify and validate the combination of SNPs most closely associated with postprandial CM LYC response. The postprandial CM LYC response to the meal was notably variable with a CV of 70%. A significant (P=0.037) and validated partial least squares regression model, which included 28 SNPs in 16 genes, explained 72% of the variance in the postprandial CM LYC response. The postprandial CM LYC response was also positively correlated to fasting plasma LYC concentrations (r=0.37, P&lt;0.05). The ability to respond to LYC is explained, at least partly, by a combination of 28 SNPs in 16 genes. Interindividual variability in bioavailability apparently affects the long-term blood LYC status, which could ultimately modulate the biological response following LYC supplementation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021180</affiliation-url><afid>60021180</afid><affilname>INRA Avignon</affilname><name-variant>INRA</name-variant><affiliation-city>Avignon</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102127</affiliation-url><afid>60102127</afid><affilname>Aix Marseille Universite</affilname><name-variant>Aix-Marseille University</name-variant><affiliation-city>Marseille</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004567436</author-url><authid>7004567436</authid><authname>Borel P.</authname><surname>Borel</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004567436</author-url><authid>7004567436</authid><authname>Borel P.</authname><surname>Borel</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004567436</author-url><authid>7004567436</authid><authname>Borel P.</authname><surname>Borel</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55049767900</author-url><authid>55049767900</authid><authname>Desmarchelier C.</authname><surname>Desmarchelier</surname><given-name>Charles</given-name><initials>C.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55049767900</author-url><authid>55049767900</authid><authname>Desmarchelier C.</authname><surname>Desmarchelier</surname><given-name>Charles</given-name><initials>C.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55049767900</author-url><authid>55049767900</authid><authname>Desmarchelier C.</authname><surname>Desmarchelier</surname><given-name>Charles</given-name><initials>C.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37038163300</author-url><authid>37038163300</authid><authname>Nowicki M.</authname><surname>Nowicki</surname><given-name>Marion</given-name><initials>M.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37038163300</author-url><authid>37038163300</authid><authname>Nowicki M.</authname><surname>Nowicki</surname><given-name>Marion</given-name><initials>M.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37038163300</author-url><authid>37038163300</authid><authname>Nowicki M.</authname><surname>Nowicki</surname><given-name>Marion</given-name><initials>M.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37115330500</author-url><authid>37115330500</authid><authname>Bott R.</authname><surname>Bott</surname><given-name>Romain</given-name><initials>R.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37115330500</author-url><authid>37115330500</authid><authname>Bott R.</authname><surname>Bott</surname><given-name>Romain</given-name><initials>R.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:37115330500</author-url><authid>37115330500</authid><authname>Bott R.</authname><surname>Bott</surname><given-name>Romain</given-name><initials>R.</initials><afid>60021180</afid><afid>60000905</afid><afid>60102127</afid></author><authkeywords>Absorption/Single nucleotide polymorphisms | Carotenoid | Genetic polymorphisms | Nutrigenetic</authkeywords><intid>535780484</intid><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926463293"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926463293?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926463293&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926463293&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0008874915000775"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926463293</prism:url><dc:identifier>SCOPUS_ID:84926463293</dc:identifier><eid>2-s2.0-84926463293</eid><dc:title>Inhibition of Toll-like receptor 9 attenuates sepsis-induced mortality through suppressing excessive inflammatory response</dc:title><dc:creator>Hu D.</dc:creator><prism:publicationName>Cellular Immunology</prism:publicationName><prism:issn>00088749</prism:issn><prism:eIssn>10902163</prism:eIssn><prism:volume>295</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>92-98</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cellimm.2015.03.009</prism:doi><pii>S0008874915000775</pii><dc:description>© 2015 Elsevier Inc. Sepsis, a major clinical problem with high morbidity and mortality, is caused by overwhelming systemic host-inflammatory response. Toll-like receptors (TLRs) play a fundamental role in induction of hyperinflammation and tissue damage in sepsis. In this study, we demonstrate a protective role of TLR9 inhibition against the dysregulated inflammatory response and tissue injury in sepsis. TLR9 deficiency decreased the mortality of mice following cecal ligation and puncture (CLP)-induced sepsis. TLR9 knockout mice showed dampened p38 activation and augmented Akt phosphorylation in the spleen, lung and liver. In addition, TLR9 deficiency decreased the levels of inflammatory cytokines and attenuated splenic apoptosis after CLP. These results indicate that TLR9 inhibition might offer a novel therapeutic strategy for the management of sepsis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001426</affiliation-url><afid>60001426</afid><affilname>East Tennessee State University</affilname><name-variant>East Tennessee State University</name-variant><affiliation-city>Johnson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60080982</affiliation-url><afid>60080982</afid><affilname>Hubei General Hospital</affilname><name-variant>Renmin Hospital of Wuhan University</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004752</affiliation-url><afid>60004752</afid><affilname>Shandong University School of Medicine</affilname><name-variant>Shandong University School of Medicine ^</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010170</affiliation-url><afid>60010170</afid><affilname>Shanghai University of Traditional Chinese Medicine</affilname><name-variant>Shanghai University of Traditional Chinese Medicine</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35483987600</author-url><authid>35483987600</authid><authname>Hu D.</authname><surname>Hu</surname><given-name>Dan</given-name><initials>D.</initials><afid>60001426</afid><afid>60080982</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35483987600</author-url><authid>35483987600</authid><authname>Hu D.</authname><surname>Hu</surname><given-name>Dan</given-name><initials>D.</initials><afid>60001426</afid><afid>60080982</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55317738900</author-url><authid>55317738900</authid><authname>Yang X.</authname><surname>Yang</surname><given-name>Xiaohua</given-name><initials>X.</initials><afid>60001426</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:50462608100</author-url><authid>50462608100</authid><authname>Xiang Y.</authname><surname>Xiang</surname><given-name>Yanxiao</given-name><initials>Y.</initials><afid>60001426</afid><afid>60004752</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:50462608100</author-url><authid>50462608100</authid><authname>Xiang Y.</authname><surname>Xiang</surname><given-name>Yanxiao</given-name><initials>Y.</initials><afid>60001426</afid><afid>60004752</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56156424500</author-url><authid>56156424500</authid><authname>Li H.</authname><surname>Li</surname><given-name>Hui</given-name><initials>H.</initials><afid>60001426</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56583106200</author-url><authid>56583106200</authid><authname>Yan H.</authname><surname>Yan</surname><given-name>Hui</given-name><initials>H.</initials><afid>60001426</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56582869700</author-url><authid>56582869700</authid><authname>Zhou J.</authname><surname>Zhou</surname><given-name>Jun</given-name><initials>J.</initials><afid>60010170</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55914889000</author-url><authid>55914889000</authid><authname>Caudle Y.</authname><surname>Caudle</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60001426</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56583860900</author-url><authid>56583860900</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xiumei</given-name><initials>X.</initials><afid>60004752</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:8600349400</author-url><authid>8600349400</authid><authname>Yin D.</authname><surname>Yin</surname><given-name>Deling</given-name><initials>D.</initials><afid>60001426</afid></author><authkeywords>Cytokines | Immune response | Sepsis | TLR9</authkeywords><intid>2035449096</intid><source-id>20712</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925967550"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925967550?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925967550&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925967550&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S000527361500067X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925967550</prism:url><dc:identifier>SCOPUS_ID:84925967550</dc:identifier><eid>2-s2.0-84925967550</eid><dc:title>Docosahexaenoic acid promotes micron scale liquid-ordered domains. A comparison study of docosahexaenoic versus oleic acid containing phosphatidylcholine in raft-like mixtures</dc:title><dc:creator>Georgieva R.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Biomembranes</prism:publicationName><prism:issn>00052736</prism:issn><prism:eIssn>18792642</prism:eIssn><prism:volume>1848</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1424-1435</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbamem.2015.02.027</prism:doi><pii>S000527361500067X</pii><dc:description>© 2015 Elsevier B.V. The understanding of the functional role of the lipid diversity in biological membranes is a major challenge. Lipid models have been developed to address this issue by using lipid mixtures generating liquid-ordered (Lo)/liquid-disordered (Ld) immiscibility. The present study examined mixtures comprising Egg sphingomyelin (SM), cholesterol (chol) and phosphatidylcholine (PC) either containing docosahexaenoic (PDPC) or oleic acid (POPC). The mixtures were examined in terms of their capability to induce phase separation at the micron- and nano-scales. Fluorescence microscopy, electron spin resonance (ESR), X-ray diffraction (XRD) and calorimetry methods were used to analyze the lateral organization of the mixtures. Fluorescence microscopy of giant vesicles could show that the temperature of the micron-scale Lo/Ld miscibility is higher for PDPC than for POPC ternary mixtures. At 37 °C, no micron-scale Lo/Ld phase separation could be identified in the POPC containing mixtures while it was evident for PDPC. In contrast, a phase separation was distinguished for both PC mixtures by ESR and XRD, indicative that PDPC and POPC mixtures differed in micron vs nano domain organization. Compared to POPC, the higher line tension of the Lo domains observed in PDPC mixtures is assumed to result from the higher difference in Lo/Ld order parameter rather than hydrophobic mismatch.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001694</affiliation-url><afid>60001694</afid><affilname>Institute of Biophysics Bulgarian Academy of Sciences</affilname><name-variant>Bulgarian Academy of Sciences</name-variant><affiliation-city>Sofia</affiliation-city><affiliation-country>Bulgaria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009907</affiliation-url><afid>60009907</afid><affilname>Hopital Saint-Antoine</affilname><name-variant>Hopital Saint-Antoine</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37018111700</author-url><authid>37018111700</authid><authname>Georgieva R.</authname><surname>Georgieva</surname><given-name>R.</given-name><initials>R.</initials><afid>60001694</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004383947</author-url><authid>7004383947</authid><authname>Chachaty C.</authname><surname>Chachaty</surname><given-name>C.</given-name><initials>C.</initials><afid>60001422</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55546653700</author-url><authid>55546653700</authid><authname>Hazarosova R.</authname><surname>Hazarosova</surname><given-name>R.</given-name><initials>R.</initials><afid>60001694</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006733635</author-url><authid>7006733635</authid><authname>Tessier C.</authname><surname>Tessier</surname><given-name>C.</given-name><initials>C.</initials><afid>60001422</afid><afid>60009907</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006733635</author-url><authid>7006733635</authid><authname>Tessier C.</authname><surname>Tessier</surname><given-name>C.</given-name><initials>C.</initials><afid>60001422</afid><afid>60009907</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003649969</author-url><authid>7003649969</authid><authname>Nuss P.</authname><surname>Nuss</surname><given-name>P.</given-name><initials>P.</initials><afid>60001422</afid><afid>60009907</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003649969</author-url><authid>7003649969</authid><authname>Nuss P.</authname><surname>Nuss</surname><given-name>P.</given-name><initials>P.</initials><afid>60001422</afid><afid>60009907</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603633933</author-url><authid>6603633933</authid><authname>Momchilova A.</authname><surname>Momchilova</surname><given-name>A.</given-name><initials>A.</initials><afid>60001694</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6507325217</author-url><authid>6507325217</authid><authname>Staneva G.</authname><surname>Staneva</surname><given-name>G.</given-name><initials>G.</initials><afid>60001694</afid></author><authkeywords>Docosahexaenoic acid | Liquid-ordered phase | Oleic acid | PUFA | Raft</authkeywords><intid>1535386400</intid><source-id>18406</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928017503"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928017503?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928017503&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928017503&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928017503</prism:url><dc:identifier>SCOPUS_ID:84928017503</dc:identifier><eid>2-s2.0-84928017503</eid><dc:title>Changes in mitochondrial morphology induced by calcium or rotenone in primary astrocytes occur predominantly through ros-mediated remodeling</dc:title><dc:creator>Deheshi S.</dc:creator><prism:publicationName>Journal of Neurochemistry</prism:publicationName><prism:issn>00223042</prism:issn><prism:eIssn>14714159</prism:eIssn><prism:volume>133</prism:volume><prism:issueIdentifier>5</prism:issueIdentifier><prism:pageRange>684-699</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/jnc.13090</prism:doi><dc:description>© 2015 International Society for Neurochemistry. Morphological changes in mitochondria have been primarily attributed to fission and fusion, while the more pliable transformations of mitochondria (remodeling, rounding, or stretching) have been largely overlooked. In this study, we quantify the contributions of fission and remodeling to changes in mitochondrial morphology induced by the Ca&lt;sup&gt;2+&lt;/sup&gt; ionophore 4Br-A23187 and the metabolic toxin rotenone. We also examine the role of reactive oxygen species (ROS) in the regulation of mitochondrial remodeling. In agreement with our previous studies, mitochondrial remodeling, not fission, is the primary contributor to Ca&lt;sup&gt;2+&lt;/sup&gt;-mediated changes in mitochondrial morphology induced by 4Br-A23187 in rat cortical astrocytes. Treatment with rotenone produced similar results. In both paradigms, remodeling was selectively blocked by antioxidants whereas fission was not, suggesting a ROS-mediated mechanism for mitochondrial remodeling. In support of this hypothesis, inhibition of endogenous ROS by overnight incubation in antioxidants resulted in elongated reticular networks of mitochondria. Examination of inner and outer mitochondrial membranes revealed that they largely acted in concert during the remodeling process. While mitochondrial morphology is traditionally ascribed to a net output of fission and fusion processes, in this study we provide evidence that the acute pliability of mitochondria can be a dominant factor in determining their morphology. More importantly, our results suggest that the remodeling process is independently regulated through a ROS-signaling mechanism. Mitochondrial morphology is traditionally ascribed to a balance of fission and fusion processes. We have shown that mitochondria can undergo more pliable transformations; remodeling, rounding, or stretching. We demonstrate that remodeling, not fission, is the primary contributor to calcium mediated changes in mitochondrial morphology in primary astrocytes. Others have shown fission is mediated by calcineurin. Our results suggest the remodeling process distinct from fission and is independently regulated through a ROS-signaling mechanism.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018491</affiliation-url><afid>60018491</afid><affilname>Simon Fraser University</affilname><name-variant>Simon Fraser University</name-variant><affiliation-city>Burnaby</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36715863000</author-url><authid>36715863000</authid><authname>Deheshi S.</authname><surname>Deheshi</surname><given-name>Samineh</given-name><initials>S.</initials><afid>60018491</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56595042400</author-url><authid>56595042400</authid><authname>Dabiri B.</authname><surname>Dabiri</surname><given-name>Bahram</given-name><initials>B.</initials><afid>60018491</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56594120300</author-url><authid>56594120300</authid><authname>Fan S.</authname><surname>Fan</surname><given-name>Susu</given-name><initials>S.</initials><afid>60018491</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56594478400</author-url><authid>56594478400</authid><authname>Tsang M.</authname><surname>Tsang</surname><given-name>Michelle</given-name><initials>M.</initials><afid>60018491</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6602940325</author-url><authid>6602940325</authid><authname>Rintoul G.</authname><surname>Rintoul</surname><given-name>Gordon L.</given-name><initials>G.L.</initials><afid>60018491</afid></author><authkeywords>antioxidants | intracellular calcium | mitochondria | mitochondrial dynamics | mitochondrial morphology | reactive oxygen species</authkeywords><intid>1535716740</intid><source-id>17620</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928346704"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928346704?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928346704&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928346704&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928346704</prism:url><dc:identifier>SCOPUS_ID:84928346704</dc:identifier><eid>2-s2.0-84928346704</eid><dc:title>Potential contributions of intimal and plaque hypoxia to atherosclerosis</dc:title><dc:creator>Fong G.</dc:creator><prism:publicationName>Current Atherosclerosis Reports</prism:publicationName><prism:issn>15233804</prism:issn><prism:eIssn>15346242</prism:eIssn><prism:volume>17</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>1-10</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s11883-015-0510-0</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Injury of arterial endothelium by abnormal shear stress and other insults induces migration and proliferation of vascular smooth muscle cells (VSMCs), which in turn leads to intimal thickening, hypoxia, and vasa vasorum angiogenesis. The resultant new blood vessels extend from the tunica media into the outer intima, allowing blood-borne oxidized low-density lipoprotein (oxLDL) particles to accumulate in outer intimal tissues by extravasation through local capillaries. In response to oxLDL accumulation, monocytes infiltrate into arterial wall tissues, where they differentiate into macrophages and subsequently evolve into foam cells by uptaking large quantities of oxLDL particles, the latter process being stimulated by hypoxia. Increased oxygen demand due to expanding macrophage and foam cell populations contributes to persistent hypoxia in plaque lesions, whereas hypoxia further promotes plaque growth by stimulating angiogenesis, monocyte infiltration, and oxLDL uptake into macrophages. Molecularly, the accumulation of hypoxia-inducible factor (HIF)-1α and the expression of its target genes mediate many of the hypoxia-induced processes during plaque initiation and growth. It is hoped that further understanding of the underlying mechanisms may lead to novel therapies for effective intervention of atherosclerosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000209</affiliation-url><afid>60000209</afid><affilname>University of Connecticut Health Center</affilname><name-variant>Univ. of Connecticut Health Center</name-variant><affiliation-city>Farmington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004978759</author-url><authid>7004978759</authid><authname>Fong G.</authname><surname>Fong</surname><given-name>Guo Hua</given-name><initials>G.H.</initials><afid>60000209</afid></author><authkeywords>Angiogenesis | Atherosclerosis | Hypoxia | Inflammation | Intima | Vasa vasorum</authkeywords><intid>1785768210</intid><source-id>23116</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928943738"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928943738?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928943738&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928943738&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928943738</prism:url><dc:identifier>SCOPUS_ID:84928943738</dc:identifier><eid>2-s2.0-84928943738</eid><dc:title>Efficacy and Safety of Endovascular Intervention for the Management of Primary Entire-Inferior Vena Cava Occlusion</dc:title><dc:creator>Zhang Q.</dc:creator><prism:publicationName>CardioVascular and Interventional Radiology</prism:publicationName><prism:issn>01741551</prism:issn><prism:eIssn>1432086X</prism:eIssn><prism:volume>38</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>665-671</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1007/s00270-014-0980-4</prism:doi><dc:description>© 2014, Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Purpose: This study was designed to investigate the safety and efficacy of endovascular intervention for the treatment of primary entire-inferior vena cava (IVC) occlusion. Methods: Endovascular interventions were performed in six patients for the treatment of primary entire-IVC occlusion. IVC and hepatic venography were performed via the jugular and femoral veins. Balloon angioplasty was used to revascularize the hepatic vein and IVC and a stent was placed in the IVC to maintain patency. Postoperative color Doppler ultrasonography was performed at 1, 3, 6, and 12 months, and then annually, to monitor the patency of the hepatic vein and IVC. Results: The IVC and one or two hepatic veins were successfully revascularized in five patients. Revascularization was successful in the right and left hepatic veins in one patient; however, IVC patency could not be established in this patient. Eleven Z-type, self-expanding stents were placed into the IVCs of five patients (three stents in two patients, two stents in two patients, and one stent in one patient). There were no instances of postoperative bleeding or mortality. Follow-up was conducted for 18–90 months (42.8 ± 26.5 months). None of the five patients suffered restenosis of the IVC or hepatic veins. However, there was one of the six cases of right hepatic vein restenosis at 18 months postprocedure that was revascularized after a second balloon dilatation. Conclusions: Endovascular intervention is safe and efficacious for the treatment of primary entire-IVC occlusion.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022050</affiliation-url><afid>60022050</afid><affilname>Xuzhou Medical College</affilname><name-variant>Affiliated Hospital of Xuzhou Medical College</name-variant><affiliation-city>Xuzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15064884500</author-url><authid>15064884500</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qingqiao</given-name><initials>Q.</initials><afid>60022050</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56305512200</author-url><authid>56305512200</authid><authname>Huang Q.</authname><surname>Huang</surname><given-name>Qianxin</given-name><initials>Q.</initials><afid>60022050</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55840459700</author-url><authid>55840459700</authid><authname>Shen B.</authname><surname>Shen</surname><given-name>Bin</given-name><initials>B.</initials><afid>60022050</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56306753500</author-url><authid>56306753500</authid><authname>Sun J.</authname><surname>Sun</surname><given-name>Jingmin</given-name><initials>J.</initials><afid>60022050</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55337768200</author-url><authid>55337768200</authid><authname>Wang X.</authname><surname>Wang</surname><given-name>Xiaolong</given-name><initials>X.</initials><afid>60022050</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56624055900</author-url><authid>56624055900</authid><authname>Liu H.</authname><surname>Liu</surname><given-name>Hongtao</given-name><initials>H.</initials><afid>60022050</afid></author><authkeywords>Angioplasty | Endovascular intervention | Inferior vena cava | Stent</authkeywords><intid>1535875866</intid><source-id>16597</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928163419"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928163419?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928163419&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928163419&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0959437X15000258"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928163419</prism:url><dc:identifier>SCOPUS_ID:84928163419</dc:identifier><eid>2-s2.0-84928163419</eid><dc:title>Islet formation in mice and men: Lessons for the generation of functional insulin-producing β-cells from human pluripotent stem cells</dc:title><dc:creator>Nair G.</dc:creator><prism:publicationName>Current Opinion in Genetics and Development</prism:publicationName><prism:issn>0959437X</prism:issn><prism:eIssn>18790380</prism:eIssn><prism:volume>32</prism:volume><prism:pageRange>171-180</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.gde.2015.03.004</prism:doi><pii>S0959437X15000258</pii><dc:description>© 2015 Elsevier Ltd. The Islets of Langerhans are crucial 'micro-organs' embedded in the glandular exocrine pancreas that regulate nutrient metabolism. They not only synthesize, but also secrete endocrine hormones in a modulated fashion in response to physiologic metabolic demand. These highly sophisticated structures with intricate organization of multiple cell types, namely endocrine, vascular, neuronal and mesenchymal cells, have evolved to perform this task to perfection over time. Not surprisingly, islet architecture and function are dissimilar between humans and typically studied model organisms, such as rodents and zebrafish. Further, recent findings also suggest noteworthy differences in human islet development from that in mouse, including delayed appearance and gradual resolution of key differentiation markers, a single-phase of endocrine differentiation, and prenatal association of developing islets with neurovascular milieu. In light of these findings, it is imperative that a systematic study is undertaken to compare islet development between human and mouse. Illuminating inter-species differences in islet development will likely be critical in furthering our pursuit to generate an unlimited supply of truly functional and fully mature β-cells from human pluripotent stem cell (hPSC) sources for therapeutic purposes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56122591600</author-url><authid>56122591600</authid><authname>Nair G.</authname><surname>Nair</surname><given-name>Gopika</given-name><initials>G.</initials><afid>60023691</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603011864</author-url><authid>6603011864</authid><authname>Hebrok M.</authname><surname>Hebrok</surname><given-name>Matthias</given-name><initials>M.</initials><afid>60023691</afid></author><intid>1035730043</intid><source-id>22080</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927511513"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927511513?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927511513&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927511513&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S000398611500154X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927511513</prism:url><dc:identifier>SCOPUS_ID:84927511513</dc:identifier><eid>2-s2.0-84927511513</eid><dc:title>Kinetic and hysteretic behavior of ATP hydrolysis of the highly stable dimeric ATP synthase of Polytomella sp.</dc:title><dc:creator>Villavicencio-Queijeiro A.</dc:creator><prism:publicationName>Archives of Biochemistry and Biophysics</prism:publicationName><prism:issn>00039861</prism:issn><prism:eIssn>10960384</prism:eIssn><prism:volume>575</prism:volume><prism:pageRange>30-37</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.abb.2015.03.018</prism:doi><pii>S000398611500154X</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Abstract The F&lt;inf&gt;1&lt;/inf&gt;F&lt;inf&gt;O&lt;/inf&gt;-ATP synthase of the colorless alga Polytomella sp. exhibits a robust peripheral arm constituted by nine atypical subunits only present in chlorophycean algae. The isolated dimeric enzyme exhibits a latent ATP hydrolytic activity which can be activated by some detergents. To date, the kinetic behavior of the algal ATPase has not been studied. Here we show that while the soluble F&lt;inf&gt;1&lt;/inf&gt; sector exhibits Michaelis-Menten kinetics, the dimer exhibits a more complex behavior. The kinetic parameters (V&lt;inf&gt;max&lt;/inf&gt; and K&lt;inf&gt;m&lt;/inf&gt;) were obtained for both the F&lt;inf&gt;1&lt;/inf&gt; sector and the dimeric enzyme as isolated or activated by detergent, and this activation was also seen on the enzyme reconstituted in liposomes. Unlike other ATP synthases, the algal dimer hydrolyzes ATP on a wide range of pH and temperature. The enzyme was inhibited by oligomycin, DCCD and Mg-ADP, although oligomycin induced a peculiar inhibition pattern that can be attributed to structural differences in the algal subunit-c. The hydrolytic activity was temperature-dependent and exhibited activation energy of 4 kcal/mol. The enzyme also exhibited a hysteretic behavior with a lag phase strongly dependent on temperature but not on pH, that may be related to a possible regulatory role in vivo.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069652</affiliation-url><afid>60069652</afid><affilname>Instituto de Fisiologia Celular de la UNAM</affilname><name-variant>UNAM</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032442</affiliation-url><afid>60032442</afid><affilname>Universidad Nacional Autonoma de Mexico</affilname><name-variant>Universidad Nacional Autónoma de México</name-variant><affiliation-city>Mexico City</affiliation-city><affiliation-country>Mexico</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26637322800</author-url><authid>26637322800</authid><authname>Villavicencio-Queijeiro A.</authname><surname>Villavicencio-Queijeiro</surname><given-name>Alexa</given-name><initials>A.</initials><afid>60069652</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7201755155</author-url><authid>7201755155</authid><authname>Pardo J.</authname><surname>Pardo</surname><given-name>Juan Pablo</given-name><initials>J.P.</initials><afid>60032442</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003307981</author-url><authid>7003307981</authid><authname>González-Halphen D.</authname><surname>González-Halphen</surname><given-name>Diego</given-name><initials>D.</initials><afid>60069652</afid></author><authkeywords>Chlorophycean algae | Dimeric complex V | Hysteresis | Mitochondrial F&lt;inf&gt;1&lt;/inf&gt;F&lt;inf&gt;O&lt;/inf&gt;-ATP synthase | Polytomella sp</authkeywords><intid>1535634353</intid><article-number>6955</article-number><source-id>16811</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929990870"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929990870?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929990870&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929990870&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929990870</prism:url><dc:identifier>SCOPUS_ID:84929990870</dc:identifier><eid>2-s2.0-84929990870</eid><dc:title>The effect of tafamidis on the QT&lt;inf&gt;c&lt;/inf&gt; interval in healthy subjects</dc:title><dc:creator>Klamerus K.</dc:creator><prism:publicationName>British Journal of Clinical Pharmacology</prism:publicationName><prism:issn>03065251</prism:issn><prism:eIssn>13652125</prism:eIssn><prism:volume>79</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>918-925</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bcp.12561</prism:doi><dc:description>© 2015 The British Pharmacological Society. Aims The transthyretin (TTR) stabilizer, tafamidis, has demonstrated efficacy and safety in the treatment of TTR familial amyloid polyneuropathy (20 mg day&lt;sup&gt;-1&lt;/sup&gt;). Tafamidis use in TTR cardiomyopathy led to the study of the potential effect of tafamidis on the QT&lt;inf&gt;c&lt;/inf&gt; interval in healthy subjects. Methods This randomized, three treatment, three period, six sequence crossover study with placebo, a positive control (moxifloxacin 400 mg) and tafamidis (400 mg, to achieve a supra-therapeutic C&lt;inf&gt;max&lt;/inf&gt; of ~20 μg ml&lt;sup&gt;-1&lt;/sup&gt;) was conducted in healthy volunteers at three clinical research units. Oral dosing in each of the three treatment periods was separated by a washout period of ≥14 days. Serial triplicate 12-lead electrocardiograms were performed. QT&lt;inf&gt;c&lt;/inf&gt; intervals were derived using the Fridericia correction method. Safety and tolerability were assessed by physical examination, vital signs measurement, laboratory analyses and monitoring of adverse events (AEs). Results A total of 42 subjects completed the study. The upper limit of the two-sided 90% confidence intervals (CIs) for the difference in baseline-adjusted QT&lt;inf&gt;c&lt;/inf&gt;F between tafamidis 400 mg and placebo was &lt;10 ms (non-inferiority criterion) for all time points. The lower limit of the two-sided 90% CI between moxifloxacin 400 mg and placebo exceeded 5 ms at the pre-specified moxifloxacin t&lt;inf&gt;max&lt;/inf&gt; of 3 h post-dose, confirming assay sensitivity. C&lt;inf&gt;max&lt;/inf&gt; and AUC(0,24 h) for tafamidis were 20.36 μg ml&lt;sup&gt;-1&lt;/sup&gt; and 305.4 μg ml&lt;sup&gt;-1&lt;/sup&gt; h, respectively. There were no serious/severe AEs or treatment discontinuations due to AEs. Conclusions This thorough QT&lt;inf&gt;c&lt;/inf&gt; study suggests that a supra-therapeutic single 400 mg oral dose of tafamidis does not prolong the QT&lt;inf&gt;c&lt;/inf&gt; interval and is well-tolerated in healthy volunteers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006989</affiliation-url><afid>60006989</afid><affilname>Pfizer</affilname><name-variant>Pfizer</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006989</affiliation-url><afid>60006989</afid><affilname>Pfizer</affilname><name-variant>Pfizer</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6602623597</author-url><authid>6602623597</authid><authname>Klamerus K.</authname><surname>Klamerus</surname><given-name>Karen J.</given-name><initials>K.J.</initials><afid>60006989</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6505885508</author-url><authid>6505885508</authid><authname>Watsky E.</authname><surname>Watsky</surname><given-name>Eric</given-name><initials>E.</initials><afid>60006989</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7004451721</author-url><authid>7004451721</authid><authname>Moller R.</authname><surname>Moller</surname><given-name>Robert</given-name><initials>R.</initials><afid>60006989</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56658066200</author-url><authid>56658066200</authid><authname>Wang R.</authname><surname>Wang</surname><given-name>Ronnie</given-name><initials>R.</initials><afid>60006989</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:34767462000</author-url><authid>34767462000</authid><authname>Riley S.</authname><surname>Riley</surname><given-name>Steve</given-name><initials>S.</initials><afid>60006989</afid></author><authkeywords>cardiomyopathy | familial amyloid polyneuropathy | QT&lt;inf&gt;c&lt;/inf&gt; prolongation | tafamidis | transthyretin amyloidosis</authkeywords><intid>536050212</intid><source-id>20082</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924236664"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924236664?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924236664&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924236664&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S8756328215000708"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924236664</prism:url><dc:identifier>SCOPUS_ID:84924236664</dc:identifier><eid>2-s2.0-84924236664</eid><dc:title>Lectin-like oxidized low-density lipoprotein receptor-1 abrogation causes resistance to inflammatory bone destruction in mice, despite promoting osteoclastogenesis in the steady state</dc:title><dc:creator>Nakayachi M.</dc:creator><prism:publicationName>Bone</prism:publicationName><prism:issn>87563282</prism:issn><prism:volume>75</prism:volume><prism:pageRange>170-182</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bone.2015.02.025</prism:doi><pii>S8756328215000708</pii><dc:description>© 2015 Elsevier Inc. Inflammatory bone diseases have been attributed to increased bone resorption by augmented and activated bone-resorbing osteoclasts in response to inflammation. Although the production of diverse proinflammatory cytokines is induced at the inflamed sites, the inflammation also generates reactive oxygen species that modify many biological compounds, including lipids. Among the oxidized low-density lipoprotein (LDL) receptors, lectin-like oxidized LDL receptor-1 (LOX-1), which is a key molecule in the pathogenesis of multifactorial inflammatory atherosclerosis, was downregulated with osteoclast differentiation. Here, we demonstrate that LOX-1 negatively regulates osteoclast differentiation by basically suppressing the cell-cell fusion of preosteoclasts. The LOX-1-deleted (LOX-1-/-) mice consistently decreased the trabecular bone mass because of elevated bone resorption during the growing phase. In contrast, when the calvaria was inflamed by a local lipopolysaccharide-injection, the inflammation-induced bone destruction accompanied by the elevated expression of osteoclastogenesis-related genes was reduced by LOX-1 deficiency. Moreover, the expression of receptor activator of NF-κB ligand (RANKL), a trigger molecule for osteoclast differentiation, evoked by the inflammation was also abrogated in the LOX-1-/- mice. Osteoblasts, the major producers of RANKL, also expressed LOX-1 in response to proinflammatory agents, interleukin-1β and prostaglandin E2. In the co-culture of LOX-1-/- osteoblasts and wild-type osteoclast precursors, the osteoclastogenesis induced by interleukin-1β and prostaglandin E2 decreased; this process occurred in parallel with the downregulation of osteoblastic RANKL expression. Collectively, LOX-1 abrogation results in resistance to inflammatory bone destruction, despite promoting osteoclastogenesis in the steady state. Our findings indicate the novel involvement of LOX-1 in physiological bone homeostasis and inflammatory bone diseases. •Osteoclastogenesis from LOX-1 knockout (KO) osteoclast precursors was increased because of the accelerated preosteoclast cell-cell fusion.•Consistently, LOX-1 KO mice decreased trabecular bone mass due to elevated bone resorption during growth phase in steady state.•Conversely, inflammatory bone destruction induced by lipopolysaccharide-injection accompanied by elevation of osteoclastogenesis-related genes was reduced by LOX-1 deficiency.•In co-culture of LOX-1 KO osteoblasts and wild-type osteoclast precursors, osteoclastogenesis was decreased with downregulation of osteoblastic RANKL expression.•Collectively, LOX-1 abrogation results in resistance to inflammatory bone destruction, despite promoting osteoclastogenesis in steady state.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024008</affiliation-url><afid>60024008</afid><affilname>Meikai University</affilname><name-variant>Meikai Univ. School of Dentistry</name-variant><affiliation-city>Sakado</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024008</affiliation-url><afid>60024008</afid><affilname>Meikai University</affilname><name-variant>Meikai Univ. School of Dentistry</name-variant><affiliation-city>Sakado</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024008</affiliation-url><afid>60024008</afid><affilname>Meikai University</affilname><name-variant>Meikai Univ. School of Dentistry</name-variant><affiliation-city>Sakado</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>National Cerebral and Cardiovascular Center</affilname><name-variant>Department of Vascular Physiology</name-variant><affiliation-city>Suita, Osaka</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004225</affiliation-url><afid>60004225</afid><affilname>University of Tokyo Hospital</affilname><name-variant>The University of Tokyo Hospital</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003677</affiliation-url><afid>60003677</afid><affilname>Hoshi University</affilname><name-variant>Hoshi University</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002106</affiliation-url><afid>60002106</afid><affilname>Shinshu University Faculty of Medicine</affilname><name-variant>Shinshu University</name-variant><affiliation-city>Matsumoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54793451400</author-url><authid>54793451400</authid><authname>Nakayachi M.</authname><surname>Nakayachi</surname><given-name>Mai</given-name><initials>M.</initials><afid>60024008</afid><afid>60024008</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54793451400</author-url><authid>54793451400</authid><authname>Nakayachi M.</authname><surname>Nakayachi</surname><given-name>Mai</given-name><initials>M.</initials><afid>60024008</afid><afid>60024008</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54793014700</author-url><authid>54793014700</authid><authname>Ito J.</authname><surname>Ito</surname><given-name>Junta</given-name><initials>J.</initials><afid>60024008</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:54792956000</author-url><authid>54792956000</authid><authname>Hayashida C.</authname><surname>Hayashida</surname><given-name>Chiyomi</given-name><initials>C.</initials><afid>60024008</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56121453300</author-url><authid>56121453300</authid><authname>Ohyama Y.</authname><surname>Ohyama</surname><given-name>Yoko</given-name><initials>Y.</initials><afid>60024008</afid><afid>60024008</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56121453300</author-url><authid>56121453300</authid><authname>Ohyama Y.</authname><surname>Ohyama</surname><given-name>Yoko</given-name><initials>Y.</initials><afid>60024008</afid><afid>60024008</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:22635090700</author-url><authid>22635090700</authid><authname>Kakino A.</authname><surname>Kakino</surname><given-name>Akemi</given-name><initials>A.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54793343200</author-url><authid>54793343200</authid><authname>Okayasu M.</authname><surname>Okayasu</surname><given-name>Mari</given-name><initials>M.</initials><afid>60024008</afid><afid>60004225</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:54793343200</author-url><authid>54793343200</authid><authname>Okayasu M.</authname><surname>Okayasu</surname><given-name>Mari</given-name><initials>M.</initials><afid>60024008</afid><afid>60004225</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55628566925</author-url><authid>55628566925</authid><authname>Sato T.</authname><surname>Sato</surname><given-name>Takuya</given-name><initials>T.</initials><afid>60024008</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56539373400</author-url><authid>56539373400</authid><authname>Ogasawara T.</authname><surname>Ogasawara</surname><given-name>Toru</given-name><initials>T.</initials><afid>60004225</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:15738418200</author-url><authid>15738418200</authid><authname>Kaneda T.</authname><surname>Kaneda</surname><given-name>Toshio</given-name><initials>T.</initials><afid>60003677</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7006430844</author-url><authid>7006430844</authid><authname>Suda N.</authname><surname>Suda</surname><given-name>Naoto</given-name><initials>N.</initials><afid>60024008</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7102279261</author-url><authid>7102279261</authid><authname>Sawamura T.</authname><surname>Sawamura</surname><given-name>Tatsuya</given-name><initials>T.</initials><afid/><afid>60002106</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7102279261</author-url><authid>7102279261</authid><authname>Sawamura T.</authname><surname>Sawamura</surname><given-name>Tatsuya</given-name><initials>T.</initials><afid/><afid>60002106</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:55392827500</author-url><authid>55392827500</authid><authname>Hakeda Y.</authname><surname>Hakeda</surname><given-name>Yoshiyuki</given-name><initials>Y.</initials><afid>60024008</afid></author><authkeywords>Inflammatory bone destruction | Lectin-like oxidized low-density lipoprotein receptor-1 | Osteoblasts | Osteoclastogenesis | Osteoclasts</authkeywords><intid>1785104047</intid><source-id>29551</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928552592"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928552592?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928552592&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928552592&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S001448001500057X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928552592</prism:url><dc:identifier>SCOPUS_ID:84928552592</dc:identifier><eid>2-s2.0-84928552592</eid><dc:title>Pyruvate dehydrogenase kinase 4 (PDK4) could be involved in a regulatory role in apoptosis and a link between apoptosis and insulin resistance</dc:title><dc:creator>Dlamini Z.</dc:creator><prism:publicationName>Experimental and Molecular Pathology</prism:publicationName><prism:issn>00144800</prism:issn><prism:eIssn>10960945</prism:eIssn><prism:volume>98</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>574-584</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yexmp.2015.03.022</prism:doi><pii>S001448001500057X</pii><dc:description>© 2015. Pyruvate dehydrogenase kinase 4 (PDK4), a mammalian mitochondrial serine kinase has emerged as an interesting candidate for diabetes therapy. Due to the high prevalence of this disease especially type 2 diabetes (T2D) and the health complications associated with it, there is extensive effort to find the appropriate treatment. Understanding the regulation of PDK4 activity would therefore contribute significantly to the development of therapeutic agents. This research outlines the utilization of bioinformatics tools such as Interweaver, ClustalW and Protein Structure Visualizer, in order to predict proteins that potentially interact with PDK4 and possibly regulate its activity. Interweaver database identified 96 proteins that have possible interaction sites for PDK4. Protein p100/p49, containing a death domain that is known to have a role in suppressing apoptosis, was identified as a potential partner for PDK4. The alignment between p100/p49 primary sequence and that of PDK4 using ClustalW demonstrated sequence similarity between the two proteins. Swiss PDB Viewer then located the positions of the amino acids that are in the hypothetical protein binding motif of p100/p49 within the 3D structure of hPDK4. These amino acids were found to be located in the region of PDK4 which is known to bind protein substrates of PDK4 and may be accessible to other proteins as well. These findings were very interesting as PDK4 has not previously been associated with apoptosis and this could be the link between apoptosis and insulin resistance. Cell biology studies were then performed to verify the relationship between PDK4 and apoptosis. In this regard, HeLa and HepG2 cells were treated with apoptosis-inducing agents such as TNFα, C2-ceramide, and linoleic acid. These cells were then monitored for apoptosis and PDK4 mRNA expression using a DNA laddering assay as well as Real Time PCR. The results showed that these factors induced apoptosis in a concentration dependent manner and suppressed PDK4 mRNA levels. These findings suggested a relationship between PDK4 and apoptosis.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102780</affiliation-url><afid>60102780</afid><affilname>Mangosuthu University of Technology</affilname><name-variant>Mangosuthu Technikon</name-variant><affiliation-city>Umlazi</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115191616</affiliation-url><afid>115191616</afid><affilname>Merck Chemicals (Pty) Ltd</affilname><name-variant>Merck Chemicals (Pty) Ltd</name-variant><affiliation-city>Germiston</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017614</affiliation-url><afid>60017614</afid><affilname>University of Limpopo</affilname><name-variant>University of Limpopo</name-variant><affiliation-city>Sovenga</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115192250</affiliation-url><afid>115192250</afid><affilname>Technology Innovation Agency</affilname><name-variant>Technology Innovation Agency</name-variant><affiliation-city>Durban</affiliation-city><affiliation-country>South Africa</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507506844</author-url><authid>6507506844</authid><authname>Dlamini Z.</authname><surname>Dlamini</surname><given-name>Zodwa</given-name><initials>Z.</initials><afid>60102780</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56607359300</author-url><authid>56607359300</authid><authname>Ntlabati P.</authname><surname>Ntlabati</surname><given-name>Patricia</given-name><initials>P.</initials><afid>115191616</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8765245500</author-url><authid>8765245500</authid><authname>Mbita Z.</authname><surname>Mbita</surname><given-name>Zukile</given-name><initials>Z.</initials><afid>60017614</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55505191800</author-url><authid>55505191800</authid><authname>Shoba-Zikhali L.</authname><surname>Shoba-Zikhali</surname><given-name>Lungile</given-name><initials>L.</initials><afid>115192250</afid></author><authkeywords>ClustalW | Interweaver | Protein p100/p49 | Protein structure visualizer | Swiss PDB viewer | Type 2 diabetes (T2D)</authkeywords><intid>1035797183</intid><source-id>13247</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930225873"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930225873?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930225873&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930225873&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930225873</prism:url><dc:identifier>SCOPUS_ID:84930225873</dc:identifier><eid>2-s2.0-84930225873</eid><dc:title>A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation</dc:title><dc:creator>Hoehlig K.</dc:creator><prism:publicationName>British Journal of Pharmacology</prism:publicationName><prism:issn>00071188</prism:issn><prism:eIssn>14765381</prism:eIssn><prism:volume>172</prism:volume><prism:issueIdentifier>12</prism:issueIdentifier><prism:pageRange>3086-3098</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1111/bph.13110</prism:doi><dc:description>© 2015 The British Pharmacological Society. Background and Purpose Calcitonin gene-related peptide (CGRP) plays an important role in the pathology of migraine, and recent clinical trials suggest the inhibition of CGRP-mediated processes as a new therapeutic option in migraine. In this study, we describe the generation of NOX-L41, a CGRP-neutralizing mirror-image (l-)aptamer (Spiegelmer) and investigate its in vitro and in vivo function. Experimental Approach A CGRP-binding Spiegelmer was identified by in vitro selection. Binding studies were performed using surface plasmon resonance (SPR), and the inhibitory activity was determined in cell-based assays. The pharmacokinetic profile comparing i.v. and s.c. dosing was analysed in rats. Intravital two-photon microscopy was employed to follow extravasation from meningeal vessels. Finally, in vivo efficacy was tested in a model of electrically evoked meningeal plasma protein extravasation (PPE) in rats. Key Results We identified NOX-L41, a novel CGRP-neutralizing Spiegelmer. SPR studies showed that NOX-L41 binds to human and rat/mouse CGRP with sub-nanomolar affinities and is highly selective against related peptides such as amylin. In vitro, NOX-L41 effectively inhibited CGRP-induced cAMP formation in SK-N-MC cells. In rats, NOX-L41 had a plasma half-life of 8 h. Pharmacodynamic studies showed that NOX-L41 extravasates from blood vessels in the dura mater and inhibits neurogenic meningeal PPE for at least 18 h after single dosing. Conclusions and Implications This is the first description of the CGRP-neutralizing Spiegelmer NOX-L41. Preclinical studies confirmed a role for CGRP in neurogenic PPE and provided proof-of-concept for the potential use of this new drug candidate for the treatment or prevention of migraine.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100472584</affiliation-url><afid>100472584</afid><affilname>NOXXON Pharma AG</affilname><name-variant>Noxxon Pharma AG</name-variant><affiliation-city>Berlin</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025685</affiliation-url><afid>60025685</afid><affilname>Eli Lilly and Company</affilname><name-variant>Lilly Corporate Center</name-variant><affiliation-city>Indianapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112804884</affiliation-url><afid>112804884</afid><affilname>Neurotar LTD</affilname><name-variant>Neurotar Ltd.</name-variant><affiliation-city>Helsinki</affiliation-city><affiliation-country>Finland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16202414700</author-url><authid>16202414700</authid><authname>Hoehlig K.</authname><surname>Hoehlig</surname><given-name>K.</given-name><initials>K.</initials><afid>100472584</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55487277000</author-url><authid>55487277000</authid><authname>Johnson K.</authname><surname>Johnson</surname><given-name>K. W.</given-name><initials>K.W.</initials><afid>60025685</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15835882100</author-url><authid>15835882100</authid><authname>Pryazhnikov E.</authname><surname>Pryazhnikov</surname><given-name>E.</given-name><initials>E.</initials><afid>112804884</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602783856</author-url><authid>6602783856</authid><authname>Maasch C.</authname><surname>Maasch</surname><given-name>C.</given-name><initials>C.</initials><afid>100472584</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6508245916</author-url><authid>6508245916</authid><authname>Clemens-Smith A.</authname><surname>Clemens-Smith</surname><given-name>A.</given-name><initials>A.</initials><afid>60025685</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603610604</author-url><authid>6603610604</authid><authname>Purschke W.</authname><surname>Purschke</surname><given-name>W. G.</given-name><initials>W.G.</initials><afid>100472584</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:15836060900</author-url><authid>15836060900</authid><authname>Vauléon S.</authname><surname>Vauléon</surname><given-name>S.</given-name><initials>S.</initials><afid>100472584</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7005201191</author-url><authid>7005201191</authid><authname>Buchner K.</authname><surname>Buchner</surname><given-name>K.</given-name><initials>K.</initials><afid>100472584</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:12797329400</author-url><authid>12797329400</authid><authname>Jarosch F.</authname><surname>Jarosch</surname><given-name>F.</given-name><initials>F.</initials><afid>100472584</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:6602933529</author-url><authid>6602933529</authid><authname>Khiroug L.</authname><surname>Khiroug</surname><given-name>L.</given-name><initials>L.</initials><afid>112804884</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:8093959100</author-url><authid>8093959100</authid><authname>Vater A.</authname><surname>Vater</surname><given-name>A.</given-name><initials>A.</initials><afid>100472584</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:6701554321</author-url><authid>6701554321</authid><authname>Klussmann S.</authname><surname>Klussmann</surname><given-name>S.</given-name><initials>S.</initials><afid>100472584</afid></author><intid>536086944</intid><source-id>20084</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927725579"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927725579?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927725579&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927725579&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915015002300"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927725579</prism:url><dc:identifier>SCOPUS_ID:84927725579</dc:identifier><eid>2-s2.0-84927725579</eid><dc:title>Fractal dimension: A novel clot microstructure biomarker use in ST elevation myocardial infarction patients</dc:title><dc:creator>Lawrence M.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>240</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>402-407</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2015.04.012</prism:doi><pii>S0021915015002300</pii><dc:description>© 2015 Elsevier Ireland Ltd. Objectives: Changes in clot microstructure are increasingly implicated in the pathology of atherosclerosis although most data are from techniques in the remote laboratory using altered blood. We validate the novel biomarker Gel Point in STEMI patients and assess therapeutic interventions. Gel Point marks the transition of blood from a visco-elastic liquid to visco-elastic solid and is rapidly measured using unadulterated blood. The Gel Point provides measurements of three parameters to reflect clot microstructure (fractal dimension (d&lt;inf&gt;f&lt;/inf&gt;)), real-time clot formation time (T&lt;inf&gt;GP&lt;/inf&gt;) and blood clot strength (elasticity at the Gel Point (G'&lt;inf&gt;GP&lt;/inf&gt;)). Methods: We prospectively recruited 38 consecutive patients with STEMI undergoing primary percutaneous coronary intervention (pPCI). Venous blood samples were collected on admission, after pPCI and 24h after admission for assessment of the new biomarkers, standard coagulation tests and scanning electron microscopy (SEM). Results: d&lt;inf&gt;f&lt;/inf&gt; after pPCI was lower than d&lt;inf&gt;f&lt;/inf&gt; on admission (mean 1.631 [SD 0.063] vs 1.751 [0.052], p&lt;0.000001) whereas d&lt;inf&gt;f&lt;/inf&gt; at 24h was similar to that on admission. G'&lt;inf&gt;GP&lt;/inf&gt; also showed similar trend to d&lt;inf&gt;f&lt;/inf&gt; (p&lt;0.001). T&lt;inf&gt;GP&lt;/inf&gt; was prolonged at after-PCI measurement compared with admission (median 854s [IQR 581-1801] vs 217 [179-305], p&lt;0.00001). Changes in the values of d&lt;inf&gt;f&lt;/inf&gt; and G'&lt;inf&gt;GP&lt;/inf&gt; were consistent with changes in the SEM images of the mature clot. Conclusions: We characterise Gel Point derived markers of clot microstructure in patients admitted with emergency arterial thrombosis. This point of care test can potentially be used to assess the efficacy of therapeutic interventions by measuring changes in clot microstructure.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031920</affiliation-url><afid>60031920</afid><affilname>Morriston Hospital</affilname><name-variant>Morriston Hospital</name-variant><affiliation-city>Swansea</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004572</affiliation-url><afid>60004572</afid><affilname>Swansea University</affilname><name-variant>University of Wales</name-variant><affiliation-city>Swansea</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031920</affiliation-url><afid>60031920</afid><affilname>Morriston Hospital</affilname><name-variant>Morriston Hospital</name-variant><affiliation-city>Swansea</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103682</affiliation-url><afid>60103682</afid><affilname>Cardiff Metropolitan University</affilname><name-variant>Cardiff Metropolitan University</name-variant><affiliation-city>Cardiff</affiliation-city><affiliation-country/></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004572</affiliation-url><afid>60004572</afid><affilname>Swansea University</affilname><name-variant>University of Wales</name-variant><affiliation-city>Swansea</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029204</affiliation-url><afid>60029204</afid><affilname>NHS Foundation Trust</affilname><name-variant>NHS Foundation Trust</name-variant><affiliation-city>Leeds</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24767374000</author-url><authid>24767374000</authid><authname>Lawrence M.</authname><surname>Lawrence</surname><given-name>Matthew J.</given-name><initials>M.J.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:24767374000</author-url><authid>24767374000</authid><authname>Lawrence M.</authname><surname>Lawrence</surname><given-name>Matthew J.</given-name><initials>M.J.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56215602000</author-url><authid>56215602000</authid><authname>Sabra A.</authname><surname>Sabra</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56215602000</author-url><authid>56215602000</authid><authname>Sabra A.</authname><surname>Sabra</surname><given-name>Ahmed</given-name><initials>A.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56594069500</author-url><authid>56594069500</authid><authname>Thomas P.</authname><surname>Thomas</surname><given-name>Phillip</given-name><initials>P.</initials><afid>60031920</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:15049826100</author-url><authid>15049826100</authid><authname>Obaid D.</authname><surname>Obaid</surname><given-name>Daniel R.</given-name><initials>D.R.</initials><afid>60031920</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55232218600</author-url><authid>55232218600</authid><authname>D'Silva L.</authname><surname>D'Silva</surname><given-name>Lindsay A.</given-name><initials>L.A.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55232218600</author-url><authid>55232218600</authid><authname>D'Silva L.</authname><surname>D'Silva</surname><given-name>Lindsay A.</given-name><initials>L.A.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:8386016300</author-url><authid>8386016300</authid><authname>Morris R.</authname><surname>Morris</surname><given-name>Roger H K</given-name><initials>R.H.K.</initials><afid>60103682</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23094209100</author-url><authid>23094209100</authid><authname>Hawkins K.</authname><surname>Hawkins</surname><given-name>Karl</given-name><initials>K.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:23094209100</author-url><authid>23094209100</authid><authname>Hawkins K.</authname><surname>Hawkins</surname><given-name>Karl</given-name><initials>K.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56416839700</author-url><authid>56416839700</authid><authname>Brown M.</authname><surname>Brown</surname><given-name>Martin R.</given-name><initials>M.R.</initials><afid>60004572</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:35555200000</author-url><authid>35555200000</authid><authname>Williams P.</authname><surname>Williams</surname><given-name>Phylip R.</given-name><initials>P.R.</initials><afid>60004572</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55559475400</author-url><authid>55559475400</authid><authname>Davidson S.</authname><surname>Davidson</surname><given-name>Simon J.</given-name><initials>S.J.</initials><afid>60029204</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005052329</author-url><authid>7005052329</authid><authname>Chase A.</authname><surname>Chase</surname><given-name>Alexander J.</given-name><initials>A.J.</initials><afid>60031920</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56451841000</author-url><authid>56451841000</authid><authname>Smith D.</authname><surname>Smith</surname><given-name>David</given-name><initials>D.</initials><afid>60031920</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55732336100</author-url><authid>55732336100</authid><authname>Evans P.</authname><surname>Evans</surname><given-name>Phillip A.</given-name><initials>P.A.</initials><afid>60031920</afid><afid>60004572</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:55732336100</author-url><authid>55732336100</authid><authname>Evans P.</authname><surname>Evans</surname><given-name>Phillip A.</given-name><initials>P.A.</initials><afid>60031920</afid><afid>60004572</afid></author><authkeywords>Acute myocardial infarction | Coagulation | Drug monitoring | Fractal dimension | Gel point | Percutaneous coronary intervention</authkeywords><intid>1535664747</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929590203"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929590203?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929590203&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929590203&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929590203</prism:url><dc:identifier>SCOPUS_ID:84929590203</dc:identifier><eid>2-s2.0-84929590203</eid><dc:title>A convergent total synthesis of ouabagenin</dc:title><dc:creator>Mukai K.</dc:creator><prism:publicationName>Chemical Science</prism:publicationName><prism:issn>20416520</prism:issn><prism:eIssn>20416539</prism:eIssn><prism:volume>6</prism:volume><prism:issueIdentifier>6</prism:issueIdentifier><prism:pageRange>3383-3387</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1039/c5sc00212e</prism:doi><dc:description>© The Royal Society of Chemistry 2015. A convergent total synthesis of ouabagenin, an aglycon of cardenolide glycoside ouabain, was achieved by assembly of the AB-ring, D-ring and butenolide moieties. The multiply oxygenated cis-decalin structure of the AB-ring was constructed from (R)-perillaldehyde through the Diels-Alder reaction and sequential oxidations. The intermolecular acetal formation of the AB-ring and D-ring fragments, and combination of the intramolecular radical and aldol reactions, assembled the requisite steroidal skeleton in a stereoselective fashion. Finally, stereoselective installation of the C17-butenolide via the Stille coupling and hydrogenation led to ouabagenin. This journal is</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025272</affiliation-url><afid>60025272</afid><affilname>University of Tokyo</affilname><name-variant>University of Tokyo</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55681617700</author-url><authid>55681617700</authid><authname>Mukai K.</authname><surname>Mukai</surname><given-name>Ken</given-name><initials>K.</initials><afid>60025272</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35074260700</author-url><authid>35074260700</authid><authname>Kasuya S.</authname><surname>Kasuya</surname><given-name>Satoshi</given-name><initials>S.</initials><afid>60025272</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56650500100</author-url><authid>56650500100</authid><authname>Nakagawa Y.</authname><surname>Nakagawa</surname><given-name>Yuki</given-name><initials>Y.</initials><afid>60025272</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602698631</author-url><authid>6602698631</authid><authname>Urabe D.</authname><surname>Urabe</surname><given-name>Daisuke</given-name><initials>D.</initials><afid>60025272</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7406271007</author-url><authid>7406271007</authid><authname>Inoue M.</authname><surname>Inoue</surname><given-name>Masayuki</given-name><initials>M.</initials><afid>60025272</afid></author><intid>35981520</intid><source-id>19700200838</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926467771"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926467771?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926467771&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926467771&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0891584915000775"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926467771</prism:url><dc:identifier>SCOPUS_ID:84926467771</dc:identifier><eid>2-s2.0-84926467771</eid><dc:title>MKK3 mediates inflammatory response through modulation of mitochondrial function</dc:title><dc:creator>Srivastava A.</dc:creator><prism:publicationName>Free Radical Biology and Medicine</prism:publicationName><prism:issn>08915849</prism:issn><prism:eIssn>18734596</prism:eIssn><prism:volume>83</prism:volume><prism:pageRange>139-148</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.freeradbiomed.2015.01.035</prism:doi><pii>S0891584915000775</pii><dc:description>© 2015 Elsevier Inc. Abstract Mitochondria are increasingly recognized as drivers of inflammatory responses. MAP kinase kinase 3 (MKK3), a dual-specificity protein kinase, is activated in inflammation and in turn activates p38 MAP kinase signaling. Here we show that MKK3 influences mitochondrial function and acts as a critical mediator of inflammation. MKK3-deficient (MKK3&lt;sup&gt;-/-&lt;/sup&gt;) mice and bone marrow-derived macrophages (BMDMs) secreted smaller amounts of cytokines than wild type (WT) after lipopolysaccharide (LPS) exposure. There was improved mitochondrial function, as measured by basal oxygen consumption rate, mitochondrial membrane potential, and ATP production, in MKK3&lt;sup&gt;-/-&lt;/sup&gt; BMDMs. After LPS exposure, MKK3&lt;sup&gt;-/-&lt;/sup&gt; BMDMs did not show a significant increase in cellular reactive oxygen species production or in mitochondrial superoxide compared to WT. Activation of two important inflammatory mediators, i.e., the nuclear translocation of NF-κB and caspase-1 activity (a key component of the inflammasome), was lower in MKK3&lt;sup&gt;-/-&lt;/sup&gt; BMDMs. p38 and JNK activation was lower in MKK3&lt;sup&gt;-/-&lt;/sup&gt; BMDMs compared to WT after exposure to LPS. Knockdown of MKK3 by siRNA in wild-type BMDMs improved mitochondrial membrane potential, reduced LPS-induced caspase-1 activation, and attenuated cytokine secretion. Our studies establish MKK3 as a regulator of mitochondrial function and inflammatory responses to LPS and suggest that MKK3 may be a therapeutic target in inflammatory disorders such as sepsis.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017994</affiliation-url><afid>60017994</afid><affilname>Yale University School of Medicine</affilname><name-variant>Yale University School of Medicine</name-variant><affiliation-city>New Haven</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8978033100</author-url><authid>8978033100</authid><authname>Srivastava A.</authname><surname>Srivastava</surname><given-name>Anup</given-name><initials>A.</initials><afid>60017994</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56592289300</author-url><authid>56592289300</authid><authname>Shinn A.</authname><surname>Shinn</surname><given-name>Amanda S.</given-name><initials>A.S.</initials><afid>60017994</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56591011300</author-url><authid>56591011300</authid><authname>Lee P.</authname><surname>Lee</surname><given-name>Patty J.</given-name><initials>P.J.</initials><afid>60017994</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7801592526</author-url><authid>7801592526</authid><authname>Mannam P.</authname><surname>Mannam</surname><given-name>Praveen</given-name><initials>P.</initials><afid>60017994</afid></author><authkeywords>Acute lung injury | Caspase 1 | Free radicals | Inflammasome | Inflammation | Mitochondria | NF-κB | Oxidants | Sepsis</authkeywords><intid>535465777</intid><article-number>12316</article-number><source-id>15095</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928474564"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928474564?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928474564&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928474564&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091305715001197"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928474564</prism:url><dc:identifier>SCOPUS_ID:84928474564</dc:identifier><eid>2-s2.0-84928474564</eid><dc:title>Hypertension exacerbates predisposition to neurodegeneration and memory impairment in the presence of a neuroinflammatory stimulus: Protection by angiotensin converting enzyme inhibition</dc:title><dc:creator>Goel R.</dc:creator><prism:publicationName>Pharmacology Biochemistry and Behavior</prism:publicationName><prism:issn>00913057</prism:issn><prism:eIssn>18735177</prism:eIssn><prism:volume>133</prism:volume><prism:pageRange>132-145</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>1 June 2015</prism:coverDisplayDate><prism:doi>10.1016/j.pbb.2015.04.002</prism:doi><pii>S0091305715001197</pii><dc:description>© 2015 Elsevier Inc. Hypertension is a risk factor for cognitive impairment. Furthermore, neuroinflammation and neurodegeneration are intricately associated with memory impairment. Therefore, the present study aimed to explore the involvement of hypertension and angiotensin system in neurodegeneration and memory dysfunction in the presence of neuroinflammatory stimulus. Memory impairment was induced by chronic neuroinflammation that was developed by repeated intracerebroventricular (ICV) injections of lipopolysaccharide (LPS) on the 1st, 4th, 7th, and 10th day. Memory functions were evaluated by the Morris water maze (MWM) test on days 13-15, followed by biochemical and molecular studies in the cortex and hippocampus regions of rat brain. LPS at the dose of 25 μg ICV caused memory impairment in spontaneously hypertensive rats (SHRs) but not in normotensive Wistar rats (NWRs). Memory deficit was obtained with 50 μg of LPS (ICV) in NWRs. Control SHRs already exhibited increased angiotensin converting enzyme (ACE) activity and expression, neuroinflammation (increased TNF-α, GFAP, COX-2 and NF-kB), oxidative stress (increased iNOS, ROS and nitrite levels), TLR-4 expression and TUNEL positive cells as compared to control NWRs. Further, LPS (25 μg ICV) exaggerated inflammatory response, oxidative stress and apoptosis in SHRs but similar effects were witnessed at 50 μg of LPS (ICV) in NWRs. Oral administration of perindopril (ACE inhibitor), at non-antihypertensive dose (0.1 mg/kg), for 15 days attenuated LPS induced deleterious changes in both NWRs and SHRs. Our data suggest that susceptibility of the brain for neurodegeneration and memory impairment induced by neuroinflammation is enhanced in hypertension, and that can be protected by ACE inhibition.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030536</affiliation-url><afid>60030536</afid><affilname>Central Drug Research Institute India</affilname><name-variant>Central Drug Research Institute</name-variant><affiliation-city>Lucknow</affiliation-city><affiliation-country>India</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113888869</affiliation-url><afid>113888869</afid><affilname>Academy of Scientific and Innovative Research (AcSIR</affilname><name-variant>Academy of Scientific and Innovative Research (AcSIR</name-variant><affiliation-city/><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201969818</author-url><authid>7201969818</authid><authname>Goel R.</authname><surname>Goel</surname><given-name>Ruby</given-name><initials>R.</initials><afid>60030536</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56605837100</author-url><authid>56605837100</authid><authname>Bhat S.</authname><surname>Bhat</surname><given-name>Shahnawaz Ali</given-name><initials>S.A.</initials><afid>60030536</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:38862707800</author-url><authid>38862707800</authid><authname>Rajasekar N.</authname><surname>Rajasekar</surname><given-name>N.</given-name><initials>N.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:38862707800</author-url><authid>38862707800</authid><authname>Rajasekar N.</authname><surname>Rajasekar</surname><given-name>N.</given-name><initials>N.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:10139118700</author-url><authid>10139118700</authid><authname>Hanif K.</authname><surname>Hanif</surname><given-name>Kashif</given-name><initials>K.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:10139118700</author-url><authid>10139118700</authid><authname>Hanif K.</authname><surname>Hanif</surname><given-name>Kashif</given-name><initials>K.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8651405600</author-url><authid>8651405600</authid><authname>Nath C.</authname><surname>Nath</surname><given-name>Chandishwar</given-name><initials>C.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8651405600</author-url><authid>8651405600</authid><authname>Nath C.</authname><surname>Nath</surname><given-name>Chandishwar</given-name><initials>C.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7202274115</author-url><authid>7202274115</authid><authname>Shukla R.</authname><surname>Shukla</surname><given-name>Rakesh</given-name><initials>R.</initials><afid>60030536</afid><afid>113888869</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7202274115</author-url><authid>7202274115</authid><authname>Shukla R.</authname><surname>Shukla</surname><given-name>Rakesh</given-name><initials>R.</initials><afid>60030536</afid><afid>113888869</afid></author><authkeywords>Hypertension Lipopolysaccharide Neuroinflammation Memory impairment Angiotensin converting enzyme Perindopril</authkeywords><intid>1035789191</intid><source-id>21197</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927661144"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927661144?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927661144&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927661144&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0091743515000900"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927661144</prism:url><dc:identifier>SCOPUS_ID:84927661144</dc:identifier><eid>2-s2.0-84927661144</eid><dc:title>Association of self-perceived body image with body mass index and type 2 diabetes-The ADDITION-PRO study</dc:title><dc:creator>Bjerggaard M.</dc:creator><prism:publicationName>Preventive Medicine</prism:publicationName><prism:issn>00917435</prism:issn><prism:eIssn>10960260</prism:eIssn><prism:volume>75</prism:volume><prism:pageRange>64-69</prism:pageRange><prism:coverDate>2015-06-01</prism:coverDate><prism:coverDisplayDate>June 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ypmed.2015.03.018</prism:doi><pii>S0091743515000900</pii><dc:description>© 2015 Elsevier Inc. Objective: Weight loss is important for prevention of type 2 diabetes and an accurate self-perceived body image can promote weight reduction. We evaluated the association of self-perceived body image with body mass index (BMI) and type 2 diabetes. Methods: Data from the Danish ADDITION-PRO cohort study (2009-2011) were used. A total of 2082 men and women attended a health examination including assessment of BMI, waist circumference, the Stunkard scale of self-perceived obesity and an oral glucose tolerance test for assessment of diabetes risk. Results: Mean (SD) age was 66.2 (6.9) years and 24% were obese (BMI ≥30kg/m&lt;sup&gt;2&lt;/sup&gt;). However, only 7% of obese men and 11% of obese women perceived themselves as obese. Among obese women, for a given level of BMI and waist circumference, one unit higher self-perceived body image was associated with 52% (95% CI: 14-73) lower risk of having type 2 diabetes and 45% (95% CI: 12-65) lower risk of having pre-diabetes. Overweight, but not obese, men had a 35% (95% CI: 36-56) lower risk of type 2 diabetes per unit increase in body image. Conclusions: Obese individuals seem to underestimate their body shape. However, having a realistic body image (higher self-perceived obesity) is independently associated with lower diabetes risk. Self-perceived body image might serve as a valuable tool for type 2 diabetes risk assessment.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016428</affiliation-url><afid>60016428</afid><affilname>Steno Diabetes Center</affilname><name-variant>Steno Diabetes Center</name-variant><affiliation-city>Gentofte</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029616</affiliation-url><afid>60029616</afid><affilname>Aarhus Universitet</affilname><name-variant>University of Aarhus</name-variant><affiliation-city>Aarhus</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56593043900</author-url><authid>56593043900</authid><authname>Bjerggaard M.</authname><surname>Bjerggaard</surname><given-name>Mette</given-name><initials>M.</initials><afid>60016428</afid><afid>60029616</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56593043900</author-url><authid>56593043900</authid><authname>Bjerggaard M.</authname><surname>Bjerggaard</surname><given-name>Mette</given-name><initials>M.</initials><afid>60016428</afid><afid>60029616</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55519911800</author-url><authid>55519911800</authid><authname>Philipsen A.</authname><surname>Philipsen</surname><given-name>Annelotte</given-name><initials>A.</initials><afid>60016428</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202500297</author-url><authid>7202500297</authid><authname>Jørgensen M.</authname><surname>Jørgensen</surname><given-name>Marit E.</given-name><initials>M.E.</initials><afid>60016428</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56073173700</author-url><authid>56073173700</authid><authname>Charles M.</authname><surname>Charles</surname><given-name>Morten</given-name><initials>M.</initials><afid>60029616</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8361260800</author-url><authid>8361260800</authid><authname>Witte D.</authname><surname>Witte</surname><given-name>Daniel R.</given-name><initials>D.R.</initials><afid>60029616</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55784722000</author-url><authid>55784722000</authid><authname>Sandbæk A.</authname><surname>Sandbæk</surname><given-name>Annelli</given-name><initials>A.</initials><afid>60029616</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35391292200</author-url><authid>35391292200</authid><authname>Lauritzen T.</authname><surname>Lauritzen</surname><given-name>Torsten</given-name><initials>T.</initials><afid>60029616</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:8577664900</author-url><authid>8577664900</authid><authname>Færch K.</authname><surname>Færch</surname><given-name>Kristine</given-name><initials>K.</initials><afid>60016428</afid></author><authkeywords>Body image | Body mass index | Type 2 diabetes</authkeywords><intid>1035640811</intid><source-id>17665</source-id></entry></search-results>
